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0.0 ABSTRACT 
Purpose: Recreational and elite sporting performers may look to use ergogenic aids as a 
means of improving their training ability and enhancing recovery and performance on 
competition days. New Zealand Blackcurrant Extract (NZBC) is an ergogenic aid that has 
been shown to improve endurance performance in time trial (TT) cycling protocols. Previous 
research has found significant improvements in medium duration TT performance related 
disciplines following chronic intake of NZBC over a multi-day period. Currently no research 
has addressed the potential acute effects of NZBC on similar exercise disciplines or TT 
performance under simulated altitude. The following research sought to explore the acute 
effects of NZBC intake on 10 kilometre (km) TT cycling performance. Methods: Two 
experimental studies were carried out as part of this research. The first study examined the 
acute, dose-response effects of NZBC intake on short term cycling performance following 
ingestion of 300, 600 or 900 mg of NZBC. The second study examined the influence of acute 
NZBC intake on TT cycling performance under simulated altitude. Results: Acute NZBC 
intake had a strong, significant trend towards faster TT completion (P = 0.053) and a 
significant improvement in peak power output (PO) following intake of 900 mg when 
compared to 600 mg NZBC (P < 0.05). Additionally, peak blood lactate ([La]) values and [La] 
removal were greatest following 900 mg of NZBC, indicating post-exercise recovery benefits. 
Acute NZBC intake had no significant effect on TT cycling performance at simulated altitude 
or any parameters of endurance performance when compared to a placebo (PLA). 
Conclusion: Although acute NZBC intake has no significant effects on medium duration TT 
cycling performance, further research is required to determine if these findings would be 
replicated if a chronic, dose-response intake protocol of NZBC is implemented for exercise 
under both normoxic and hypoxic conditions.  
Keywords: Blackcurrant, Cycling, Time Trial, Dose, Hypoxia 
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1.0 THESIS OVERVIEW
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1.1 THESIS JUSTIFICATION 
One of the five primary components of physical fitness is cardiorespiratory 
endurance, defined as “the ability of the circulatory and respiratory systems to supply 
fuel during sustained physical activity and to eliminate waste products after supplying 
fuel” [1]. During prolonged periods of physical activity, cardiorespiratory endurance is 
determined through the interaction of maximal oxygen uptake (VO2 max) and the [La] 
threshold, termed “performance VO2” [2]. The speed or PO that is generated at the 
point of performance VO2 determines exercise efficiency in endurance-based 
exercise disciplines [2]. For this reason, race-based athletic events have become the 
primary source of determining cardiorespiratory endurance relative to simulated 
exercise competition [3]. Short and long-term improvements in cardiorespiratory 
endurance can assist athletes performance when undertaking race-based 
performance disciplines [4].  
Regular training improves cardiorespiratory endurance and significant effects can be 
seen irrespective of age [5] or training ability [6] from baseline. Combination training 
interventions such as endurance-resistance exercise protocols can amplify these 
effects to a greater extent than a single training modality [7] over the same period of 
time. The benefits of long-term adaption are important for consistent improvements 
in endurance performance. But many athletes may seek methods of acute 
physiological stimulation as a means of giving themselves an edge both physically 
and mentally for upcoming exercise tasks, particularly in race-based performance 
events. One of these methods is the intake of ergogenic aids, especially nutritional 
supplements that contain ingredients linked to physiological adaptions leading to 
improved performance when consumed. One ergogenic aid that has been studied 
extensively in recent years is NZBC which has been shown to improve endurance 
performance in different exercise modalities and disciplines. There are still gaps 
 13 
missing in the current literature, particularly when analysing duration of intake prior to 
exercise and the environment in which individuals undertake exercise following 
intake. 
1.2 SIGNIFICANCE OF THE RESEARCH 
The two experimental studies that form the basis of this thesis aim to build on current 
areas of research that analyse the effects of NZBC intake on cardiorespiratory 
performance. Supplement use within the UK’s athletic population is widespread with 
around 48% of young elite athletes taking at least one ergogenic aid [8], a figure 
identical to a sample of elite Polish athletes [9]. A body of evidence suggests that 
intake of particular supplements in specific performance-based scenarios leads to a 
marginal but significant improvement on maximal and submaximal endurance 
performance [10]. The presented research builds on previous research firstly by 
including an endurance exercise protocol, typically similar to protocols used in 
previous research, following ergogenic aid supplementation. Secondly an acute 
supplementation protocol of NZBC with emphasis on identifying a dose-response 
effect was implemented, and lastly by analysing the effects that occur following acute 
NZBC intake on endurance performance in simulated altitude.  
The studies aim to produce novel findings in previously unresearched areas. The 
testing protocols used to achieve this were created following a review of previous 
exercise data, methodologies, results, ideas and testing procedures from peer 
reviewed research studies and literature. An extensive online review of the available 
literature relating to NZBC supplementation and human performance formed the 
development of the experimental chapters within this thesis. The findings from the 
experimental studies help to improve an athlete’s knowledge of ergogenic aid 
supplementation when it comes to cardiorespiratory based fitness and performance 
adaptions.  
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1.3 THESIS AIMS 
The subject of this thesis aims to identify immediate changes in exercise 
performance following a single bolus of NZBC during submaximal time trial cycling 
performance in a dose-dependent manner and under simulated altitude. In order for 
these aims to be met, two studies were conducted: 
Study 1: Dose Response Effects of NZBC on Endurance Cycling Performance. 
Specific aims for this study were:- 
1. To identify the magnitude of any acute physiological effects on cycling 
performance and parameters of endurance performance, including PO, 
volume of oxygen uptake (VO2) and heart rate (HR) following consumption of 
a single dose of NZBC at three different doses 
2. To identify whether the proposed effects on pre-, during and post-exercise 
variables, including resting values for HR, blood pressure, cardiac output 
(CO), total peripheral resistance (TPR) and [La] are greater following higher 
doses of NZBC  
Study 2: Acute effects of NZBC on Endurance Performance in Simulated Altitude. 
Specific aims for this study were:- 
1. To identify whether acute intake of NZBC has any effects on time trial cycling 
performance or physiological parameters under simulated altitude 
1.4 THESIS STRUCTURE 
This current section along with the literature review in section 2 forms the rationale 
and general basis for the current thesis. In section 3, the first experimental study is 
presented, designed to examine (i) the acute effects of NZBC and (ii) the dose-
response effects of NZBC on endurance cycling performance and physiological 
parameters of endurance performance. In section 4, the second experimental study 
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is presented, designed to examine the influence of acute NZBC intake on endurance 
performance in simulated altitude. Section 5 forms the final part of the thesis and 
summarises the findings from the two research studies, compares the results relative 
to specific athletic populations and provides recommendations for future research in 
this area. 
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2.0 LITERATURE REVIEW 
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2.1 SYNOPSIS 
The primary aim of this review is to analyse the findings of studies which examine 
the influence of NZBC on exercise performance, specifically, the purported effects of 
supplements on exercise performance following intake. Firstly, the definition of 
endurance performance and parameters that are used to measure this type of 
performance will be discussed to identify the variables that will be analysed in the 
upcoming research studies. Following this, an introduction to ergogenic aids and the 
potential for the enhancement of endurance performance post ingestion will be 
addressed. Details focusing specifically on NZBC with regards to its nutritional 
properties and physiological processes that occur following ingestion will be 
provided. These adaptions will then be linked to the resulting enhancement of 
endurance performance. 
Following this, the effects of NZBC during cycling, particularly with regards to the 
dose-response relationship is discussed. Finally, the influence of supplements on 
exercise under simulated altitude is analysed and the potential effects following 
NZBC intake are taken into consideration. The potential effects of acute intake of 
NZBC will be taken into account in both situations. During this review, the formation 
of the study protocols and statistical analysis were formed based on the rationale 
behind previous research which included observations of exercise protocols included 
in the selected studies.   
During the construction of the literature review, a selection of key search terms were 
identified. These can be found in the appendices section, accompanying this thesis. 
2.2 LITERATURE REVIEW METHODOLOGY  
An online search was carried out on the following databases: Google Scholar, 
ResearchGate, MEDLINE, PubMed, SPORTDiscus and the Web of Science. A total 
 18 
of 391 studies published in the English language between 1986 and 2019 were 
analysed. For study inclusion, abstracts were judged against the following eligibility 
criteria: exercise, supplementation and physiological testing protocols were 
undertaken in human subjects; supplementation protocols were short term (< 6 
weeks) to acute (< 2 intake periods); and the results of NZBC consumption were 
intended for use and application in the recreational and elite athletic populations.  
Systematic review publications were included if the conclusion was defined from the 
eligibility criteria. A total of 126 abstracts were excluded from the final analysis. 
Initially, studies were excluded if the full text paper was unavailable, the research 
was not published in a peer reviewed journal, the paper formed part of a 
postgraduate thesis or if the study was not published in English language and could 
not be translated. In terms of specific research methodology, studies initially included 
in the final  analysis were excluded if (1) animals such as laboratory rats or mice 
were selected as the study sample, (2) polyphenol consumption was not included 
and (3) the time of the intervention protocols lasted for a duration greater than 6 
weeks.. These criteria led to the exclusion of a further 54 studies. Full details of the 
production of the literature review are presented in figure 1. 
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Figure 1. PRISMA flow diagram for studies included in the literature review 
Section 2.3 provides a description of cardiorespiratory fitness and how it is defined 
and measured in different populations. This includes an analysis of physiological 
factors that determine cardiorespiratory fitness, the type of exercise tests that are 
undertaken by athletes to measure these factors and how cardiorespiratory 
performance is interpreted depending on the results of exercise tests.  
Systematic Review 
Protocol: Search engines, Titles, 
Keywords, Research Questions 
Planning 
Execution 
Search: Selected Databases 
(Google Scholar, Researchgate, 
MEDLINE, PubMed, SportDiscus, 
Web of Science) 
Total records found 
(n = 391) 
 
Total records excluded 
(n = 126) 
 
Full text articles assessed 
(n = 265) 
 
Full text articles excluded 
(n = 54) 
 
Studies included in qualitative 
synthesis 
(n = 211) 
(n = 252) 
 
Exclusion Set 
• Study sample: animals/cells 
• Polyphenol consumption: absent 
• Intake period > 6 weeks 
 
 20 
Following this, section 2.4 focuses on ergogenic aid consumption as a method of 
improving cardiorespiratory performance. This includes a general overview of 
literature analysing the effects of different nutritional supplements on 
cardiorespiratory endurance, how these effects might be different in comparison to 
power and sprint-based exercise and the rate of supplementation in trained athletic 
populations. Subsections 2.4.1 and 2.4.2 specifically review antioxidant intake with 
particular reference to polyphenol intake and the effects this had on exercise 
performance following both a single intake (acute) and numerous intakes over a 
multi-day period (chronic). 
Section 2.5 provides an analysis of NZBC, an ergogenic aid with extensive, recent 
literature that has previously been shown to improve cardiorespiratory performance 
both at rest and during exercise. This includes a specification of the unique chemical 
properties and nutritional content of NZBC and the physiological adaptions 
associated with consumption over a particular period of time. Section 2.6 details 
literature specifically based on post ingestion exercise effects in cycling, running and 
rowing disciplines along with evidence for dose-response effects. 
Section 2.7 provides an analysis of literature based on exercise in hypoxia. This 
section compares fundamental differences of real altitude against simulated altitude 
protocols, the cardiorespiratory, musculoskeletal and metabolic adaptions associated 
with a reduction in VO2 and whether exercise responses in hypoxia are influenced by 
individual training status. Finally section 2.8 includes an analysis of research 
surrounding NZBC intake on exercise performance in hypoxia, antioxidant and 
polyphenol activity influencing physiological responses and adaptions to hypoxia 
exposure and the potential for changes in cognitive markers of exercise 
performance.   
 
 21 
2.3 DEFINITION AND MEASUREMENT OF ENDURANCE PERFORMANCE 
Endurance based exercises such as running, cycling or rowing, are activities that are 
undertaken to improve cardiorespiratory endurance. Performing any of these sports 
involves repetitive actions that use large muscle groups for an extended period of 
time. Oxidative phosphorylation forms the primary metabolic pathway during this 
form of exercise to regenerate adenosine triphosphate (ATP) for energy production. 
Endurance performance is the product of CO (the amount of oxygen taken around 
the body in one minute) multiplied by the arteriovenous oxygen difference (A-vO2; 
the ability of the skeletal muscles to extract oxygen) [11]. Basset and Howley [12] 
determined that endurance performance is limited by four primary factors, three of 
which are central and one of which is peripheral. These include (1) pulmonary 
diffusing capacity, (2) CO (3) the capacity of the blood to carry oxygen and (4) 
characteristics of skeletal muscle (figure 2).  
 
 
 
 
 
 
Figure 2. The Primary Physiological Factors that limit endurance performance 
in humans12 
Although measurement of VO2 max represents the greatest performance velocity 
that can be achieved during aerobic metabolism [13], cardiorespiratory endurance 
performance can be predicted to a greater extent through the use of an anaerobic 
threshold [14]. The anaerobic threshold (determined as [La] at a continuous PO that 
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does not increase greater than 1 mmol/L within 20 minutes) is deemed more 
important than onset of blood lactate accumulation (OBLA) alone with regards to 
endurance performance and exercise velocity [15].  
Although used interchangeably, OBLA represents the second significant increase in 
[La] during intensive exercise and is achieved when [La] reaches a value of 4 
millimoles per litre (mmol/L) [16]. VO2 at the anaerobic threshold contributes to 67% 
of the variance in endurance performance while the addition of HR increases this by 
up to 84% for short distance endurance events [15]. Other common thresholds 
include peak PO and power at the ventilatory and [La] thresholds [17]. Percentage of 
maximal HR (HRmax) is the most common cardiovascular (CV) threshold used for 
determining exercise intensity as a strong correlation exists between age and 
HRmax [18].  
Using the formula 208 – (0.7 X age) by Tanaka et al. [18], Percentage of HRmax 
correlated significantly with [La] threshold, [La] at a running speed of 14.5 km/h and 
peak running speed performance in recreational athletes [19]. Storen et al [20] found 
the greatest correlation with cycling TT performance was PO at the [La] threshold, 
suggesting that the exercise modality predicts which submaximal variables are most 
appropriate when determining endurance performance.  
Borszcz et al. [21] found maximal and submaximal physiological parameters tend to 
correlate significantly with TT events lasting ~60 minutes in duration in comparison to 
medium- and short-term endurance events. But evidence also suggests that mean 
PO during moderate length cycling disciplines, usually around 20 minutes in 
duration, significantly correlates to a number of similar variables, especially peak PO 
and VO2 max [21]. Chronic enhancements in metabolic thresholds are likely to have 
a positive effect on performance in ultra-endurance stipulations. Overall from an 
objective basis, a combination of specifically selected CV, respiratory and 
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biochemical measurements in combination with the most appropriate form of 
exercise is required when predicting and determining an athlete’s maximal 
performance capacity. 
Studies measuring endurance performance focus primarily on data obtained from 
VO2 measurements. From the start of exercise, the affinity of haemoglobin for 
oxygen is reduced and greater amounts are released from red blood cells into 
skeletal muscle tissue to increase the rate of oxidative phosphorylation. This results 
in an increase in the A-vO2 difference with a greater amount of oxygen brought in 
through increased respiration and less oxygen returning to the heart [22]. 
Physiological factors leading to reduced blood oxygen levels include a decrease in 
blood pH (acidosis), increased body temperature, greater levels of 2,3-
biphosphoglycerate (2,3-BPG) and an increase in the partial pressure of carbon 
dioxide (PCO2) [23].  
Measuring endurance performance presents some complications when it comes to 
the environment in which it is undertaken and characteristics of the individual 
undertaking exercise. One factor that has been studied is body mass. A study by 
Jobson et al [24] determined that cyclists with lower body mass (<65kg) can produce 
valid findings in a field-based environment. Laboratory based testing is 
recommended for heavier cyclists however due to the absence of environmental 
factors that decrease the external validity of exercise results to a greater extent than 
in cyclists of average mass. With the present research including participants with an 
average mass greater than 70kg, laboratory-based testing protocols were employed 
during the research testing period.  
2.4 ERGOGENIC AIDS AND THE USE OF BERRIES AS A SUPPLEMENT 
Athletes may aim to improve endurance performance further through the use of 
supplements, commercially available items, commonly advertised as having a 
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positive influence on multiple physical and psychological health factors [25]. 
Supplements designed to improve sports performance are generally termed 
ergogenic aids, which are defined as “any training technique, mechanical device, 
nutritional practice, pharmacological method or psychological technique that can 
improve exercise performance capacity and/or enhance training adaptions” [26].  
Following oral ingestion, nutritional supplements induce a series of hormonal, 
biochemical and musculoskeletal changes with the aim of stimulating physiological 
preparation prior to exercise, increasing efficiency during exercise and reducing 
recovery time following training [27]. These changes may occur in an acute or 
chronic manner depending on the chemical properties of the supplement and the 
length of time taken for stimulation of the affected physiological system. Based on 
limited data, maximal plasma anthocyanin concentration occurs 0.5-4 hours post 
ingestion at doses ranging between 68-1300 mg [28]. 
Ergogenic aids may include, but are not limited to vitamins, minerals, herbal 
remedies, amino acids, whey protein and caffeine [29]. Evidence suggests that 
supplementation rates are significantly higher amongst elite athletes in comparison 
to non-elite performers [30] with 58.8% of elite UK performers reporting the use of at 
least one ergogenic aid and 48.6% using more than one nutrition supplement for a 
single period of time [31]. At the elite level, the margin between success and failure 
is smaller, often by just a matter of seconds in some endurance events. A cross-
sectional analysis by Zdesar Kotnik et al. [32] revealed the primary reasons for 
supplement use included improvements in sports performance and skeletal muscle 
enhancement by male adolescents while female adolescents cited improvements in 
immune system function. 
Exercise duration has a big influence on the efficacy of a supplement. Ergogenic 
aids designed to improve performance in endurance sports, for example beetroot 
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juice (BRJ), aim to stimulate blood flow, improve mitochondrial respiration efficiency 
and VO2 kinetics whilst reducing ATP cost during muscle force production [33]. In 
contrast, ergogenic aids designed to improve performance in exercise events lasting 
<150 seconds, for example creatine monohydrate, stimulate the re-synthesis of 
phosphocreatine (PCr) and the conversion of adenosine diphosphate (ADP) to ATP 
whilst increasing the expression of Insulin-like growth factor I (IGF-I) mRNA levels 
[34].  
Ergogenic aid supplementation is not without risk given that intake with regards to 
sports performance is not endorsed and detrimental effects on long term health may 
occur with substantial, prolonged doses [35]. Intake of illegal ergogenic aids is 
especially prominent in track and field athletic events where the use of non-steroidal 
anti-inflammatory drugs (NSAIDS) is twice as high in comparison to team-based 
sports [36]. This makes the risk of testing positive for a banned substance 
considerably higher due to possible contamination from unchecked manufacturing 
processes [35]. Alongside physiological changes, psychological factors may present 
another risk with regards to supplementation.  
In a two-part study, Hurst et al. [37] concluded that athletes who use ergogenic aids 
regularly with the strong belief that they are effective are more likely to commit 
doping than short term users. Literature has concluded that when used 
appropriately, there are no safety issues or adverse effects with short term use of 
antioxidants [38], creatine [39] and multi-ingredient pre-workout supplements [40] 
over a period of a few days or weeks.  
2.4.1 ANTIOXIDANT INTAKE ON EXERCISE PERFORMANCE  
The topic of supplementation is covered extensively when it comes to analysing the 
effects of antioxidants on sporting performance [41]. Antioxidants are substances 
that are produced in the presence of radicals and other reactive oxygen species 
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(ROS) to delay the oxidation of substrates that lead to oxidative stress [42]. Fruit 
extracts are becoming popular as supplements in scientific literature due to trends in 
antioxidant capacity improvement following consumption. Naderi et al. [43] however 
argued that data supporting improvements in exercise performance are not as clear 
cut as initially thought, suggesting poor clarity when it comes to the purity and 
consistency of the extracts provided in these studies.  
2.4.2 THE USE OF BERRIES AS A SUPPLEMENT 
Polyphenols are a class of antioxidant, found primarily in plants, and are present in 
multiple food and drink products including green tea, wine, chocolate and berries 
[44]. The effects of polyphenol intake are well documented in both clinical and 
trained populations [45,46,47]. Rodriguez-Mateos et al. [45] found total cranberry 
polyphenol intake (up to 1238 mg) was associated with a dose-response effect on 
flow mediated dilation, peaking at 4 hours post intake. Following ingestion, sixty new 
metabolites were identified within plasma, twelve of which were linked to increased 
skeletal muscle blood flow. A meta-analysis from Marx et al. [46] concluded that 
there is preliminary evidence to support polyphenol-rich interventions in patients 
undergoing haemodialysis to reduce or manage cardiovascular disease risk. 
However no intervention is currently superior due to limited studies in this area.  
In a double study, Venables et al. [48] found acute supplementation with green tea 
extract increased fat oxidation by 17% during moderate intensity exercise and 
increased insulin sensitivity by 13% in healthy male participants. The focus of this 
section will include an analysis of polyphenols in berries with respect to the chemical 
structure and intake. A meta-analysis from Somerville et al. [47] consisting of 14 
studies showed mean improvements in maximal and submaximal endurance 
performance of 1.9% following 7 days of polyphenol intake. The primary samples in 
the selected studies included trained male athletes on an intervention dose of 688 ± 
478 mg per day.  
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Over the same time period, intake of Quercetin, a plant based flavanol found 
primarily in apples, cranberries and blueberries [49], improved physical performance 
in running and cycling based events by 2.8%. In one particular study involving 
inactive but healthy individuals, Khan et al. [50] found an increase in flow mediated 
dilation and plasma vitamin C concentration following intake of low and high 
polyphenol concentrated blackcurrant juice. This, in combination with a reduction in 
F2-isoprostane levels, demonstrates the potential for polyphenol intake to improve 
cardiorespiratory exercise performance by attenuating the accumulation of waste 
products in peripheral muscle.  
Although the current review involves studies that demonstrated the beneficial 
aspects of chronic polyphenol supplementation, very few studies have analysed the 
acute effects of polyphenol consumption (a single intake point) on short term 
exercise performance (< 30 minutes). Despite this, an updated review from Bowtell 
and Kelly [51] highlighted timing of polyphenol intake as a particularly important 
factor in acute studies. Studies where exercise was undertaken up to 60 minutes 
following supplement ingestion had evidenced ergogenic effects on performance [52] 
but no performance improvements were present for studies where intake was > 2 
hours prior to exercise despite an acute increase in total antioxidant capacity [53].  
Polyphenols are categorised into one of four groups (1) phenolics, (2) flavonoids, (3) 
stilbenes and (4) lignans [54]. Anthocyanins (Greek Anthos, Flower and Greek 
kyanos, dark blue) are one of six classes of flavonoids that make up the largest 
group of natural, water soluble pigments in plants [55]. Primarily these molecules are 
glycosides that bind to a sugar group including glucose, galactose, rhamnose, xylose 
or arabinose attached to an aglycon [56]. Up until 2015, more than 700 derivatives 
had been identified from 27 aglycon groups [57]. Large quantities of anthocyanins 
are found in red, blue and purple fruits including bilberries, chokeberries, raspberries 
and blackcurrants [58].  
 28 
Anthocyanins contain both anti-inflammatory and anti-oxidant properties [59] which 
may attenuate depression of sodium-potassium pump activity, one of the primary 
biochemical factors in ROS production [60]. Clinically, anthocyanin consumption is 
linked to a reduction in markers of CV disease risk [61], attributed to the reduction of 
low-density lipoproteins and the increase in cholesterol efflux [62], and the inhibition 
of cancer cell growth [63], demonstrating the benefits of polyphenol intake on cellular 
disease prevention. In an alternative finding, Giordano et al. [64] found no 
differences in cellular markers of platelet and leukocyte activation following one 
month of blood orange juice supplementation.  
With regards to recommended intake of anthocyanins, the Food and Agriculture 
organisation and the world health organisation (WHO) expert committee established 
a safe intake of 2.5 mg/kg per day of grape skin extracts [57]. However this does not 
include total anthocyanins, and values are likely to differ between other fruits 
depending on the type, quantity and quality of anthocyanins. Geographical location 
and cultural diet also affects rate of anthocyanin intake. Zamora-Ros et al. [65] 
determined that mean anthocyanin consumption was highest in Turin, Italy with 
values of 64.9 mg/day for males and 44.1 mg/day for females. The primary reason 
for this is the Mediterranean diet, adopted in Italy which includes a high portion of 
berries, red coloured fruit and vegetables and red wine [66]. 
The anti-oxidant properties in anthocyanins stimulate the release of nitric oxide (NO), 
a molecule synthesised from the amino acid L-Arginine [67] by NO synthase (NOS) 
enzymes. Neuronal and endothelial NOS stimulate the production of low levels of 
NO which help to maintain or increase vasodilation, vascular homeostasis, 
antiplatelet aggregation and neurotransmission (figure 3) [68]. In effect, NO 
increases circulating blood flow, delivering more oxygen to exercising tissues, 
leading to a reduction in oxidative stress and subsequent physical fatigue.  
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Acute intake of blueberry polyphenols increases flow-mediated dilation and pulse 
wave velocity in the brachial artery accompanied by a reduction in Nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase activity [69]. This is a biochemical 
reaction that increases production of NO [70] and correlates with levels of circulating 
polyphenol metabolites and greater flow mediated dilation. L-citrulline, a non-
essential amino acid produced alongside NO, is converted back to L-arginine to 
repeat the cycle (figure 3) [68].  
Following intake of blackcurrant anthocyanins, two biochemical events take place in 
human umbilical veins. The first is the release of NO via activation of the AKT 
pathway and phosphorylation of endothelial NO synthase (eNOS) [71]. The second 
is stimulation of the nuclear erythroid 2-related factor 2 (NRF2) pathway; NRF2 is a 
transcription factor that regulates gene expression of antioxidant proteins [72]. NRF2 
increases oxidant signalling rates leading to greater regulation of mitochondrial 
biogenesis and cellular autophagy in the event of severe, prolonged oxidative stress 
[73]. NO has a half-life between 0.1-2 seconds [74], illustrating the speed at which 
this molecule acts to stimulate the desired CV and neurological events. The CV 
effects of increased NO concentration are evident in multiple studies. 
 
 
 
 
 
 
 
Figure 3. Generation of Nitric Oxide (NO) from L-Arginine and Physiological 
Effects Depending on Tissues Levels68 
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Matsumoto et al. [75] observed a 22% increase in peripheral blood flow following 
blackcurrant intake in nine healthy male subjects. Although no differences were 
present in keyboard typing performance in both groups, biochemically anthocyanin 
intake attenuated the reduction of oxy-haemoglobin and muscular stiffness. The 
increase in NO production following blackcurrant intake leads to an increase in 
peripheral blood flow as a result of anthocyanin induced vasorelaxation and 
vasodilation [76], increasing skeletal muscle oxygen saturation (StO2) and 
attenuating the effects of muscle fatigue. This suggests a potentially ergogenic effect 
for exercise performance through the reduction of oxidative stress and fatigue. 
These fruits are also very high in levels of vitamin C and vitamin E, which have been 
shown to improve immune function and the maintenance of red blood cell structure 
respectively [77,78].  
Research also shows a psychological effect following anthocyanin consumption with 
one study reporting improved cognitive task performance and a reduction in 
monoamine oxidase-B (MAO-B) levels [79]. Inhibition of MAO-B prevents the 
breakdown of dopamine, a neurotransmitter responsible for stimulation of motor 
performance and a reduction in the energy cost of physical activity [79]. This 
biochemical effect could therefore be the mechanism behind the stimulation of the 
sympathetic nervous system, producing a psychophysiological effect that increases 
participant’s motivation to perform, thus improving performance in time trial exercise 
disciplines.  
2.5 NEW ZEALAND BLACKCURRANT EXTRACT  
Blackcurrant (Ribes nigrum L.) has been studied extensively within dietary and 
supplement-based literature in recent years. Anthocyanin content in blackcurrant is 
greater in comparison to 22 other types of fruit including cranberries, strawberries 
and blueberries [80] at an estimated 250 mg per 100 grams of fresh fruit [81]. Four 
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major anthocyanin groups make up 90% of the polyphenol structure in blackcurrant 
(1) cyanidin-3-O-glucoside, [3-10%], (2) cyanidin-3-O-rutinoside [30-45%], (3) 
delphinidin-3-O-glucoside [5-20%] and (4) delphinidin-3-O-rutinoside [35-50%] 
[82,83]. Furthermore, both rutinoside groups make up 80% of the total anthocyanin 
structure in blackcurrants [84] (figure 4). 
 
 
 
 
 
 
 
Figure 4. Chemical Structure of New Zealand Blackcurrant Anthocyanins84 
Upon ingestion, the primary phenolic metabolites, hippuric acid and ferulic acid, 
amongst other compounds appear in serum blood and urine. Serum phenolic 
metabolite concentration in plasma ranges between 10-2000 nanomoles per litre 
(nMol/L) and peaks between 2-30 hours post consumption with a half-life between 
0.5-96 hours [85]. When focusing specifically on the chemical structure of NZBC, the 
four primary anthocyanins are immediately absorbed into the blood upon 
consumption in humans with maximal plasma concentration levels between 1.25-
1.75 hours post intake [86].  
The effects each group is unique in terms of both quantity and the physiological 
adaptions that take place following intake. The primary anthocyanin in blackcurrant is 
delphinidin-3-O-rutinoside whereas cyanidin-3-glucosylrutinoside is the primary 
anthocyanin in cherry [87], suggesting different potential effects on exercise 
performance, depending on the physiological pathway. Anthocyanins are also unique 
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in terms of their effective properties in the treatment of medical conditions. 
Delphinidin is associated with a reduction in physiological markers of CV and 
metabolic disease [88] whereas cyanidin does not produce the same effect [89].  
This could provide evidence for suggesting potential benefits for exercise 
performance with both short- and long-term use. Research also links delphinidin-3-
O-rutinoside intake to an increase in glucose tolerance [90] and cyanidin-3-O-
glucoside to an increase in eNOS activity [91]. Blackcurrant intake might therefore 
prove useful in the prevention of type 2 diabetes [92] and CV disease [93], 
particularly when used in combination with a high intensity exercise programme.  
While these findings demonstrate the benefits of blackcurrant intake for sedentary 
individuals, there is currently minimal research analysing the comparative effects 
against trained performers at rest. Anthocyanin concentration is approximate 1.5 
times greater in NZBC with some new cultivars presenting concentrations as high as 
850 milligrams per 100 grams of fresh fruit [94]. This, in combination with high levels 
of Oxygen Radical Absorbance Capacity (ORAC) and vitamin C [95] suggests 
possible improvements in immune function as well as exercise performance. ORAC 
was a method of measuring antioxidant capacities in fruits through the methods of 
fluorescent quenching [96]. 
Indeed a 10% solution of blackcurrant powder from New Zealand and Poland 
inhibited four different strains of the influenza virus as determined by Ikuta et al [97]. 
By reducing the rate of viral activity within cells, there is a reduction in the risk of 
contracting upper respiratory tract infections, the most prominent of all acute 
illnesses in athletes [98]. The quality of blackcurrant yields is determined by a 
mixture of cultivar properties and environmental conditions [99]. An analysis by 
Woznicki et al [100] using the primary markers of total polyphenolic compounds, 
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anthocyanins and ascorbic acid concentration determined growth of blackcurrant 
was greatest in cool summer conditions with adequate precipitation.  
In research studies, NZBC is often taken in the form of 300 mg capsules, each 
containing 35% blackcurrant extract (105 mg), the nutritional equivalent of 85 
blackcurrants [101]. This accounts for 35% of the nutritional structure in these fruits. 
The antioxidant properties of NZBC might explain the reduction in VO2 for the same 
exercise intensity, and [La] production during incremental endurance exercise 
following consumption [102].  
2.5.1 SIMILARITIES TO BEETROOT JUICE 
The properties and proposed exercise effects of NZBC are comparable to that of 
BRJ, a supplement that contains high levels of dietary nitrate [103]. Upon ingestion, 
this ion is broken down into nitrite in the mouth before being converted into NO via 
the digestive tract. From here the same CV, metabolic and musculoskeletal effects 
take place, leading to greater exercise efficiency, greater exercise performance and 
a reduction in fatigue (figure 5) [104].  
Supplements taken in capsule form bypass breakdown in the oral cavity and take 
between 20-30 minutes to breakdown in the stomach. The delay of the physiological 
response to NZBC could influence the magnitude of any acute effect on endurance 
performance, even if such an effect exists. By increasing physiological levels of NO, 
the biochemical reactions are equivalent to those that take place following NZBC 
intake. Research suggests NO production following BRJ intake is immediate with 
effects seen 45 minutes following consumption [105]. The length of time for NO 
production following NZBC intake has yet to be studied. Studies analysing BRJ 
intake have identified improvements in exercise performance with both acute [106] 
and chronic intake protocols [107].  
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Common findings in the literature in this area includes a reduction in the oxygen cost 
of exercise [108] and improvements in mitochondrial efficiency [109]. BRJ contains 
high levels of polyphenols and antioxidant properties. A study by Wootton-Beard et 
al [110] analysing 23 different vegetable juices revealed total polyphenol and 
antioxidant levels were greatest in BRJ. A follow up study revealed a three-fold 
increase in total antioxidant capacity during the gastric phase and remaining high 
during the duodenal phase, even with a slight decrease, from a single 70 millilitre 
(ml) dose of BRJ [111]. 
 
 
 
 
 
 
 
Figure 5. Cardiovascular, respiratory and musculoskeletal processes following 
Nitric Oxide (NO) production. Dietary Nitrate (NO3-) intake acts as a production 
pathway for NO104 
2.6 EFFECTS OF NEW ZEALAND BLACKCURRANT EXTRACT ON 
EXERCISE PERFORMANCE 
A large portion of studies analysing the effects of NZBC have primarily involved 
chronic supplementation with a dose of either 300 mg or 600 mg over a period of 
seven days from trained or elite male performers. The current optimal dosing 
strategy for NZBC is unknown with doses prescribed in line with manufacturers 
guidelines. Some studies have based their selected dose period on previous 
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research looking at the effects of berry intake over a multi-day period [102,128,137]. 
As of yet, no single study has analysed the effects of both acute and chronic intake 
of berries on endurance exercise performance. This makes it impossible to compare 
the differences in the magnitude of these effects following ingestion over different 
periods of time.  
Although three studies have used female participants as part of the sample, there is 
currently minimal research concluding the effects of NZBC in untrained individuals or 
the general population. The first study to analyse NZBC intake in human participants 
was conducted by Willems et al. [102]. The participants, thirteen male triathletes, 
took either 6 grams (g) of Sujon NZBC powder or a placebo (PLA) for seven days 
prior to basic resting measurements of CV function. Despite no significant effects on 
HR and blood pressure, there was a 25% and 26% increase in CO and stroke 
volume (SV) respectively, accompanied by a 16% decrease in TPR. During two 
incremental cycling protocols, PO at OBLA was higher following NZBC in 
comparison to PLA during incremental exercise. This suggests that at the same 
exercise intensity, work can be produced for a greater amount of time due to a 
reduction of waste product accumulation in skeletal muscle tissue and increased 
peripheral blood flow.  
Research following this study has employed either the same incremental protocol, 
where participants are required to exercise until volitional exhaustion, or a time trial 
(TT) protocol which involves participants being required to complete a set distance 
as quickly as possible. It is important to differentiate the validity and impact of the 
protocol on exercise results as effect sizes suggest that a 15% improvement in time 
to exhaustion protocols translates to a 1% improvement in time trial performance 
[112].  
 36 
However, TT protocols represent a more accurate evaluation of performance due to 
greater external validity in the “real” athletic world [113]. Furthermore results from a 
laboratory based 10 km TT cycle revealed a significant correlation between average 
PO and already measured VO2 max to field-based performance when normalised to 
body mass [114]. A large portion of studies measuring the effects of NZBC on TT 
performance have exercise protocols ranging from 25-30 minutes, with TT protocols 
having a set distance of 16.1km. A full summary of the literature of NZBC intake and 
exercise performance can be found below in table 1. 
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Table 1. Systematic Review of the Effects of NZBC on Exercise Performance 
Author/s Year Subjects Background/Intervention Measures Results Summary 
Cook et al. 2017 15 
endurance 
trained male 
cyclists 
300, 600 or 900 mg NZBC 
(CurraNZTM 105, 210 or 315 mg 
ANT) for 7 days 
Alternatively PLA 
Final intake 2 hr prior to 2 hr 
cycle at 65% VO2 peak 
Randomised, counter balanced, 
Latin square study design 
2 wk washout  
VO2 
VCO2 
[La] 
RER 
CHO 
FO 
GLU 
Significant dose effect of 
FO following NZBC 
consumption compared 
to PLA.  
No significant difference 
in [La], VO2, VCO2, GLU 
between conditions. 
Dose response effect on 
CHO but no significant 
differences between 
doses 
7 day NZBC 
supplementation 
has a significant 
dose response 
effect on FO during 
2 hr cycle in 
endurance trained 
male cyclists. 
A dose response 
effect on CHO, 
although 
insignificant, is 
present between 
conditions 
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Willems et al. 2015 13 trained 
triathletes  
6g Sujon NZBC powder (138.6 
mg ANT) or PLA taken for 7 
days 
Final intake 2 hr before INC 
cycle 
Double blind, PLA controlled, 
randomised, crossover study 
design  
4 wk washout 
HR 
Plasma [La] 
BP 
SV 
CO 
MAP 
TPR 
VO2 
PO 
OBLA 
No differences in BP, 
MAP & HR at rest and 
during exercise 
Significant increase in 
SV, TPR and CO 
following NZBC 
consumption at rest but 
not during exercise  
No significant effect on 
maximal VO2 or PO 
PO at OBLA significantly 
higher following NZBC 
compared to PLA 
7 day NZBC 
supplementation 
has a significant 
effect on certain 
CV parameters at 
rest and attenuates 
the lactate 
response during 
incremental 
exercise in trained 
triathletes. 
Strauss et al. 2018 16 trained 
females 
600 mg NZBC (CurraNZTM, 210 
mg ANT) for 7 days or PLA 
Randomised, double blind, 
crossover study design 
Taken 2 hr before 2 hr cycle at 
FO 
CHO 
VO2 
Plasma NEFA 
FO significantly higher 
following NZBC 
consumption compared 
to PLA 
 
7 day NZBC 
supplementation 
significantly 
increases fat 
oxidation during 
prolonged cycling 
which could be due 
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65% VO2 max Glycerol 
RER 
Plasma NEFA and 
glycerol significantly 
higher following NZBC 
intake at rest but not 
during exercise 
No significant effect of 
NZBC on CHO oxidation 
and RER 
to an increase in 
resting NEFA and 
glycerol levels  
Cook et al. 2015 14 healthy 
men 
300 mg NZBC (CurraNZTM 105 
mg ANT) or PLA for 7 days 
Taken 2 hr prior to 16.1 km 
cycle 
Randomised, double blind, 
crossover study design 
2 wk washout 
TT 
FO 
Plasma [LA] 
BP 
Blood Glucose 
PO 
RER 
TT performance and FO 
significantly increased 
following NZBC 
consumption. Plasma 
[La] was significantly 
higher immediately 
following TT 
7 day NZBC 
consumption 
significantly 
improves both TT 
performance and 
FO during a 16.1 
km cycle  
Willems et al. 2014 9 male 
endurance 
athletes 
300 mg NZBC (CurraNZTM 105 
mg ANT) or PLA for 7 days 
16.1 km TT cycle followed by 
[La] sampling for 20 min PE 
Randomised, double blind, 
TT 
FO 
CHO oxidation 
[La] 
TT performance 
significantly improved 
following NZBC 
consumption.  
[La] clearance 
significantly greater 
7 day NZBC 
supplementation 
significantly 
improves 16.1 km 
TT cycling 
performance and 
[La] clearance 
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crossover study design 
2 wk washout  
RER 
HR 
 
following TT in NZBC 
than PLA.  
No significant difference 
on CHO oxidation, FO, 
HR & RER at any 
intensity between 
conditions 
following 
endurance 
exercise.  
 
 
Lyall et al. 2009 10 healthy 
individuals (5 
male, 5 
female)  
Single bolus of 48 g NZBC 
(Vitec, ANT (240 mg) or PLA 
taken on day of trial 
120 mg taken immediately 
before 30 min row 
120 mg taken immediately 
following exercise 
Double blind, crossover study 
design 
1 wk washout 
 
HR 
THP-1 
Plasma 
Carbonyl levels 
IL-6 
Significant reduction in 
Plasma carbonyl levels 
cytokine secretion 
following BC ANT 
consumption. 
 
 
BC ANT 
consumption 
reduces markers of 
oxidative stress 
and enhances 
immune system 
responses 
Perkins et al. 2015 13 active 
males 
300 mg NZBC (CurraNZTM, 105 
mg ANT) or PLA for 7 days 
Final intake 3 hr prior to INT 
[La] 
Running 
distance 
Significant increase in 
running distance and 
sprint performance 
following NZBC in 
7 day NZBC 
supplementation 
significantly 
improves 
 41 
running protocol 
Double blind, randomised, 
crossover study design 
2 wk washout 
Sprint 
performance 
HR 
VO2 
RPE 
comparison to PLA. 
No significant effect of 
NZBC consumption on 
HR, RPE, VO2 and [La] 
during exercise following 
NZBC 
[La] clearance 
significantly greater 
immediately following 
exercise in NZBC 
compared to PLA 
performance in 
high intensity 
intermittent 
running. 
 
This is 
accompanied with 
a significant 
increase in [La] 
clearance following 
exercise, 
suggesting 
enhanced recovery 
benefits 
Braakhuis et al. 2014 23 trained 
female 
runners 
NZBC juice powder (300 mg 
ANT, 15 mg VC) 
VC (1g) or PLA taken for 3 week 
training block 
Randomised, three treatment, 
PLA controlled, crossover study 
design 
 
Protein 
Carbonyl levels 
ASC acid 
Uric acid 
Running Speed 
5 km TT 
performance 
INC test 
Significant increase 
following VC compared 
to NZBC juice and PLA 
in protein carbonyl levels 
and oxidative markers at 
rest  
Trend towards significant 
decrease in speed 
following VC 
consumption compared 
Chronic use of VC 
significantly 
increases markers 
of oxidative stress 
which may impair 
running 
performance. 
 
Chronic intake of 
BC juice may 
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3.7 wk washout performance 
 
to BC juice and PLA improve 
performance in 
trained female 
runners.  
Murphy et al. 2017 10 trained 
male cyclists 
300 mg NZBC (CurraNZTM, 105 
mg ANT) for 7 days 
Alternatively PLA 
Randomised, double-blind, 
crossover study design 
1 wk washout 
4 km TT 
HR 
[La] 
 
Significant reduction in 
overall 4 km TT times 
following NZBC 
consumption compared 
to PLA 
No significant effect of 
NZBC consumption on 
HR or [La] at any point in 
the study 
7 day NZBC 
supplementation 
significantly 
improves repeated 
short term TT 
cycling 
performance but 
has no significant 
effect on HR or [La] 
during or after 
exercise. 
Godwin et al. 2017 24 males (15 
recreationally 
active, 9 
trained) 
600 mg NZBC (CurraNZTM, 210 
mg ANT) for 7 days 
Alternatively PLA 
Double blind, randomised, 
crossover study design 
2 wk washout 
Anaerobic sprint 
test 
performance 
FI 
 
Sprint no. 5 significantly 
faster in trained 
individuals following 
NZBC consumption 
compared to PLA. 
No significance of NZBC 
consumption on sprint 
performance in 
recreationally active 
individuals in comparison 
7 day NZBC 
supplementation 
significantly 
improves sprint 
based performance 
in trained males 
 43 
to PLA. 
Strong trend towards 
significantly lower FI 
following NZBC 
consumption in both 
trained and recreationally 
active individuals. 
Willems et al. 2016 13 healthy 
males 
300 mg NZBC (CurraNZTM, 105 
mg ANT) for 7 days 
Double blind, randomised, 
crossover study design 
1 wk washout 
Peak running 
speed 
HR 
Vertical jump 
power 
[La] 
Time to 
exhaustion 
No significant effect of 
NZBC consumption on 
HR, jump power, [La] or 
time to exhaustion. 
Strong trend for greater 
maintenance of sprint 
times in running block 4 
following NZBC 
compared to PLA. 
Significantly greater 
maintenance of sprint 
times in running block 5 
following NZBC 
compared to PLA 
7 day 
supplementation 
with NZBC may be 
beneficial in 
repeated short 
duration sprint 
based running 
performance 
Willems et al 2018 17 healthy 
Thai males 
600 mg NZBC (CurraNZTM, 210 
mg ANT) or PLA for 7 days 
Randomised, double blind, PLA 
VE 
VO2 
No significant effect of 
NZBC consumption on 
VE, VO2, BP, RER, FO, 
7 day NZBC 
supplementation 
has no significant 
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controlled, crossover study 
design 
2 wk washout 
BP 
RER 
FO 
CHO 
HR 
SV 
CO 
 
TPR 
CHO, HR, SV, CO AND 
TPR at rest or during 
exercise 
Trend towards significant 
effect on SV and CO with 
a significant difference in 
TPR during 30 minute 
exercise following NZBC 
in comparison to PLA 
effect on any 
cardiovascular, 
physiological or 
metabolic 
responses at rest 
in healthy Thai 
males. 
7 day NZBC 
supplementation 
significantly affects 
TPR during 
exercise with a 
trend towards 
significantly higher 
SV and CO in 
healthy Thai males 
   
 
 
Willems et al 2019 11 healthy 
male cyclists 
600 mg NZBC (CurraNZTM 210 
mg ANT) or PLA for 7 days 
Randomised, double-blind, 
crossover study design 
Steady state 
cycle 
TT 
No significant effect of 
NZBC consumption on 
TT performance, blood 
glucose & [La], HR, RER 
during steady state 
7 day NZBC 
supplementation 
has no significant 
effect on steady 
state exercise-
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Blood Glucose 
[La] 
HR 
RER 
VO2 
VCO2 
CHO Oxidation 
Fat Oxidation 
cycling and 16.1 km TT 
cycling performance 
induced metabolic 
parameters and TT 
cycling 
performance in 
healthy male 
cyclists under 
normobaric 
hypoxia 
 
Abbreviations: ANT (anthocyanins), AIX (augmentation index), BC (blackcurrant), BP (blood pressure), CHO (carbohydrate oxidation), CJ (cranberry juice), 
CO (cardiac output), CV (cardiovascular), DVP (Digital Volume Pulse), FAD (femoral artery diameter), FI (fatigue index), FMD (flow mediated dilation), FO 
(fatty acid oxidation), g (grams), Hb (haemoglobin), hr (hour), HR (heart rate), INC (incremental), [La] (Blood Lactate), MAP (mean arterial pressure), mg 
(milligrams), ml (millilitres), MVC (maximal voluntary contraction), NZBC (New Zealand Blackcurrant Extract), PE (post exercise), PLA (placebo), PO (power 
output), POLPH (polyphenol), PW (pulse wave), PWA (Pulse Wave Analysis), PWV (Pulse Wave Velocity), RER (respiratory exchange ratio), RPE (rating of 
perceived exertion), SMO2 (skeletal muscle oxygen saturation), SV (stroke volume), TPR (total peripheral resistance), TT (time trial), VE (ventilation), VO2 
(volume of oxygen consumption), VCO2 (volume of carbon dioxide production), VC (vitamin C), wk (week)
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2.6.1 EFFECTS ON CYCLING PERFORMANCE 
Following NZBC intake, Willems et al. [115] found a significant improvement in 16.1 
km TT performance accompanied by an increase in [La] clearance following 
exercise. These findings put forth the idea that there is an ergogenic effect on 
recovery time as well as performance following NZBC intake, providing a benefit to 
performers with busy training schedules. As the definition of recovery involves a 
multifaceted, restorative approach of physiological and psychological factors relative 
to time [116], researchers often look to use performance recovery measures, e.g. 
peak power in countermovement jump tasks and changes in submaximal HR during 
running tasks [117].  
Cook et al. [118] found a 2.4% improvement in TT performance along with an 
increase in fat oxidation of 27% during a 2 hour steady state cycle at an intensity 
eliciting 65% VO2 max in trained male cyclists following NZBC consumption (figure 
6). Both of these differences were significant in comparison to PLA. When this 
change was identified in another study by Strauss et al. [119], using twice the dose 
of NZBC compared with other studies, an associated correlation was found with a 
reduction in carbohydrate oxidation in a sample of trained female subjects.  
These changes were attributed to higher blood levels of both non-esterified fatty acid 
and glycerol pre-exercise. Performance improvements are not only limited to single 
exercise bouts, as evidenced by Murphy et al. [120] where trained male cyclists 
completed a double 4 km TT cycle 0.82% quicker following NZBC compared to PLA. 
Three of the aforementioned studies included a dose of 300 mg per day 
[115,118,120] with a 600 mg dose incorporated in the alternative study [119]. 
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Figure 6. Mean 16.1 km TT performance times following NZBC or PLA intake118   
2.6.2 EFFECTS ON RUNNING PERFORMANCE 
Findings also show an ergogenic effect on alternative endurance capacity events. In 
a study by Perkins et al. [121], running distance covered during a multiple sprint 
protocol increased significantly by 10.6%. Distance covered during active recovery 
was also higher following NZBC consumption suggesting attenuation of fatigue 
during periods of low exercise intensity. There was also a trend towards greater [La] 
clearance following 15 minutes of passive recovery, in line with research from 
Willems et al [102], suggesting recovery benefits for multiple cardiorespiratory 
exercise disciplines.  
However these findings are opposite to those of Cook et al. [122] who found no 
dose-response effect of NZBC on plasma [La] post-exercise in any condition 
following a 30 minute steady state cycle and 16.1km TT. This indicates that rate of 
physiological recovery might be affected by exercise modality, the intensity of 
exercise and the length of exercise protocols. In a study analysing sprint based 
running performance, Godwin et al. [123] found a reduction in fatigue index, 
demonstrated by a greater reduction in sprint speed in participants who were 
supplied a PLA. NZBC intake extends time to exhaustion during simulated team 
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sport activity, demonstrated by greater maintenance of running intensity during the 
Loughborough Intermittent Shuttle Run Test in trained males [124].  
2.6.3 EFFECTS ON ROWING PERFORMANCE 
Although no significant difference was found between groups for 2,000 metre rowing 
performance, a reduction in markers of superoxide dismutase and glutathione 
peroxidase, enzymes that act as oxidising agents [125], was present in individuals 
supplementing with 250 mg of a ground blackcurrant supplement in comparison to a 
PLA. These biochemical events were accompanied by an increase in total 
antioxidant capacity 24 hours following exercise, suggesting sustained enhancement 
of the immune response to physiological stressors. Ingestion of NZBC attenuated 
markers of oxidative stress immediately prior to and following a 30 min rowing TT 
[126], indicating that there is an acute effect on the level of certain biochemical 
parameters that define endurance performance following ingestion.  
These findings are replicated by Braakhuis et al. [127] who compared the effects of 
blackcurrant juice against vitamin C supplementation. Interestingly, while an 
ergogenic effect was spotted for peak running speed following blackcurrant intake, 
chronic vitamin C intake resulted in a reduction in performance and potentially 
harmful effects on immune function. Researchers found an increase in antioxidant 
markers of catalase and protein carbonyl levels markers at rest and superoxide 
dismutase levels following exercise.  
2.6.4 DOSE-RESPONSE EFFECTS OF NEW ZEALAND BLACKCURRANT EXTRACT 
Currently only two studies have analysed the dose-response effects of NZBC on 
physiological adaptions following intake [122,128]. When analysing CV parameters 
during supine rest, no differences in blood pressure, HR and ejection time were 
identified between doses. However a linear response was seen between 600 and 
900 mg for CO, SV and TPR [128]. During prolonged cycling however, a dose 
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response effect was found for decreased carbohydrate oxidation and increased fatty 
acid oxidation [122]. When compared to baseline data, individual percentage change 
in fat oxidation increased by 21.5% and 24.1% following 600 mg and 900 mg doses 
of NZBC respectively. As NZBC anthocyanins stimulate the release of NO through 
activation of eNOS, CV and respiratory parameters are stimulated in a manner that 
leads to an improvement in endurance performance.  
Although the results of NZBC intake on CV markers at rest and during exercise is 
evident in previous literature [102,128], there is currently no research regarding the 
dose-response effects of NZBC on the relation of CV markers to peripheral muscle 
fatigue during exercise. Although no effects were found for rating of perceived 
exertion (RPE) and HRmax between conditions, Potter et al. [129] found an 8% 
increase in wall hang time, a 23% increase in climb duration and a reduction in mean 
HR values across three different climb disciplines following NZBC intake in 
comparison to PLA. Rock climbing involves sustained isometric contractions, muscle 
activity in the absence of joint movement, to hold the individual in position.  
Evidence demonstrates increased arterial diameter and CO for up to 120 seconds 
during a voluntary isometric contraction [130] following NZBC intake. This reduces 
the rate of fatigue by increasing peripheral blood flow, an initial finding by Matsumoto 
et al. [75]. Therefore future research should analyse whether this remains the case 
during cycling, an exercise modality involving concentric muscular contractions, and 
whether changes in variables including [La], StO2 and interleukin-6 are linear 
following higher doses of NZBC. 
2.6.5 EFFECTS OF NZBC ON POST-EXERCISE RECOVERY 
While literature on the effects of NZBC prior to and during exercise is evident, 
Hutchison et al. [131] produced research findings suggesting post exercise recovery 
benefits. Reductions in post exercise creatine-kinase and ORAC levels were evident 
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48 hours post exercise with lower interleukin-6 levels at 24 hours post exercise, 
suggesting reduced muscle damage, inflammation and oxidative stress. Another 
study found a reduction in post-exercise plasma oxidative activity and carbonyl levels 
in combination with maintained neutrophil function following intake of NZBC, 
suggesting attenuation of innate immunity damage [132].  
Some research suggests endurance performance remains affected 48 hours 
following exercise induced muscle damage, with reduced VO2 uptake and PO during 
a 15 min TT cycle as well as increased minute ventilation at the ventilatory threshold 
[133]. This suggests that optimal recovery following exercise is a minimum of two 
days. Future research should involve post-exercise ingestion of NZBC to determine 
whether recovery to a specified pre-exercise physiological state and resulting 
physical performance is affected with supplementation. A dose-response protocol 
should be implemented to determine if the rate of recovery is linear depending on the 
amount of NZBC ingested. 
2.6.6 EFFECTS OF ETHNICITY ON RESPONSES TO NZBC 
The level of physiological response to exercise and recovery following ingestion of 
NZBC may be different depending on gender or ethnicity of the research sample. A 
recent study [101] involving males from Thailand found no physiological effects 
during rest and only a greater reduction in TPR during a 30 min walking exercise. 
The authors concluded that ethnicity may act as quite a prominent factor in the 
physiological response to NZBC but as there is limited data at present, care should 
be taken with the sample chosen for research in this area.  
2.7 EXERCISE PERFORMANCE IN HYPOXIA 
Medically, hypoxia is a condition resulting from a partial or complete reduction in 
peripheral tissue oxygenation [134]. Although the terms are similar, hypoxia is not to 
be confused with hypoxemia, a condition where partial pressure of oxygen in the 
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blood is lower than normal. A commonly used method of chronically enhancing 
endurance performance is exercising in hypoxia. This is achieved most practically by 
going to an area of high altitude and training for a number of weeks in an area with 
low atmospheric levels of oxygen. This type of environment is termed hypobaric 
hypoxia (HH) and refers to an outdoor environment where lower atmospheric levels 
of oxygen result in a reduction in the fraction of inspired oxygen (FiO2). However 
because of the financial and time bound constraints of altitude training for elite 
performers, many research studies adopt a normobaric hypoxia (NH) discipline and 
achieve this by reducing FiO2 in an environment with regular atmospheric pressure 
[135].  
Acute exposure to hypoxia lowers arterial oxygen pressure (SaO2) and increases 
markers of oxidative stress including [La], plasma malondialdehyde, superoxide 
dismutase, lipid and protein oxidation, a reduction in glutathione levels and increased 
PCO2 [136]. These are generated in response to the overproduction of ROS and free 
radicals including advanced oxidation protein products. This primary physiological 
response occurs at both rest and during exercise in hypoxia [137]. The mechanisms 
associated with ROS overproduction might include mitochondrial reductive stress 
[138], increased catecholamine production [139] and activation of the Xanthine 
oxidase pathway [140].    
The detrimental effects of hypoxia are particularly prominent on the brain, an organ 
which makes up 2% of an average human’s body mass but consumes 20% of 
oxygen supplied to the body [141]. The composition and properties of NZBC which 
initiate a number of CV adaptions could alleviate symptoms of significant oxidative 
stress, which in serious cases include a reduction in oxidative phosphorylation, 
decreased blood pH and creatine phosphate levels, a collapse of ion balance and a 
reduction in cellular sodium-potassium balance and ATPase from insufficient 
cytochrome c oxidase activity [142].     
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These changes lower exercise capacity in both recreational and elite performers and 
stimulate the mechanisms leading to increases in CO and minute ventilation to a 
greater extent than exercise in normoxia [143]. This has a significant effect on 
oxygen uptake kinetics at the start and end of exercise. At the start of exercise, 
performers spend 25-30% longer during the primary VO2 component phase [144], 
represented by a sudden, sharp increase in VO2 due to increased muscle oxygen 
demand [145]. This is accompanied by a greater reduction in the amplitude of the 
slow component phase following exercise of the same intensity [144].   
Physiologically damaging effects from hypoxia are evidenced further through a 
greater number of strand breaks in deoxyribonucleic acid (DNA) molecules [146] 
during exhaustive exercise. The extent of this damage significantly increases 
following a bout of exhaustive exercise, suggesting that potential genetic defects 
could occur that lead to long term changes in cellular processes. Despite no acute 
effects on short duration sprint based performance, exposure to hypoxia leads to a 
reduction in overall endurance exercise performance of 17%, including a 16% 
reduction in TT performance [147]. Biochemical changes in mitochondrial and 
enzymatic activity increase the physiological response pathways to allow humans to 
adapt to this environment (figure 7) [148].  
The magnitude of these changes is different between hypobaric and normobaric 
conditions. A meta-analysis conducted by Coppel et al. [149] determined that minute 
and alveolar ventilation were lower in HH than NH and this was accompanied by a 
significantly greater reduction in NO. An unexpected finding was that under HH, 
blood pH levels were higher above 4,500m when compared to NH despite a greater 
presence of acute mountain sickness.  
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Figure 7. Physiological adaptions to exercise under hypobaric hypoxia at 
altitude or normobaric hypoxia (simulated altitude) via biochemical and 
enzymatic activity148 
When a prolonged reduction in SaO2 occurs, the hypoxia-inducible factor-1 (HIF-1) 
pathway is activated, creating a cascade of cellular events that lead to homeostatic 
responses via the regulation and transcription of multiple genes (figure 8) [150]. 
These include the formation of new blood vessels (angiogenesis) or cells 
(proliferation), metabolism of glucose and production of erythropoietin (EPO), a 
hormone that is released from the kidneys that stimulates red bone marrow to 
produce more red blood cells (erythropoiesis). Knaupp et al. [151] found a 50% 
increase in EPO production just four hours following acute exposure to hypoxia.  
Training status appears to heavily influence the exercise response to a reduction in 
VO2. One example from Faiss et al. [152] determined a greater decrement in VO2 
max in elite athletes in comparison to recreational performers during an incremental 
treadmill run. A correlation was also present between the VO2 max decrement and 
SaO2 levels in the elite performers only. There is also evidence that peak HR is 
decreased either due to lower oxygen tension or training status [153] with elite 
performers exhibiting lower SaO2 and a reduction in HRmax in comparison to 
recreational performers.   
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Figure 8. The Hypoxia Inducible Factor-1 (HIF-1) Pathway. In a state of cellular 
hypoxia, Prolyl Hydroxylase prevents HIF-1a binding to VHL Protein, leading to 
the formation of the hypoxia response element and subsequent genetic 
transcription150 
2.8 POTENTIAL EFFECTS OF NEW ZEALAND BLACKCURRANT 
EXTRACT IN NORMOBARIC HYPOXIA 
Given the evidence that cardiorespiratory, biochemical and cellular alterations 
associated with chronic NZBC consumption under normoxic conditions (FiO2 = 21%) 
produce an ergogenic effect on exercise performance, there is reason to suggest 
that performance under hypoxia could be enhanced to a greater extent following 
NZBC intake. To date only one study has tested this hypothesis. Willems et al. [154] 
determined that both steady state and TT cycling performance at a simulated altitude 
of 2500m (FiO2 = 15%) were not affected following seven day intake of NZBC at a 
dose of 600 mg. Fat oxidation, carbohydrate oxidation and [La] during the steady 
state cycle were also the same between conditions. Although often perceived as 
detrimental, oxidative stress regulates ventilation responses during sudden exposure 
to hypoxia lowering sudden, negative physiological effects that are associated with a 
reduction in oxygen [155]. Supplementation with antioxidants may therefore be 
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detrimental as opposed to beneficial when it comes to acclimatising and exercising in 
hypoxia. Currently there have been no studies analysing the acute effects of NZBC 
on exercise in hypoxia, particularly at high doses.  
2.8.1 ACUTE EFFECTS OF ERGOGENIC AIDS IN HYPOXIA 
The findings of Willems et al. [154] correlate with those of Macleod et al. [156] who 
found the no effects on TT cycling performance in hypoxia and normoxia following 
BRJ consumption. A study by Muggeridge et al. [157] contradicts these findings 
when, following a single 70ml intake of BRJ, performance under simulated altitude 
improved by 2.2% in comparison to a PLA. This value similarly matches the 
improvement seen in cycling performance in Lansley et al. [106] and Cook et al. 
[118] for BRJ and NZBC respectively. Intake of BRJ regulates blood flow in skeletal 
muscle tissue as determined by Masschelein et al. [158]. Under severe hypoxia 
(FiO2 = 11%), no differences were found for changes in cerebral oxidation but an 
increase in peripheral (SpO2) and muscle oxygenation was present. Potential factors 
influencing this could have included the dose of BRJ given, nitrate concentration or 
the time period between supplementation and the exercise protocol. Whether these 
differences are seen under moderate hypoxia (FiO2 = 15-16%) following acute NZBC 
consumption is yet to be proven.  
All of the aforementioned studies included a sample of trained cyclists or athletes, 
indicating that the effects of BRJ intake on exercise performance in recreationally 
active individuals is limited. The size of the sample used in these studies were small, 
typically ranging from 8-13 individuals. Therefore it is likely that with a greater 
variance in differences between the experimental and control groups, the true effects 
of BRJ on cycling performance require greater scrutiny. Unlike the current research 
on NZBC, intake of BRJ prior to the exercise was mixed with some implementing an 
acute protocol with a single bolus and others involving chronic intake over a 
specified number of days prior to exercise.  
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Particular ergogenic aids may elicit greater physiological responses to acute hypoxic 
exposure in comparison to others. A single bolus of caffeine, a popularly used 
ergogenic aid taken by around 75% of endurance performance athletes [159], 
improves cycling efficiency during a time to exhaustion test by up to 12% under 
acute NH, despite no effects on neuromuscular or central fatigue [160]. The extent of 
these proposed effects on TT based cycling performance in hypoxia is yet to be 
analysed. A study by Mariacher et al. [161] found that a concentrated supplement of 
Alpha-Ketoglutaric acid and 5-hydroxymethylfurfural reduced performance deficits 
during an incremental cycling test to exhaustion when compared to a multi-
antioxidant supplement, containing beta-carotene, ascorbic acid and riboflavin.  
In all of the aforementioned studies, no psychological measurements were 
implemented. Indeed it has been demonstrated previously that blackcurrant intake 
stimulates an improvement in motor and cognitive performance, factors leading to an 
improvement in motivation and reaction times during the digit vigilance task, 
accompanied by reductions in fatigue [162]. To date, there is no research to suggest 
detrimental effects of hypoxia on performance in cognition tests [163] despite 
significant reductions in SaO2, SpO2 and cerebral oxygenation [164].  
Certain compounds within NZBC may particularly influence in the physiological 
response. Infusion of cyanidin-3-O-glucoside into human endothelial cells reduced 
the presence of HIF-1a protein in the blood [165]. This decreases the rate of 
angiogenesis and proliferation, events associated with mRNA transcription from the 
HIF-1 pathway.  
The antioxidant compounds in NZBC may influence the breakdown of glucose for 
energy production. Ingestion of antioxidants increases the phosphorylation of 
pyruvate dehydrogenase (PDH) and reduces the rate of [La] elimination following 
sprint-based exercise [166]. PDH is an enzyme involved in the conversion of 
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pyruvate to acetyl-CoA in the presence of oxygen [167]. Acetyl-CoA is taken through 
the citric acid cycle where it releases carbon dioxide and converts ADP into ATP 
[168]. The increase in NO production and the higher antioxidant properties in 
comparison to other fruits [169] indicate the effects of NZBC intake on performance 
in hypoxia warrant further investigation.  
2.9 THESIS RATIONALE 
This review highlights the current gaps in the literature based on NZBC intake and 
endurance exercise performance. There is no study that has analysed the effects of 
a single bolus of NZBC taken 1-2 hours prior to exercise performance, the time after 
which blood plasma levels of NZBC anthocyanins peaks following intake. Currently 
only two studies have analysed the dose-response effects of NZBC with one study 
looking at CV effects at rest [128] and another looking at fat and carbohydrate 
oxidation during prolonged exercise [122]. Both studies used the same three doses 
of 300 mg, 600 mg and 900 mg. There is no study analysing the acute dose-
response effects or resulting effects on TT cycling disciplines using the same doses 
of NZBC.  
Currently there is just a single study looking at the effects of NZBC intake on TT 
performance under simulated altitude [154]. As with studies conducted under 
normoxic conditions, this study also implemented a chronic intake protocol over a 
period of 7 days. Therefore no acute intake analysis has been conducted for 
exercise participation in hypoxic conditions. Studies which included cycling as the 
exercise modality and TT as the exercise discipline have used a 16.1-km distance 
but to date no studies have yet analysed performance up to 20 minutes in duration. 
In recreational cyclists,  this translates to a distance of ~10-km where commonly 
measured parameters such as mean PO are linked to peak PO and VO2 max, 
indicating maximal performance effort over this time period. 
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The two research studies that formed the basis of the research in this thesis, cover 
previously unresearched areas in the field of NZBC in exercise performance. 
Following an analysis of existing studies, specifically the exercise procedures 
implemented, the dose ingested prior to performance and variables used to indicate 
subsequent endurance exercise performance, the protocols for the two studies were 
formed. A single bolus of NZBC was taken one hour prior to exercise to analyse 
whether acute intake of NZBC had any beneficial effects on TT cycling performance. 
Performance following three different doses was analysed to determine if any acute 
effects indicating improvements in performance were linear with higher doses of 
NZBC. The dose that had the biggest influence on TT cycling performance and 
endurance performance parameters in study 1 was used to analyse whether acute 
intake of NZBC would have a positive influence on TT cycling performance under 
simulated altitude, an environment with higher levels of oxidative stress. Mean PO, 
HR, VO2, RER, RPE and [La] at rest and post-exercise were variables that were 
included to analyse the true influences on TT performance times. 
2.9.1 AIMS AND HYPOTHESES 
Three primary aims were proposed for this thesis, (i) to identify whether there are 
any acute effects on TT cycling performance or parameters of endurance 
performance including PO, VO2 and HR following consumption of a single bolus of 
NZBC, (ii) to identify whether the proposed effects on these variables including 
resting values for HR, blood pressure, CO, TPR and [La] are greater following higher 
doses of NZBC pre-, during and post-exercise and (iii) to identify whether acute 
NZBC intake has any effects on TT cycling performance under moderate simulated 
altitude.  
The research hypothesis for study 1 was that an acute dose-response effect for TT 
cycling performance and parameters of endurance performance pre-, during and 
post-exercise would be identified and that the magnitude of these effects would be 
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significantly greater following 900 mg in comparison to 300 and 600 mg NZBC. 
Following this, the research hypothesis for study 2 was that acute intake of NZBC 
would improve TT cycling performance and parameters of endurance performance to 
a greater extent under NH in comparison to a PLA under the same conditions.  
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Abstract 
Purpose: To examine the acute dose-response effects of New Zealand Blackcurrant Extract 
(NZBC) intake on short duration time trial (TT) cycling performance & cardiometabolic 
parameters at rest and following exercise. Methods: Using a randomised, repeated 
measures, three-way cross-over design, eight physically active participants (5 males, 3 
females; Mean ± SD age 21.1 ± 3.7 years, stature 172.1 ± 6.2 cm, mass 72.3 ± 13.7 kg) 
completed three 10 km TT cycling protocols after ingesting one of three doses (CurraNZTM; 
300, 600 or 900 mg) of NZBC. During testing, heart rate (HR), power output (PO), oxygen 
consumption (VO2), and respiratory exchange ratio (RER) values were taken every km. Prior 
to exercise, cardiovascular (CV) function was measured through a number of different 
parameters (heart rate, systolic blood pressure, diastolic blood pressure, cardiac output and 
total peripheral resistance) to analyse changes pre- and post-intake (Portapres Model-2). A 
resting measurement of blood lactate [La] was taken 60 minutes following NZBC intake and 
four additional samples were collected every two minutes post exercise to analyse peak [La] 
values and recovery. Data were analysed using a selection of repeated measures ANOVA 
tests. Results: A strong trend towards significance was found for TT performance (P = 0.053, 
hr2 = 0.41) and mean PO (P = 0.073) following 900 mg NZBC. No significant effects were 
found for any CV markers or [La] between conditions at any of the respective time points. 
Conclusion: Acute intake of NZBC has no significant effects on TT-based performance or 
cardiometabolic parameters pre- and post-exercise. 
3.1 INTRODUCTION 
A dose-response relationship is defined as “an association between the dose of a 
stimulus and the incidence of a defined biological event in an exposed population” 
[170]. The most fundamental research based around this concept from an exercise 
perspective is the correlation between physical activity levels and improvements in 
physical and mental health markers [171,172] and all-cause mortality [173]. Studies 
examining this often implement a longitudinal protocol within a select section of the 
general population.  
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A large portion of research analysing the rate of improvement in race-based exercise 
performance, has included intake of performance enhancing ergogenic aids as the 
primary stimulus and trained athletes as the performance population. Many studies 
tend to include a specified dose and time period where the selected ergogenic aids 
are taken prior to exercise. Butterfield [174] stated that a dose-response relationship 
should be sought where appropriate when it comes to evaluating the true effects of 
ergogenic aids.  
Literature examining the dose effects of polyphenol intake on various physiological 
markers during exercise is limited. Grosso et al. [175] observed reductions of 6% 
and 4% in all-cause and CV disease mortality, respectively, when intake of total 
flavonoids increased by 100 mg/day linearly over a period of several years. 
Rodriguez-Mateos et al. [45] found total cranberry polyphenol intake (up to 1238 mg) 
was associated with a dose-response effect on flow mediated dilation, peaking at 4 
hours post intake. Following ingestion, sixty new metabolites were identified within 
plasma, twelve of which were linked to increased skeletal muscle blood flow. Intake 
of a specified type and dosage of polyphenols have potential to improve oxygen 
delivery to muscles [176]. This is linked with greater rates of oxidative 
phosphorylation resulting in higher levels of ATP production [177]. 
Research surrounding the use of NZBC prior to physical activity has used a mixture 
of different endurance exercise protocols based around cycling [102, 
115,118,119,120, 122], running [121,123,124,127], rowing [126] and brisk walking 
[101]. The findings for each modality produced mixed conclusions. This research 
demonstrates that the cardiometabolic adaptions and performance contributions of 
NZBC are evident over a chronic intake protocol of at least seven days. Limited data 
show a dose-response effect of NZBC intake on numerous physiological parameters 
at rest and during exercise [122,128].  
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In the first study analysing whether increasing NZBC intake influences physiological 
variables in a correlative manner, Cook et al. [128] compared changes in numerous 
CV parameters following intake of either 300, 600 or 900 mg of NZBC for 7 days. 
During rest, CO and stroke volume (SV) increased significantly at 600 and 900 mg 
per day compared to baseline. Additionally, TPR decreased linearly indicating 
possible stress reductions on the heart during the diastolic phase. The linear effects 
on cardiorespiratory parameters were supported in a follow up study by Cook et al. 
[122] who found a dose-response effect on average fat oxidation up to 900 mg 
NZBC during 2 hours of steady state cycling at 65% VO2 max.  
At exercise intensities ranging between 55-74% VO2 max, fat oxidation is the primary 
source of energy production [178]. During submaximal exercise of up to 2 hours in 
duration, it has been demonstrated that trained subjects rely on intramuscular 
triglyceride oxidation [179]. During short to medium term TT cycling performance, 
energy is generated through a combination of both aerobic and anaerobic systems 
[180] and the predominant physiological pathways are affected by pacing, which 
varies heavily at different points of race-based exercise [181]. Although Willems et 
al. [115] found an increase in [La] clearance following a 16.1-km time trial cycle 
compared to a PLA, there is no current research concluding if a dose-response 
effect exists for recovery parameters following exercise. Additionally, Cook et al. 
[122] concluded that a dose-response effect on TT based exercise protocols has yet 
to be carried out, despite evidence of fuel utilisation changes during steady state 
cycling of up to two hours in duration with higher doses of NZBC.  
Taking everything into account, this study aims to describe the influence of a single 
bolus of NZBC on changes during and recovery following medium duration TT 
cycling performance. Changes in CV parameters & [La] were measured before and 
immediately following exercise at specified time points while changes in PO, VO2 
and respiratory exchange ratio (RER) were measured during exercise. The effects of 
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acute NZBC intake on exercise performance were analysed to a greater extent 
through the comparison of three different doses taken at the same time points prior 
to exercise to determine if physiological and exercise responses would appear linear.  
A 10-km TT cycle was selected as the exercise mode based on the evidence that 
mean PO during cycling disciplines of up to 20 minutes in duration, significantly 
correlates with peak PO and VO2 max [21]. A 10-km cycle will take around 20 
minutes for recreational athletes to complete, indicating that a TT of this length will 
involve participants working at a high percentage of their maximal endurance 
capacity. This exercise modality has been selected as the exercise discipline in 
previous research listed in the literature review [107,114,156].  
The research hypothesis posed for this study was that an acute dose-response 
effect for TT cycling performance and parameters of endurance performance pre-, 
during and post-exercise would be identified and that the magnitude of these effects 
would be significantly greater following 900 mg in comparison to 300 and 600 mg 
NZBC.  
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3.2 METHODOLOGY 
3.2.1 SUBJECTS 
The number of required participants was determined on G*Power, based on the test 
hypothesis, the statistical tests to be used, the alpha value required to determine 
significance, the smallest effect size for scientific interest and the selected power 
value. The specified number of participants required to determine a statistically 
significant difference was 32. However due to time constrains, this number was not 
met. Power was calculated based on the sample size and statistics provided in 
previous studies along with a specified effect size that had to be met to indicate a 
substantial difference in the independent and dependent variables in two or more 
groups. 
Ten physically active sport and exercise science students (6 males, 4 females; Mean 
± SD Age 20.7 ± 3.9 yr, stature 171.9 ± 8.4 cm, mass 73.1 ± 16.1 kg), recruited from 
the University of Essex, volunteered to take part in this study. As part of the inclusion 
criteria, participants were required to (1) participate in moderate-high intensity sport 
or physical activity for a minimum of eight hours per week, (2) be free of any injuries 
or illnesses for a minimum of two weeks prior to the study and (3) be able to 
complete the 10 km TT cycle in < 25 minutes. Participants were excluded from the 
study if they were greater than 30 years of age, elite level performers, recreational 
smokers or if they were unable to complete the TT cycle in < 25 minutes during the 
familiarisation session.  
Participants visited the laboratory on four occasions; one screening and 
familiarisation trial followed by three supplementation trials to test the acute effects of 
a single bolus of NZBC on cycling performance. All visits were separate by a 
minimum time period of 48 hours. Throughout all points in the study, participants 
were reminded of the experimental procedures, the benefits of participation and 
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associated risks of taking part in endurance exercise. During the process of data 
collection, two participants voluntarily withdrew from testing and as a result any 
associated data or results were excluded from the results section. Eight full sets of 
data were included for the final analysis. 
For each visit, participants were instructed to arrive in an appropriate state for 
exercise which included having breakfast or lunch with at least 500ml of water 2 
hours prior to exercise. Participants were advised to abstain from intense, vigorous 
exercise within 24 hours before testing, from consuming alcohol within 12 hours 
before testing and from taking caffeine in any form within 4 hours before testing. 
Participants did not receive any financial incentive or compensation.  
3.2.2 ETHICAL APPROVAL 
All study procedures received approval by the University of Essex Ethics Committee 
for scientific research involving human subjects. The study procedures, and the risks 
and benefits of participation were provided in an informed consent sheet during the 
familiarisation session. Participants were required to sign both this and a physical 
activity readiness questionnaire (PAR-Q) to be cleared to participate in the study. 
Throughout the duration of the study, participants were allowed to withdraw at any 
point without reason or question. 
3.2.3 STUDY DESIGN 
A randomised, counter balanced, single blinded, crossover study design was 
implemented to compare the effects of three different doses of NZBC on TT cycling 
performance. As this study was aiming to identify any acute effects from the different 
NZBC dosages, a prolonged washout period (> 2 days) was not required. 
Participants performed no more than two experimental procedures in a single week. 
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3.2.4 FAMILIARISATION TRIAL AND DATA COLLECTION PROCEDURES 
The familiarisation session served to introduce participants to the testing protocol, 
the physiological measurements that would be taken and the methods with which 
data would be collected throughout their time on the study. For the first visit, stature 
(Wall Stadiometer: Seca 220, Birmingham, UK) and body mass (Scales: Seca 813, 
Birmingham, UK) were measured on three occasions to determine average values 
for both variables. Following this, resting CV parameters for HR, systolic blood 
pressure (SBP), diastolic blood pressure (DBP), CO & TPR (termed CV parameters) 
were measured using a PortaPres Model-2 blood pressure monitor (Finapres 
Medical Systems, Amsterdam, Netherlands) on the right middle finger for a period of 
90 seconds. A total of three measurements were taken to determine an average 
value. Coefficient of variation was calculated at 3.4% for HR and 4.8% for CO at rest 
based on limited data [182]. A sample of blood (20 µg) was taken from the left ear 
lobe to get a resting measurement of [La].  
Following exercise, the same CV parameters and [La] values were collected every 2 
minutes to analyse the specific time point at which [La] concentration peaked. In line 
with these measurements, rate of physiological recovery was determined via the rate 
of [La] clearance over four difference time points every 2 minutes following the 
cessation of the TT. The latter was done on the basis of research suggesting peak 
[La] values are observed between 3-8 minutes post exercise [183]. 
A warm-up was performed for five minutes at a frequency of 70-80 revolutions per 
minute. Participants were instructed to reduce speed if heart rate was greater than 
130 beats per minute. Participants then practised the 10 km time trial cycle on an 
initial air brake resistance of 3. This was done to reduce the risk of pacing error 
during the supplement trials and allowed participants an idea of the length of time it 
would take to complete the time trial.  
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During the TT, breath by breath values for VO2, VCO2 and RER were measured 
using gas analysis software (Oxycon Masterscreen CPX, Vyaire Medical, 
Basingstoke, UK) with values taken at the time point of every completed km. 
Participants were informed of the distance travelled every 0.5 km throughout the 
cycle and upon discretion, exercise intensity was changed to suit the needs of 
participants.  
All cycling protocols were performed on a Wattbike Pro Ergometer (Nottingham, UK). 
Throughout all exercise tests, HR was continuously monitored (Polar R300, Kimpele, 
Finland). VCO2 measurements were only taken for the calculation of RER and no 
future data analysis was conducted for this variable as a single variable Prior to 
every testing session, the breath-by-breath gas analyser was calibrated to known 
atmospheric gas concentrations. Calibration was achieved when concentration and 
time boundaries of oxygen and carbon dioxide were all < 0.5. Measurements of each 
[La] sample were produced using a Biosen 5030 blood analyser (Biosen C-Line 
Clinic, EKF Diagnostic, Magdeburg Germany) with a calculated coefficient of 
variation between 1.3-3% [184]. Calibration of both analysers was essential 
according to manufacturer’s guidelines to ensure measurements were valid and 
accurate.  
3.2.5 SUPPLEMENTATION TRIALS 
For the following visits, participants repeated the pre-exercise CVP measurements 
before ingesting one, two or three capsules of NZBC (one capsule – 300 mg active 
cassis, 105mg anthocyanins, 3-10% Cyanidin-3-O-Glucoside, 30-45% Cyanidin-3-O-
Rutinoside, 5-20% Delphinidin-3-O-Glucoside, 35-50% Delphinidin-3-O-Rutinoside, 
CurraNZTM, Health Currency Ltd., Surrey, UK). 60 minutes following ingestion, based 
on research suggesting peak circulatory levels of anthocyanins at this time point 
[185], a second set of CV measurements were taken along with a single resting 
measurement of [La] immediately prior to the cycle.  
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Resting [La] was taken 60 minutes following blackcurrant ingestion. During the time 
period following ingestion, participants were strictly informed not to consume 
anything other than water. The 10 km TT cycle and post exercise CV and [La] 
measurements were repeated with participants encouraged to complete the exercise 
in the quickest time possible. A full schematic representation of the testing protocol 
can be found in Figure 9. 
. 
 
 R  WU 10 km TT     
             
      
Time (min) 
Figure 9. Schematic Representation of the TT Cycling Experimental Protocol. R 
= Rest, WU = Warm Up, TT = Time Trial 
       NZBC Capsule = 300, 600, 900 mg  
       Capillary Blood Sample 
         PortaPres Cardiovascular Parameters 
 HR 
 PO, VO2, RER 
3.2.6 DATA AND STATISTICAL ANALYSIS 
Information on km completion times and PO were recorded on the Wattbike 
ergometer test file while statistics for gas data were recorded on the oxycon 
masterscreen software spreadsheet. Statistics for all variables were placed onto a 
data collection sheet, ready for analysis. All statistical analyses were completed 
using statistical package SPSS version 24.0 (SPSS Inc., Chicago, Illinois, USA). Due 
to the sample size, a Shapiro-Wilk’s test [186] was run for all variables to determine 
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if data were normally distributed. This included an inspection of histograms, normal 
Q-Q plots, box plots and skewness / kurtosis indices [187].  Data normality values 
were analysed on the “tests of normality” output under the “Shapiro-Wilk” column. If 
normality was not indicated, based on an alpha value greater than 0.05, further tests 
were run to detect outliers and a Friedman test was run as a non-parametric 
alternative for any variables or groups. If normality was determined, a series of 
repeated-measures analysis of variance (ANOVA) tests were run to determine 
differences between groups for TT, HR, PO, VO2, RER and resting [La] between 
dose conditions with post hoc Bonferroni tests for significant condition effects. 
Significance and effect size values were analysed on the test of within-subjects 
effects output. 
All values were reported as Mean ± SD. A two-way, repeated-measures ANOVA was 
run to determine significant differences in post exercise CV variables and [La] over 
the respective time points. For all statistical tests, power (1-b) was based on a value 
of 0.8 and significance was based on an alpha value lower than 0.05. Effects sizes 
with partial eta squared (hr2) were used to determine the magnitude of effect 
between measurements and time points. For hr2, effect sizes were deemed small at 
a value of 0.01, medium at 0.06 and large at 0.14. An alpha value greater than 0.05 
but lower than 0.1 (0.05 > P < 0.1) was interpreted according to guidelines set by 
Curran-Everett and Benos [188]. 
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3.3 RESULTS 
3.3.1 TT CYCLING PERFORMANCE TIMES 
There was a strong trend towards significance for quicker cycling performance times 
during the 10-km TT following 900 mg NZBC with a difference of 11.9 & 41.4 
seconds between 300 mg and to 600 mg respectively (F (2,14) = 4.89, P = 0.053, hr2 
= 0.41).  
 
 
 
Figure 10. TT completion values (Mean ± SD) for a 10 km time trial cycle 
following acute intake of NZBC  
Analysis of pacing revealed mean km completion times were quickest from km 4 to 
km 10 following 900 mg of NZBC compared to 600 mg and 300 mg NZBC. In all 
conditions, mean km completion time was quickest during km 10. 
 
 
 
 
 
Figure 11. Mean km completion times for all TT cycling protocols 
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3.3.2 PO FROM TT 
There was a trend towards significantly higher values for mean PO during the TT 
following 900 mg NZBC in comparison to 300 & 600 mg with percentage differences 
of 5.6% and 12.9% respectively (F (2,14) = 4.00, P = 0.073, hr2 = 0.36). 
 
Figure 12. PO values (Mean ± SD) during a 10 km TT cycle following acute 
intake of NZBC 
An analysis of PO values per km revealed mean values were highest following 900 
mg of NZBC between km 2 and km 10 during the TT when compared to 300 mg and 
600 mg NZBC.  
 
 
 
 
 
 
Figure 13. Mean PO values per km during a 10 km TT cycle 
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Peak PO values were significantly different between conditions (300 mg 178 ± 30.7; 
600 mg 161.9 ± 28.1; 900 mg 193.8 ± 38.8 Watts, F (2,14) = 6.49, P < 0.05, hr = 
0.48). Post hoc tests using the Bonferroni post hoc test revealed that intake of 900 
mg of NZBC elicited a slight increase in peak PO from 300 mg with a strong trend 
towards statistical significance (P = 0.053). However peak PO was significantly 
higher with 900 mg in comparison to 600 mg of NZBC (P < 0.05). A trend towards 
significance was also found between intake of 300 mg and 600 mg of NZBC (P = 
0.083). 
3.3.3 HR FROM TT 
There was no significant effect of NZBC intake on mean HR with values highest 
following 900 mg NZBC at a difference of 4.4 and 5.7 BPM between 300 mg and 600 
mg respectively (F (2,14) = 2.68, P > 0.05, hr2 = 0.28).  
 
 
 
 
 
 
Figure 14. HR values (Mean ± SD) during a 10 km TT cycle following acute 
intake of NZBC 
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3.3.4 VO2 AND RER FROM TT 
There was a trend towards lower VO2 values during the TT following consumption of 
600 mg NZBC during testing with a 10% difference between 300 mg and a 1.8% 
difference between 900 mg NZBC (F (2,14) = 2.89, P = 0.095, hr2 = 0.29). Negligible 
differences between groups for RER were present with no statistical significance (F 
(2,14) = 0.85, P > 0.05, hr2 = 0.11). 
 
 
 
 
 
 
Figure 15. Gas exchange data values for (Mean ± SD) during a 10 km TT cycle 
following acute intake of NZBC 
 
3.3.5 CV PARAMETERS AT REST 
Resting pre- and post-intake values of HR, SBP, DBP, PP, CO and TPR are 
presented in table 2. No significant interaction effects (dose x time) were found for 
any CV variables at rest (P > 0.05). When analysing main effects for dose and time 
in table 3, no significance was found for any CV variable (P > 0.05).
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Table 2. Resting values for cardiovascular parameters pre- and post-intake of NZBC  
 Time Point 300 mg 600 mg 900 mg F P hr2 
HR (BPM) Pre Intake 
Post Intake 
72.0 ± 13.4 
77.4 ± 7.6 
75.4 ± 3.0 
83.4 ± 14.9 
78.6 ± 11.0 
74.6 ± 14.7 
2.38 0.155 0.37 
SBP (mmHg) Pre Intake 
Post Intake 
127.0 ± 5.1 
121.8 ± 9.4 
118.6 ± 10.1 
124.8 ± 18.1 
114.6 ± 6.6 
128.2 ± 18.3 
2.47 0.147 0.38 
DBP (mmHg) Pre Intake 
Post Intake 
69.8 ± 3.8 
67 ± 10.0 
70.8 ± 7.7 
77.4 ± 10.0 
60 ± 6.0 
73.2 ± 15.9 
2.68 0.128 0.40 
PP (mmHg) Pre Intake 
Post Intake 
57.2 ± 2.9 
54.8 ± 14.8 
47.8 ± 7.8 
47.4 ± 16.0 
54.6 ± 10.9 
53.0 ± 9.0 
0.03 0.968 0.008 
CO (L.min-1) Pre Intake 
Post Intake 
5.6 ± 1.9 
6.1 ± 1.3 
5.7 ± 1.2 
6.8 ± 2.5 
5.8 ± 1.3 
5.9 ± 1.9 
1.05 0.395 0.21 
TPR (mmHg) Pre Intake 
Post Intake 
0.98 ± 0.25 
0.90 ± 0.16 
1.04 ± 0.28 
0.94 ± 0.23 
0.90 ± 0.16 
1.04 ± 0.54 
1.15 0.363 0.22 
 
Values are Mean ± SD, pre-intake, post-intake, 
HR = Heart Rate; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; PP = Pulse Pressure; CO = Cardiac Output; TPR = Total peripheral 
resistance; BPM = Beats per minute; mmHg = millimetres of mercury; L.min-1 = Litres per minute; hr2 = partial eta squared effect size 
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Table 3. Main Effects for Dose and Time in Resting CV Parameters Following NZBC Intake 
 
Variable Main Effect F P hr2 
HR (BPM) Time Point 
Dose 
0.506 
0.341 
0.516 
0.721 
0.11 
0.08 
SBP (mmHg) Time Point 
Dose 
1.373 
0.28 
0.306 
0.765 
0.26 
0.07 
DBP (mmHg) Time Point 
Dose 
3.66 
3.12 
0.128 
0.099 
0.48 
0.44 
PP (mmHg) Time Point 
Dose 
0.294 
1.76 
0.616 
0.233 
0.7 
0.31 
CO (L.min-1) Time Point 
Dose 
0.781 
0.333 
0.427 
0.726 
0.16 
0.08 
TPR (mmHg) Time Point 
Dose 
0.018 
0.119 
0.901 
0.889 
0.004 
0.03 
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3.3.6 CV PARAMETERS POST EXERCISE 
Post-exercise values for SBP, DBP, CO, PP & TPR are presented in table 4. There 
were no significant interaction effects (dose x time) for any CV variables following 
exercise (P > 0.05). When analysing main effects for dose and time in table 5, a 
post-hoc Bonferroni analysis revealed a significant main effect in the time point for 
TPR (P < 0.05, hr2 = 0.34) with a significant difference  in  TPR values between 2-
min and 8-min post-exercise (P = 0.03). 
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Table 4. Post exercise values for cardiovascular parameters following acute intake of NZBC 
 Time Point 300 mg 600 mg 900 mg F P hr2 
SBP (mmHg) 2 min 
4 min 
6 min 
8 min 
104.4 ± 15.7 
119.4 ± 20.1 
115.1 ± 16.3 
113.5 ± 20.0 
116.3 ± 20.1 
126.4 ± 28.0 
124.6 ± 25.5 
120.0 ± 21.1 
103.0 ± 14.5 
115.3 ± 14.8 
113.9 ± 25.0 
123.4 ± 21.3 
1.12 0.368 0.14 
DBP (mmHg) 2 min 
4 min 
6 min 
8 min 
60.5 ± 10.0 
68.5 ± 9.7 
65 ± 9.9 
66.3 ± 10.1 
73.6 ± 12.0 
73.5 ± 14.2 
73.6 ± 14.3 
72.4 ± 11.3 
62.8 ± 6.2 
69.3 ± 8.5 
69.1 ± 10.1 
73.6 ± 8.7 
1.79 0.125 0.20 
PP (mmHg) 2 min 
4 min 
6 min 
8 min 
43.9 ± 8.6 
50.9 ± 12.1 
46.5 ± 10.2 
47.3 ± 11.1 
42.6 ± 10.9 
52.9 ± 15.6 
51.3 ± 14.1 
47.6 ± 16.0 
40.3 ± 10.2 
46.0 ± 10.0 
44.8 ± 17.4 
49.8 ± 14.9 
0.89 0.508 0.11 
CO (L.min-1) 2 min 
4 min 
7.7 ± 2.2 
7.8 ± 2.0 
6.5 ± 1.8 
7.3 ± 2.3 
7.3 ± 2.5 
7.3 ± 1.9 
1.28 0.286 0.16 
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6 min 
8 min 
7.0 ± 2.2 
6.7 ± 1.7 
7.0 ± 2.2 
6.6 ± 1.7 
6.9 ± 2.0 
7.3 ± 3.1 
TPR (mmHg) 2 min 
4 min 
6 min 
8 min 
0.61 ± 0.21 
0.68 ± 0.23 
0.71 ± 0.21 
0.74 ± 0.18 
0.85 ± 0.31 
0.78 ± 0.29 
0.81 ± 0.30 
0.83 ± 0.21 
0.68 ± 0.23 
0.72 ± 0.21 
0.77 ± 0.22 
0.81 ± 0.29 
1.14 0.354 0.14 
Values are Mean ± SD, 2 min, 4 min, 6 min, 8 min 
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Table 5. Main Effects for Dose and Time in Post-Exercise CV Parameters Following Acute Intake of NZBC 
Variable Effect F P hr2 
SBP (mmHg) Time Point 
Dose 
2.426 
1.372 
0.094 
0.286 
0.26 
0.16 
DBP (mmHg) Time Point 
Dose 
1.96 
2.444 
0.151 
0.123 
0.22 
0.26 
PP (mmHg) Time Point 
Dose 
2.409 
0.374 
0.096 
0.695 
0.26 
0.05 
CO Time Point 
Dose 
1.723 
0.692 
0.227 
0.539 
0.19 
0.09 
TPR (mmHg) Time Point 
Dose 
3.614 
2.597 
0.03 
0.110 
0.34 
0.27 
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3.3.7 BLOOD LACTATE AT REST 
Following NZBC ingestion, there were no significant differences in blood [La] values 
at rest between conditions with values 14.2% & 18.5% lower following 900 mg NZBC 
in comparison to 300 mg and 600 mg respectively (F (2,14) = 0.65, P > 0.05).  
 
 
 
 
 
 
Figure 16. Resting [La] Values (Mean ± SD) Following Acute Intake of NZBC 
3.3.8 BLOOD LACTATE POST EXERCISE  
Post exercise values for [La] are presented in table 6. There was no significant 
interaction effect (dose x time) for [La] at any time point following exercise (P > 0.05). 
When analysing main effects for dose and time in table 7, a bonferroni post hoc test 
determined a significant main effect was found in [La] values for the time point for 
[La] (P = 0.011, hr2 = 0.52). 
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Table 6. Post Exercise [La] Values Following Acute Intake of NZBC 
 Time Point 300 mg 600 mg 900 mg F P hr2 
[La] (mmol/L) 2 min 
4 min 
6 min 
8 min 
7.77 ± 3.89 
7.22 ± 4.17 
6.83 ± 3.85 
6.67 ± 3.91 
6.82 ± 3.20 
6.49 ± 2.88 
5.91 ± 2.75 
5.48 ± 2.61 
7.73 ± 2.91 
7.90 ± 1.86 
7.02 ± 1.99 
6.03 ± 1.36 
0.88 0.524 0.15 
 
Values are Mean ± SD, 2 min, 4 min, 6 min, 8 min 
[La] = Blood Lactate, mmol/L = Millimoles per litre, mg = milligrams, min = minutes 
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Table 7. Main Effects for Dose and Time in Post-Exercise [La] Values Following Acute Intake of NZBC 
 
Variable Effect F P hr2 
[La] (mmol/L) Time Point 
Dose 
5.331 
0.693 
0.011 
0.523 
0.52 
0.12 
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3.4 DISCUSSION 
The dose-response relationship relates to the magnitude of change in physiological 
and psychological adaptions following an increase in the dose of an ergogenic aid. 
This is the first study to analyse acute, dose-response changes in physiological 
performance markers during exercise and recovery markers post exercise following 
a single bolus of NZBC in physically active participants. For this study, we 
hypothesised that acute intake of NZBC would induce physiological changes, leading 
to enhanced TT cycling performance. Additionally, we stated that a dose-response 
adaption would occur following NZBC intake with the magnitude of these effects 
significantly greater following 900 mg in comparison to 300 and 600 mg NZBC.  
The research hypothesis for this study was not supported by the findings but 
differences were present between the 300 mg, 600 mg and 900 mg intake protocols. 
The main finding was that a strong trend was present for significant improvements in 
TT completion times following 900 mg NZBC. When comparing overall differences 
between the mean values of each dose group, the TT protocol was completed 2.45% 
quicker following 900 mg in comparison to 600 mg and 300 mg NZBC. This figure 
matches the range of change found in performance in studies looking at the effects 
of BRJ [106] and NZBC [118].  
The difference between these two studies however is the duration of intake prior to 
exercise with Lansley et al. [106] comparing results to a PLA following a single bolus 
of BRJ while consumption of NZBC at a daily dose of 300 mg took place over a 
seven day period. Interestingly, the percentage differences determined by Lansley et 
al. [106] for 4 km and 16 km TT cycling protocols was 2.8% and 2.7% respectively 
following intake of BRJ. These are larger when compared with a 2.4% difference 
seen in Cook et al. [118] for a 16.1 km TT following intake of NZBC. This indicates 
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that although the physiological effects induced by these supplements are similar to 
each other, the length of time taken to experience beneficial adaptions to endurance 
performance is different for underlying reasons. 
The improvements in TT performance times were illustrated by an increase in mean 
PO values and significantly greater peak PO values during the TT following 900 mg 
of NZBC. When calculating overall differences between the mean values of each 
dose group, PO was 9.3% higher following 900 mg NZBC intake when compared to 
300 mg and 600 mg of NZBC. The significant increase in peak PO might suggest 
possible stimulation of anaerobic energy pathways, leading to greater exercise 
capacity. When taking pacing into account, mean km completion times were quicker 
at the end of the fourth km until the cessation of the TT following 900 mg of NZBC. 
This was accompanied by higher values for mean PO for all but one km during the 
TT when compared to both 300 mg and 600 mg of NZBC.  
It is difficult to suggest whether acute NZBC intake has any effect on muscle 
recovery post-exercise as there was no statistically significant differences in post-
exercise [La] values. However greater [La] removal was indicated at 6 min and 8 min 
time points following 900 mg NZBC. Although there was no statistical significance 
with regards to differences between groups based on the dose x time interaction, 
there is a significant main effect for time point with values significantly lower at 8 
mins post-exercise in comparison to 2 mins post-exercise following 300 mg and 900 
mg NZBC (P < 0.05, hr2 = 0.52). It appears that there is no influence on the amount 
of NZBC ingested and physiological recovery following exercise. Post exercise, [La] 
was greatest at 2 minutes post exercise following ingestion of 300 mg and 600 mg 
NZBC whereas [La] peaked at 4 minutes post exercise following 900 mg NZBC. 
Because no post-exercise performance measure was included in the present study, 
further research is needed to assess whether muscular performance is enhanced 
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following this, as well as the magnitude of these changes and the time points at 
which muscular performance peaks when exercise is repeated. 
In this study, the effects of NZBC on CV function were quantified by comparing HR, 
SBP, DBP, CO and TPR prior to and following exercise as well as HR during 
exercise. No significant dose- or time-dependent responses were found for any 
variable, indicating NZBC had no short-term effect on CV physiology. This matches 
the findings of Willems et al. [102] who found no significant differences in HR, SBP 
and DBP at rest and any CV variables during exercise with an intensity range 
between 40-80% intensity following intake of Sujon NZBC blackcurrant powder. 
Their study also found a significant increase in CO and SV alongside a reduction in 
TPR.  
These observations were not made in the current study but are present in previous 
research implementing a dose-response analysis with the same doses of NZBC on 
resting CV variables [122,128]. For example, Cook et al. [128] reported 15% and 
28% increases in CO with 7% and 18% increases in SV between a control group and 
600 mg and 900 mg per day respectively. A 20% linear decrease in TPR was also 
observed with a dose of 600 mg and 900 mg doses per day. In both dose-response 
studies by Cook et al. [122,128], the percentage differences indicate a linear 
response in effects based on dose with higher doses having a greater effect on the 
aforementioned variables with smaller doses seen with smaller doses.  
In this study, mean results for overall TT performance, PO, HR, VO2 and [La] were 
curvilinear, indicated by the dip in these parameters following 600 mg NZBC. This 
was not expected as values following 600 mg NZBC were predicted to indicate a 
moderate change in performance and these factors between 300 mg and 900 mg. 
Reasons for this could have included preparatory factors including poor sleep, 
nutritional intake prior to the trial or the time of day that the scheduled session took 
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place. Details of these factors should be compared against those of the other 
supplement trials to identify what might have been different on the days participants 
ingested 600 mg NZBC prior to exercise. 
Motivational factors might have reduced performance on the day the 600 mg trial 
took place, if for example, there were still sessions to undertake following completion 
of the 600 mg trial. With the prescription of a different number of capsules to match 
the stated dose, participants could have recognised the potential for a performance 
plateau with two capsules as opposed to three and might not have worked as hard 
as they could have done as a result. There is evidence to suggest that a lack of 
actual effect from NZBC itself might have caused no change in performance from 
baseline for this particular trial. Further research is warranted to identify whether a 
control group would determine if this was the case not only for 600 mg NZBC but for 
other doses as well. 
A comparison of the same CV variables post-exercise revealed no dose x time 
interaction for any variable. There is a significant main effect for time point in TPR 
with values higher at 8 mins post-exercise in comparison to 2 mins post-exercise 
following 300 mg and 900 mg NZBC (P < 0.05, hr2 = 0.34). The duration of the 
intake protocol would have likely affected the physiological responses to NZBC. Both 
research studies from Cook et al. [122,128] involved a chronic intake period of the 
specified doses of NZBC over a period of 7 days whereas the current study involved 
a single bolus prior to exercise. Along with this, the absence of a notable response in 
any CV or physiological variable, especially at 900 mg, is based on the suggestion 
that higher intakes of NZBC limit the physiological ability of various mechanisms in 
the breakdown and absorption of anthocyanins [189]. 
The measurements taken for CV variables may have been affected due to large 
variability between readings for each participant. At present data is limited regarding 
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coefficient of variation for SBP, DBP & TPR with only a single study analysing HR 
and CO values using a similar Finapres monitoring device [182]. Evidence also 
suggests that this method is inaccurate for the assessment of CO in the absence of 
invasive calibration [190], indicating that multiple devices are likely needed to 
accurately assess the level of CV stimulation in individuals, irrespective of whether 
this is at rest or during exercise. 
Evidence suggests that plasma concentration levels of anthocyanins peak between 
1.25-1.75 hours following blackcurrant consumption [86], possibly demonstrated by 
the increase in CO in all conditions and a reduction in resting HR following 900 mg 
NZBC. However the delay between the point at which plasma concentration of a 
supplement or its ingredients reach their highest levels and stimulation of the desired 
physiological mechanisms needs to be taken into account.  
The findings of Willems et al. [102] might explain the increase in mid-exercise PO 
during the current study. In the aforementioned study, exercise intensity was 6% 
higher at OBLA in comparison to a PLA with no effects on HR or VO2 following Sujon 
NZBC powder intake, demonstrating an improved physiological ability to buffer [La]. 
In the current study, negligible differences were seen between mean HR and VO2 
values but PO values during the TT were higher following 900 mg of NZBC. A 
reduction in resting [La] following NZBC intake might have improved exercise 
tolerance at the [La] threshold and OBLA. Although neither of these markers were 
not determined in the study, the increase in [La] removal following exercise provides 
evidence that the ability of the muscles to buffer [La] build up during exercise was 
greater following a higher intake of NZBC.  
Despite no significant differences found between any variables from a statistical 
sense, the effects of acute NZBC intake on improving TT performance by several 
seconds following 900 mg in comparison to 300 mg and 600 mg, presents a lot of 
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significance from a field-based perspective for recreational athletes. Mean time to 
complete the 10-km TT was quicker by more than 10 seconds following 900 mg 
NZBC and this was indicated by higher PO values per km throughout the TT from 
the second km of the protocol. Athletes participating in medium duration TT exercise 
disciplines might look to improve their personal best or previous performance by 2-
3%. With an improvement of 2.45% seen following 900 mg NZBC, a single bolus of 
900 mg NZBC appears suitable for improving performance in a suitable manner from 
baseline. As it appears that [La] removal increases following 900 mg NZBC, athletes 
undertaking multi-day exercise events or training sessions over several consecutive 
days might consider using this to improve physiological recovery. This will reduce the 
likelihood of experiencing post-exercise soreness and improve both physical resting 
state and exercise efficiency on subsequent days.  
For hr2 effect sizes, values were deemed small at 0.01, medium at 0.06 and large at 
0.14. The effect size for TT performance as 0.41 indicating a large effect of 900 mg 
of NZBC when compared to 300 mg and 600 mg. The largest effect size of 0.48 was 
found for peak PO, the only variable with a statistically significant difference between 
conditions. With regards to CV parameters, effect size values post-exercise were 
smaller in comparison to resting values with the exception of PP. indicating NZBC 
intake had more of an effect on participants in a resting state and thus might have 
health benefits in individuals who do not undertake regular physical activity.  
In this study, a control condition was not included, failing to fully replicate similar 
studies by Cook et al. [122,128]. If a control was included, participants would have 
undertaken the testing and exercise procedures without ingesting any form of NZBC 
with data from the same listed variables included in the final data analysis. This 
would have assisted the research by identifying whether NZBC was having any true 
effects or whether the experimental procedures were having the desired effects. It is 
therefore more difficult to draw a full conclusion on the true influence of acute NZBC 
 90 
intake on endurance exercise performance because of having a control group would 
have therefore allowed discrimination of the participant outcome from an outcome 
caused by external or psychological factors. Time and PO values per km from the 
familiarisation trial were included in the data analysis, providing some perspective on 
how the results might have looked if a control group was implemented for all 
variables.  
A greater number of participants and study costs would have been incurred as a 
result of having a control group. As participants had already completed a 
familiarisation session as part of the first testing session, including a control group 
where they would repeat the exact same protocol with no supplement ingestion, 
could have presented issues with regards to motivation to perform and return for 
subsequent sessions. This could have potentially lead to a greater dropout rate and 
power not being met. One of the aims of this study was to provide athletes already 
using ergogenic aids information regarding whether dose of NZBC automatically 
affects TT performance and endurance performance parameters post ingestion. 
From the perspective of these individuals, Including a control group would have had 
no significant value from a practical perspective if participants felt these improved 
their performance both physically and mentally.  
PRACTICAL APPLICATIONS 
Because mean TT completion times, mid-exercise PO, and [La] removal following 
exercise are greatest following 900 mg NZBC, it may be preferential for physically 
active individuals to use this ergogenic aid at the specified dose prior to training 
sessions or race based performance. By minimising fatigue during the latter stages 
of endurance-based exercise and increasing the rate of recovery post exercise, 
optimal physiological adaptions can be achieved without negative impacts on training 
ability.  
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Future studies should identify the magnitude of change in both TT based 
performance and physiological adaptions associated with a dose-response effect for 
chronic supplementation protocols. Additionally further research is required to 
determine the underlying mechanisms responsible for the production of eNOS and 
CV responses to NZBC and whether these responses are significantly greater 
following higher intakes of NZBC or differ depending on athletic status. 
LIMITATIONS 
Prior to the start of exercise and throughout the duration of the participants time on 
the study, diet was not directly controlled, possibly leading to aspects of performance 
being affected by alternative ingredients or nutrients than those present in NZBC. 
The use of capsules as opposed to fluid are likely to have delayed some 
physiological responses to the supplement, evidenced by the absence of linear 
responses to HR, TPR, SBP & DBP pre- and post-intake at rest. The consumption of 
supplements in capsule form bypasses potentially degrading properties of saliva in 
the oral cavity, and the breakdown of anthocyanins into the bloodstream is delayed 
[191]. A different number of capsules were prescribed to individuals corresponding to 
the specified doses. This provided participants with a firm idea of the dose they were 
being given on the day which might have influenced them to work harder. Future 
changes to this aspect would include giving participants a selection of gelatin 
capsules with a certain number of these containing NZBC powder with others filled 
with a placebo powder. This will be done to ensure participants remain unaware of 
the dose of NZBC they received at that moment. 
In an ideal scenario, blood samples would be taken from a skeletal muscle in either 
the arm or leg to measure the concentration of anthocyanins in the bloodstream prior 
to exercise. This would be done over multiple time points to determine a suitable 
value that has to be reached prior to when exercise can take place. The 
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measurements taken for CV variables may have been affected due to large 
variability between readings for each participant.  
At present data is limited regarding the coefficient of variation for the portapres 
model 2 for measurements of SBP, DBP & TPR and only a single study has 
calculated values for HR and CO using a similar Finapres monitoring device [182]. In 
an ideal study, a method of assessing blood flow invasively alongside a non-invasive 
technique such as a Portapres model system, will need to be incorporated together 
to accurately assess the level of CV stimulation in individuals, irrespective of whether 
this is at rest or during exercise. 
Although participants underwent welfare checks for injuries or any barriers that might 
have prevented them from undertaking exercise, participants were not asked 
whether they were taking any other ergogenic aids prior to testing. If ingestion of any 
form of performance enhancing supplement was taken for an extended period of 
time prior to the study, the effects present as a result of NZBC intake could have 
been overshadowed by the effects directly from these other ergogenic aids. One of 
the stipulations prior to exercise was to refrain from consuming alcohol within 12 
hours of testing.  
This presented potential issues with regards to the time of sessions on a scheduled 
day. Under these circumstances, participants with an afternoon or evening session 
would have been aloud to consume alcohol late into the previous evening, thus 
increasing the risk of exercise performance being impaired due to presence of 
alcohol in the blood and surrounding issues with cardiovascular or muscular function. 
Next time, a time boundary of 24 hours will be implemented to reduce the risk of 
these events.  
Prior to the study, a power analysis was conducted to determine the number of 
participants required to get a significance value of less than 0.05. With only 8 
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participants, the study was massively underpowered, leading to no statistically 
significant differences found in any variable and the true effects of NZBC unknown. 
In this study, male and female participants were involved and included altogether in 
one sample group. The absence of a comparison group analysing differences 
between sexes could have lead to noticeable differences in certain physiological 
variables going unnoticed.  
There is evidence to suggest that the menstrual cycle might affect performance 
negatively. One of the stipulations implemented in this study was that sessions for 
each individual had to be separated over a minimum period of 48 hours. Because of 
this, participants appeared for testing sessions over a period of 2-3 weeks. Because 
of this, it is likely female participants were in the middle of the menstrual cycle for at 
least one if not multiple sessions, which may have reduced their performance 
capacity depending on the phase they were in. Future analysis should involve a sex 
based comparison to fully determine if any particular trends or patterns in 
performance can be identified based on sex. 
CONCLUSION 
In conclusion, the findings in the present study provide important evidence for the 
use of NZBC as an ergogenic aid for recreational athletes, in terms of the dose-
response effects on TT cycling performance. The form that NZBC was taken, the 
dose of NZBC that was ingested, the duration of NZBC intake and the length of time 
between the bolus and exercise contributed to a strong trend in significant 
differences in mean TT performance and improved peak PO values seen following 
900 mg NZBC. At the same time, no significant differences were seen in mid 
exercise HR, VO2 and RER along with resting and post exercise [La] remaining 
unchanged between conditions. This work provides new understandings regarding 
the use of NZBC on endurance cycling related disciplines and may assist 
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recreational athletes in deciding whether to use NZBC prior to race based exercise 
performance. 
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4.0 ACUTE EFFECTS OF NEW ZEALAND BLACKCURRANT 
EXTRACT ON ENDURANCE CYCLING PERFORMANCE IN 
NORMOBARIC HYPOXIA 
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ABSTRACT 
Purpose: To examine the acute effects of New Zealand blackcurrant Extract (NZBC) on short 
duration time trial (TT) cycling performance in simulated altitude and cardiometabolic 
parameters pre- and post-exercise. Methods: Using a randomised, crossover design, 14 
physically active participants (8 males, 6 female; age 22.3 ± 3.4 years, stature 173.8 ± 7.2 
cm, mass 74.8 ± 13.4 kg) completed a 10 km TT cycle under normobaric hypoxia (NH; FiO2: 
15-16%) 60 minutes following ingestion of NZBC (CurraNZTM; 900 mg; ANT 315 mg) or a 
placebo (PLA; Three identical gelatin capsules; 900 mg). Resting measurements of blood 
pressure, heart rate (HR) and blood lactate [La] were taken 45 minutes following 
supplementation. During testing, measurements of power output (PO), heart rate (HR) and 
rating of perceived exertion (RPE) were taken at the end of every km. Tissue oxygen 
saturation (StO2) values were recorded every 0.5 km. Four additional [La] samples were 
taken every 2.5 mins post-exercise to analyse peak values and removal rates. Throughout 
the TT, acute mountain sickness symptoms were checked using the Lake Louise scale. Data 
were analysed through a series of paired samples t tests. Results: No improvements in 10 
km TT performance were observed between NZBC and PLA (NZBC: 1090.3 ± 109.7, PLA: 
1085 ± 101.2 seconds, d = 0.05, P > 0.05). Additionally, no changes found between 
conditions for HR, RPE, StO2 and [La] at rest and following exercise between conditions. 
Conclusion: acute intake of NZBC does not significantly improve 10 km TT cycling 
performance in NH. 
4.1 INTRODUCTION 
Hypoxia is defined as “any combination of reduced barometric pressure and/or a 
reduced inspired fraction of oxygen (FiO2), which ultimately results in an inspired 
partial pressure oxygen (PiO2) less than 150mmHg” [192]. Multiple training protocols 
based in and around hypoxic or high-altitude environments have been developed 
with the live-high, train-low method providing the greatest performance benefits in 
submaximal endurance exercise [193]. Performance effects during or following 
exposure to hypoxia are measured in one of two primary forms: HH, an environment 
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in which an individual is exposed to high altitude with lower barometric pressure in 
comparison to sea level (FiO2 = 20.9%; barometric pressure < 760 mmHg) and NH, 
an environment in which an individual is exposed to a reduction in FiO2 with no 
change in barometric pressure (NH: FiO2 < 20.9%; barometric pressure = 760 
mmHg) [194]. Oxygen manipulation has emerged as a popular ergogenic aid itself 
[195] and NH has developed into a popular method of determining performance in 
elite athletes under simulated altitude due to a reduction in the severity of acute 
mountain sickness (AMS) [196] and oxidative stress [197] when compared to HH.  
Acute exposure to hypoxia induces greater muscle sympathetic activity and heart 
rate responses through chemoreceptor stimulation [198] while endothelium derived 
NO production increases systemic vasodilation while reducing pulmonary 
vasoconstriction [199]. The effects of blackcurrant extract in activating NO production 
are well documented [65] with higher anthocyanin intake associated with reduced 
arterial stiffness and blood pressure, suggesting CV benefits [200]. Research into the 
acute effects of ergogenic aids on performance in hypoxia is limited with one study 
showing a 15% improvement in 6 km cycling performance and greater CV function 
following sildenafil supplementation [201]. Sildenafil, a phosphodiesterase-5 inhibitor, 
has been shown to stimulate pulmonary vasodilation [202] and is now a recognised 
treatment for primary and secondary pulmonary hypertension [203]. These effects 
are replicated under hypoxic conditions with the conversion of eNOS to NO 
optimised following a single bolus of sildenafil [204]. Following a single serving of 
BRJ, Muggeridge et al. [157] found an improvement in 10-km TT cycling 
performance under NH in trained cyclists, indicating short term CV stimulation 
through the breakdown of dietary nitrate [104]. 
Currently only one study has analysed the effects of NZBC on endurance 
performance in NH with Willems et al. [154] finding no change in any physiological 
parameters during steady state cycling at 45%, 55% and 65% VO2 max or TT cycling 
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performance following NZBC supplementation over 7 days at a dose of 600 mg in 
healthy male cyclists. This does not fall in line with previous research replicating the 
same supplementation and exercise protocols with NZBC [119] under normoxic 
conditions. Chronic antioxidant supplementation over a period of three weeks 
improved PO at the ventilatory threshold during acute exposure to high altitude [205], 
contrasting findings to those of Mariacher et al. [161]. However, a large portion of 
evidence suggests there is no effect of antioxidants on markers of oxidative stress 
[206] or exercise induced muscle damage [207] with suggestions that amino acid 
based ergogenic aids are more effective at reducing performance detriments in 
hypoxia [161].  
Taking everything into account, the current study aimed to describe the influence of 
a single bolus of NZBC on physiological and psychological changes during exercise 
performance and recovery following short duration TT cycling performance under 
simulated altitude. As study 1 was conducted under normoxic conditions, a hypoxia 
based study was selected as the follow up to analyse the acute effects of NZBC 
under simulated altitude. When compared to sea level conditions, oxygen intake will 
be significantly reduced to simulate exercising at altitude. As such, oxidative stress 
will increase and allow us to identify whether the proposed physiological adaptions 
following NZBC intake improve exercise under these conditions when compared to 
taking a PLA. Changes in [La] were measured before and immediately following 
exercise at specified time points while changes in PO, RPE and HR were measured 
during exercise. Based on the results of the previous study, a prescribed dose of 900 
mg of NZBC was selected. The research hypothesis for study 2 was that a single 
bolus of NZBC would improve TT cycling performance and parameters of endurance 
performance to a greater extent in comparison to a PLA.  
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4.2 METHODOLOGY 
4.2.1 SUBJECTS 
The number of required participants was determined on G*Power, based on the test 
hypothesis, the statistical tests to be used, the alpha value required to determine 
significance, the smallest effect size for scientific interest and the selected power 
value. The specified number of participants required to determine a statistically 
significant difference was 46. However due to time constrains, this number was not 
met. Power was calculated based on the sample size and statistics provided in 
previous studies along with a specified effect size that had to be met to indicate a 
substantial difference in the independent and dependent variables in two or more 
groups. 
Fifteen physically active individuals (9 males, 6 females; Mean ± SD age 22.1 ± 3.3 
yr, stature 173.6 ± 7.0 cm, mass 74.5 ± 13.0 kg), recruited from the University of 
Essex volunteered to take part in this study. As part of the inclusion criteria, 
participants were required to (1) participate in moderate-high intensity sport or 
physical activity for a minimum of eight hours per week, (2) be free of any injuries or 
illnesses for a minimum of two weeks prior to the study and (3) be able to complete 
the 10 km TT cycle in < 25 minutes. Although not essential, previous experience of 
training or exercise at real or simulated altitude was advantageous. Participants were 
excluded from the study if they were greater than 30 years of age, elite level 
performers, recreational smokers or if they were unable to complete the TT cycle in < 
25 minutes during the familiarisation session.  
Given the results from the previous study, a trained cyclist cohort was preferred, 
however due to difficulty in recruiting cyclists at this time, recreational or novice 
cyclists were approached. Participants visited the laboratory on three occasions, one 
screening and familiarisation trial followed by two supplementation trials to test the 
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acute effects of NZBC on cycling performance. All visits were separated by a 
minimum of 48 hours. Throughout all points in the study, participants were reminded 
of the experimental procedures, the benefits of participation and associated risks of 
taking part in endurance exercise. During the process of data collection, one 
participant voluntarily withdrew from testing and as a result any associated data or 
results were excluded from the results section. Fourteen full sets of data were 
included for the final analysis. 
Prior to each visit, participants were instructed to arrive in an appropriate physical 
state for exercise. This included having lunch or breakfast with at least 500ml of 
water 2 hours prior to the allocated testing session. Participants were advised to 
abstain from intense, vigorous exercise within 24 hours before testing, from 
consuming alcohol within 12 hours of testing and from taking caffeine in any form 
within 4 hours of testing. Participants did not receive any financial incentive or 
compensation.  
4.2.2 ETHICAL APPROVAL  
All study procedures were approved by the University of Essex Ethics Committee for 
scientific research involving human subjects. All participants were provided with an 
informed consent sheet detailing the study procedures, risks and benefits. 
Participants were also required to complete a Physical Activity Readiness 
Questionnaire (PAR-Q) to be cleared to participate in the study. Throughout the 
duration of the study, participants were allowed to withdraw at any point without 
reason or question. 
4.2.3 STUDY DESIGN  
A counterbalanced, single blinded, crossover study was implemented to compare the 
effects of 900 mg of NZBC on exercise performance in simulated altitude. As this 
study was aiming to identify any acute effects from NZBC intake, a prolonged 
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washout period (> 2 days) was not required. Participants performed no more than 
two experimental procedures in a single week.  
4.2.4 FAMILIARISATION TRIAL AND DATA COLLECTION PROCEDURES 
As with study 1, prior to the supplementation trials, a familiarisation session was 
implemented to introduce participants to the testing protocol, the physiological 
measurements that would be taken and the methods through which data would be 
collected throughout their time on the study. For the first visit, stature (Wall 
Stadiometer: Seca 220, Birmingham, UK) and body mass (Scales: Seca 813, 
Birmingham, UK) were measured on three occasions to determine an average value. 
Following this, resting measurements of SBP, DBP, HR, [La] and hydration were 
taken. BP and HR were measured using an upper arm cuff connected to an 
electronic monitor (Omron M2, Kyoto, Japan). A total of three measurements were 
taken to determine an average value.  
A sample of blood (20 µg) was taken from the left ear lobe and analysed for a resting 
measurement of [La]. Following exercise, [La] was measured every 2.5 minutes to 
analyse the point of peak [La] concentration. Rate of recovery was measured via the 
rate of [La] clearance over 4 different time points following cessation of the TT. 
Hydration was measured following the provision of a urine sample (90 ml) by 
participants using a portable analysis unit (Osmocheck-CRANLEA; Vitech Scientific, 
West Sussex, UK). Tests were repeated following additional hydration if a reading 
greater than 900 milliosmoles per kg body mass (mOSM/kg) was produced. 
Following all resting measurements, participants underwent a 15 min familiarisation 
breathing in hypoxic air generated from a Cloud9 simulated altitude generator (15-
16% FiO2; Sporting Edge Ltd., Basingstoke, UK).  
A warm-up was performed for five minutes at a frequency of 70-80 revolutions per 
minute. Participants were instructed to reduce speed if HR was greater than 130 
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beats per minute. Participants then undertook the 10 km time trial cycle on an initial 
air brake resistance of 3. This was done to reduce the risk of pacing error during the 
supplement trials and allowed participants an idea of the length of time it would take 
to complete the time trial. During the TT, PO, HR and RPE were collected every km. 
Participants were informed of the distance travelled every 0.5 km throughout the 
cycle and upon discretion, exercise intensity was changed to suit the needs of 
participants. 
As with study 1, all cycling protocols were conducted on a Wattbike Pro ergometer 
(Nottingham, UK). Throughout all exercise tests, heart rate was continuously 
monitored using a short-range telemetry monitor (Polar R300, Kimpele, Finland). 
Tissue oxygen saturation (StO2) was measured continuously using a pulse oximeter 
connected to the Cloud9 generator with measurements collected every 0.5 km 
during the test. Values were displayed on a screen along with HR values with 
changes seen every 10 seconds. Exercise tests were terminated with immediate 
effect if StO2 dropped below 75% for longer than 15 seconds.  
Prior to exercise, participants were familiarised with the Lake Louise acute mountain 
sickness (AMS) scale [208] for detrimental symptoms related to hypoxia exposure 
and the 6-20 RPE Borg scale [209] for subjective feelings of work rate. The AMS 
scale was only used for screening and participant welfare purposes and no future 
data analysis was conducted for this variable. Following exercise, [La] samples were 
collected on four occasions at separate 2.5 min time points. This was done on the 
basis of research suggesting that peak [La] values are observed between 3-8 
minutes post exercise [183] and was measured for the purpose of determining both 
the specific time point at which [La] peaked and the rate of recovery via [La] 
clearance. Measurements of each [La] sample were produced using a Biosen 5030 
blood analyser (Biosen C-Line Clinic, EKF Diagnostic, Magdeburg, Germany) with a 
calculated coefficient of variation between 1.3-3% [184], according to manufacturers 
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guidelines. Calibration of the analyser was essential according to manufacturer’s 
guidelines to ensure measurements were valid and accurate. 
4.2.5 SUPPLEMENTATION 
For the following visits, participants repeated the pre-exercise BP, HR, hydration and 
[La] measurements before ingesting either 900 mg NZBC (Three capsules - 900 mg 
active cassis, 315 mg anthocyanins, 3-10% Cyanidin-3-O-Glucoside, 30-45% 
Cyanidin-3-O-Rutinoside, 5-20% Delphinidin-3-O-Glucoside, 35-50% Delphinidin-3-
O-Rutinoside, CurraNZTM, Health Currency Ltd., Surrey, UK) or a placebo (3 similar 
looking opaque gelatine capsules, Cornflour 900mg; PLA). 45 minutes following 
ingestion, resting BP, HR and [La] were taken prior to a 15 minute air familiarisation. 
60 minutes post ingestion, based on research suggesting peak circulatory levels of 
anthocyanins at this time point, participants repeated the 10 km TT cycle and post 
exercise [La] measurements. A full schematic representation of the study is 
presented in figure 17.  
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Figure 17. Schematic Representation of the TT Cycling Protocol. R = Rest, WU 
= Warm up, TT = Time Trial  
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4.2.6 STATISTICAL ANALYSIS 
Information on km completion times and PO were recorded on the Wattbike 
ergometer test file while statistics for oxygen output data were indicated on a sensor 
connected to the Cloud9 altitude generator. [La] values were analysed following. 
Statistics for all variables were placed onto a data collection sheet, ready for 
analysis. As with study 1, all statistical analyses were completed using SPSS version 
24.0 (SPSS Inc., Chicago, Illinois, USA). A series of paired samples t-tests were run 
to determine differences between treatments for TT, HR, PO, RPE and resting [La]. 
Data normality was checked using a Shapiro-Wilks test [186] and included an 
inspection of z score values, histograms, normal Q-Q plots, box plots and skewness 
/ kurtosis indices [187]. Data normality values were analysed on the “tests of 
normality” output under the “Shapiro-Wilk” column. If normality was not detected, 
based on an alpha value greater than 0.05, a Wilcoxon signed-ranked test was used 
as a non-parametric alternative to any variables or groups. Effects sizes with Cohens 
d (d) were used to determine the magnitude of effect between measurements and 
time points.  
For d, effect sizes were deemed small at a value of 0.2, medium at 0.5 and large at 
0.8. A two-way repeated-measures ANOVA test was run to determine significant 
differences in post exercise [La] over respective time points. For all statistical tests, 
power (b-1) was based on a value of 0.8 and significance was based on an alpha 
value lower than 0.05. Significance values were analysed on the paired samples test 
output. D was calculated by subtracting the mean difference identified in the control 
group (PLA) from the supplement group (NZBC) and dividing this value by the 
pooled standard deviation. An alpha value greater than 0.05 but less than 0.1 (0.05 > 
P < 0.1) was interpreted according to guidelines set by Curran-Everett & Benos 
[188]. 
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4.3 RESULTS 
4.3.1 TT CYCLING PERFORMANCE TIMES 
There was a difference of 5.3 seconds between conditions with no significant 
statistical difference in the time to complete the 10 km cycle under NH (t (13) = 0.66, 
d = 0.05, P > 0.05) (figure 18). Pacing values remained consistent for each km 
between conditions throughout the TT with a notable increase in speed during km 10 
(figure 19). 
 
 
 
 
 
 
Figure 18. Time to completion values (Mean ± SD) for a 10 km time trial cycle 
under NH following acute intake of NZBC or PLA 
 
 
 
 
 
 
 
Figure 19. Mean km completion times following intake of NZBC or PLA under 
NH 
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4.3.2 PO FROM TT 
There was a negligible difference of 0.01% between conditions for peak PO (NZBC: 
203.9 ± 55.3; PLA: 201.6 ± 56.2 watts, t (13) = 0.41, d = 0.04, P > 0.05) and 0.02% 
between conditions for mean PO during the 10-km time trial cycle (t (13) = -0.99, d = 
-0.07 P > 0.05) (figure 20). PO values per km remained consistent between 
conditions at most time points with a linear increase in values between km 8 and km 
10 (figure 21). 
 
Figure 20. Power output values (Mean ± SD) during a 10 km TT cycle under NH 
following acute intake of NZBC or PLA 
 
 
 
 
 
 
Figure 21. Mean PO values per km during a 10 km TT cycle under NH  
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4.3.3 HR FROM TT 
Both mean and peak HR during the 10 km TT cycle remained unchanged between 
conditions with a difference of 0.2 (t (13) = 0.08, d = 0.02, P > 0.05) and 0.7 BPM 
respectfully (t (13) = 0.48, d = 0.05, P > 0.05). 
 
 
 
 
 
Figure 22. Mid exercise and peak HR values (Mean ± SD) during a 10 km TT 
cycle under NH following acute intake of NZBC or PLA 
4.3.4 RPE FROM TT 
Mean RPE scores during exercise remained unchanged between conditions (NZBC: 
12.7 ± 2.4; PLA 12.4 ± 2.5, t (13) = 1.05, d = 0.12, P > 0.05). For all conditions, there 
was a linear increase in values per km between conditions.  
 
 
 
 
 
Figure 23. Mean RPE values per km during a 10 km TT cycle under NH for all 
conditions 
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4.3.5 TISSUE O2 SATURATION FROM TT 
During the TT, average FiO2% values were 15.2 ± 1.2 for NZBC and 15.0 ± 0.9 for 
PLA, simulating an altitude of approximately 2,700 metres. There was no significant 
difference in mean StO2 values across the TT between conditions (NZBC: 91.2 ± 3.3; 
PLA: 92.4 ± 3.8 StO2, t (13) = -1.39, d = -0.34, P > 0.05).  
4.3.6 HEART RATE & BLOOD PRESSURE DURING REST 
A difference of 1.8% was seen between conditions for resting HR with no statistical 
significance (NZBC: 61.1 ± 9.6; PLA: 60.0 ± 7.7 BPM, t (13) = 0.59, d = 0.13, P > 
0.05). A 3% difference was observed between conditions for SBP (t (13) = 1.43, d = 
0.37, P > 0.05) while a difference of 4.5% was observed between conditions for DBP 
(t (13) = 1.40, d = 0.35, P > 0.05).  
 
 
 
 
 
 
Figure 24. Resting values for systolic and diastolic blood pressure (Mean ± SD) 
following acute intake of NZBC or PLA 
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4.3.7 BLOOD LACTATE AT REST 
There was no significant difference in [La] values at rest between conditions with 
values 9.1% lower following NZBC in comparison to PLA (t (13) = -0.91, d = -0.30, P 
> 0.05).  
 
 
 
 
 
Figure 25. Resting [La] Values (Mean ± SD) Following Acute Intake of NZBC or 
PLA 
 
4.3.8 BLOOD LACTATE POST EXERCISE 
Post-exercise values for [La] are presented in table 8. There was no significant 
interaction effect (Condition x time) for [La] at any time point following exercise (P > 
0.05). When analysing main effects for dose and time in table 9, a bonferroni post 
hoc test determined a significant main effect was found in [La] values for the time 
point (P = 0.00, hr2 = 0.42). 
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Table 8. Post Exercise [La] Values Following Exercise under NH  
 
 
 
 
 
 
Values are Mean ± SD, 2.5 min, 5 min, 7.5 min, 10 min 
[La] = blood lactate, NZBC = New Zealand Blackcurrant Extract, PLA = Placebo, min = minutes 
 
 
 
 
 
 
 
 Time Point NZBC PLA F P hr2 
[La] (mmol/L) 2.5 min 
5 min 
7.5 min 
10 min 
6.45 ± 3.13 
6.73 ± 3.28 
6.15 ± 2.92 
5.78 ± 2.99 
6.70 ± 3.64 
6.60 ± 3.34 
6.63 ± 3.37 
5.60 ± 3.09 
0.95 0.426 0.07 
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Table 9. Main Effects for Condition and Time in Post-Exercise [La] Values Following Acute Intake of NZBC or PLA 
 
Variable Effect F P hr2 
[La] (mmol/L) Condition 
Time 
0.006 
9.483 
0.941 
0.000 
0.000 
0.422 
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4.4 DISCUSSION 
This is the first study to characterise TT endurance performance under NH following 
acute consumption of NZBC in recreational athletes. For this study, we hypothesised 
that acute intake of NZBC would induce physiological changes, leading to enhanced 
TT cycling performance under NH and that the changes would be significantly 
greater in comparison to a PLA. The results showed no significant improvement in 
TT performance between NZBC and PLA. Differences in values for mean PO, StO2 
and RPE during the TT, resting values of SBP, DBP and HR and post-exercise 
values for [La] were negligible between conditions matching the findings of Willems 
et al. [154]. Intake duration prior to performance was the primary difference between 
these two studies with a single bolus of 900 mg NZBC incorporated in this study 
while intake of 600 mg NZBC over a period of 7 days was used in Willems et al. 
[154]. Therefore the research hypothesis for this study was not supported by the 
findings. The sample used in the current study included 14 recreationally active 
participants, similar to the size and training status used in Willems et al. [154] who 
included 11 healthy cyclists. 
The sample used in this study were recreationally active individuals, with limited 
experience of exercise either at altitude or hypoxia. Faiss et al. [152] concluded that 
the physiological responses to simulated altitude are heavily affected by training 
status, demonstrated by a greater detriment in SpO2 and VO2 max in elite athletes 
when compared to recreational athletes. Because of the limited experience the study 
sample had with prior simulated altitude exercise, the effects of sudden exposure to 
hypoxia could have generated a bigger effect on performance than NZBC itself. 
Objective measurements of anthocyanin concentration in the bloodstream alongside 
additional markers of the physiological responses to hypoxia could have provided 
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greater insight into the true effects of NZBC based on the level of inter-individual 
variability.  
With regards to ergogenic aid supplementation in trained athletes, previous research 
has demonstrated a mixture of conclusions with one study reporting no significant 
effects of BRJ intake on 10-km TT cycling performance [210]. It was concluded that 
the physiological and performance responses of BRJ consumption are likely reduced 
in trained athletes possibly due to previous attainment of CV and metabolic 
adaptions, similar to those induced by BRJ. In contrast, Cermak et al. [107] 
demonstrated greater performance following BRJ consumption in trained cyclists. 
The fundamental difference between the two studies was the duration of the intake 
protocol with Cermak et al. [107] analysing the effects of BRJ over a consumption 
period of six days in comparison to a single bolus implemented by Wilkerson et al 
[210]. Certainly for elite performers, this indicates that a duration-dependent 
relationship exists with the magnitude of effects correlating to the duration of 
consumption prior to exercise.  
Intake of NZBC has been proven to increase eNOS production, leading to greater 
concentration of NO in skeletal muscle. Training status has a significant impact with 
trained athletes exhibiting higher levels of eNOS compared to their untrained 
counterparts [211]. Similar to BRJ, the influence of NZBC intake is likely going to be 
reduced in more elite athletes due to previously acquired physiological adaptions not 
present in recreational performers. The selection of recreational participants in this 
study was due to the fact that the CV responses to NZBC are similar to those seen 
following BRJ under NH and likely to be more pronounced in these individuals. This 
would not only affect the responses of HR but also the rate of change in StO2 
especially towards the end of the TT where pace increased. Mean differences in 
StO2 values per km were not analysed in the current study and the absence of elite 
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athletes made a comparison between individuals of different athletic levels 
impossible.  
In the current study, overall mean StO2 remained unchanged between conditions, 
matching the findings of Muggeridge et al. [157] and Macleod et al. [156] following 
BRJ intake, whose studies involved a single bolus of BRJ prior to exercise. This 
suggests that in the current study, alternative underlying performance mechanisms 
were present but not identified. These results do not replicate those of Masschelein 
et al. [158] who found significantly higher SpO2 values at rest following BRJ intake. 
Interestingly, the effects of BRJ on TT performance under simulated altitude are 
mixed. Macleod et al. [156] found no difference in TT cycling performance in both 
normoxia and hypoxia, matching the findings of this research. However, Muggeridge 
et al. [157] found enhanced TT performance of 2.2% following acute NZBC intake, 
matching similar improvements on cycling performance seen by Lansley et al. for 
acute BRJ intake [106] and Cook et al [118] for chronic NZBC under normoxia.  
Although no differences were found in any resting CV parameter between conditions, 
previous research has found that increasing anthocyanin intake is associated with 
reductions in mean arterial stiffness and blood pressure [200]. These changes are 
especially prominent in blackcurrant consumption with Delphinidin intake associated 
with a reduction in the risk of CV and metabolic diseases [88], via a combination of 
improvements in glucose tolerance and eNOS activity [90,91]. Chronic intake of 
NZBC could prove effective for the sedentary population to use for the improvement 
of physical health [93]. Further research should focus on the longitudinal effects of 
NZBC on physical health markers with a dose-response protocol used to determine 
the ideal dose that individuals within clinical populations should use. 
No significant differences found between any variables from a statistical sense and 
numerical differences between variables were miniscule. Mean time to complete the 
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10-km TT was slower by 5.3 seconds following NZBC and this was indicated by a 
minor difference in mean PO values per km throughout the TT. Athletes participating 
in medium duration TT exercise disciplines might look to improve their personal best 
or previous performance by 2-3%. With no improvements seen following NZBC, a 
single bolus of 900 mg NZBC appears unsuitable for improving performance under 
simulated altitude, in an environment where oxygen intake is heavily reduced in 
comparison to conditions at sea level. As it appears that [La] removal is greater 
following PLA, it appears NZBC intake has no beneficial effects for athletes 
undertaking multi-day exercise events or training sessions under hypoxia over 
several consecutive days. The metabolic adaptions following exposure to hypoxia 
and how NZBC intake might effect these in a manner that causes no beneficial 
effects on performance in an environment with greater oxidation stress for the same 
exercise intensity.  
For d, effect sizes, values were deemed small at 0.2, medium at 0.5 and large at 0.8. 
The effect size for TT performance as 0.05 indicating a very small effect of NZBC 
when compared to PLA. The largest effect sizes of 0.35 and 0.37 was found for 
resting SBP and DBP, indicated by differences of 3% and 4.5% respectively. This 
indicates that acute NZBC intake had a small to moderate effect on these variables, 
indicating a possible link to improvement of CV health markers at rest. Although 
there was no significant differences between groups on the condition x time 
interaction between supplement groups, a significant main effect for [La] following 
exercise at respective time points was present with values significantly lower with 
PLA at 10 min post-exercise.  
In this study, the placebo group acted as the control with participants being given 
capsules containing no active ingredients. This replicates previous research 
involving a specified dose of NZBC and a PLA [101,115,118,119,121,124,125] and 
an analysis of the resulting effects on endurance exercise performance following 
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chronic intake. This was the first study to include a single bolus of NZBC on a TT 
exercise protocol and having a PLA would have helped to conclude if NZBC was 
having a true effect on performance. Time and PO values per km from the 
familiarisation trial were similar to values in the PLA trial when both were included in 
the data analysis. This demonstrates that there were likely no improvements in 
exercise  that were present from a psychological perspective as a result of the PLA 
effect. 
PRACTICAL APPLICATIONS 
Because mean TT completion times, mid-exercise PO, mid-exercise and peak HR 
values and RPE values per km were unchanged following NZBC intake, it may not 
be a preferred ergogenic aid for recreational athletes to use prior to endurance 
exercise at altitude. [La] removal following exercise was greatest following PLA, 
suggesting the absence of physiological pathways that aid in preventing and 
lowering oxidative stress. Additionally further research is required to determine 
whether the underlying mechanisms responsible for the production of eNOS and CV 
responses to NZBC are influenced by a reduction in FiO2. and whether these 
responses are significantly greater following higher intakes of NZBC or differ 
depending on athletic status.  
LIMITATIONS 
Prior to the start of exercise and throughout the duration of the participants time on 
the study, diet was not directly controlled, possibly leading to aspects of performance 
being affected by alternative ingredients or nutrients than those present in NZBC. 
The use of capsules as opposed to fluid are likely to have delayed some 
physiological responses to the supplement, evidenced by the absence of changes in 
HR, RPE and PO between NZBC and PLA.  
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During the TT, consistency of StO2 readings between participants was variable. The 
consumption of supplements in capsule form bypasses potentially degrading 
properties of saliva in the oral cavity, and the breakdown of anthocyanins into the 
bloodstream is delayed [191]. In an ideal scenario, blood samples would be taken 
from a skeletal muscle in either the arm or leg to measure the concentration of 
anthocyanins in the bloodstream prior to exercise. This would be done over multiple 
time points to determine a suitable value that has to be reached prior to when 
exercise can take place.  
Although participants underwent welfare checks for injuries or any barriers that might 
have prevented them from undertaking exercise, participants were not asked 
whether they were taking any other ergogenic aids prior to testing. If ingestion of any 
form of performance enhancing supplement was taken for an extended period of 
time prior to the study, the effects present as a result of NZBC intake could have 
been overshadowed by the effects directly from these other ergogenic aids. This is 
especially important with regards to supplements that affect performance more under 
hypoxia in comparison to normoxia the need to buffer oxidative stress is greater. 
One of the stipulations prior to exercise was to refrain from consuming alcohol within 
12 hours of testing. This presented potential issues with regards to the time of 
sessions on a scheduled day. Under these circumstances, participants with an 
afternoon or evening session would have been aloud to consume alcohol late into 
the previous evening, thus increasing the risk of exercise performance being 
impaired due to presence of alcohol in the blood and surrounding issues with 
cardiovascular or muscular function. As alcohol intake is likely already affecting 
oxygen carrying capacity in normoxia, the effects seen under hypoxia would likely 
have been amplified, leading to oxidative stress increasing further and performance 
intensity having to reduce. Next time, a time boundary of 24 hours will be 
implemented to reduce the risk of these events.  
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Prior to the study, a power analysis was conducted to determine the number of 
participants required to get a significance value of less than 0.05. With only 14 
participants, the study was massively underpowered, leading to no statistically 
significant differences found in any variable and the true effects of NZBC unknown. 
In this study, male and female participants were involved and included altogether in 
one sample group. The absence of a comparison group analysing differences 
between sexes could have lead to noticeable differences in certain physiological 
variables going unnoticed.  
There is evidence to suggest that the menstrual cycle might affect performance 
negatively. One of the stipulations implemented in this study was that sessions for 
each individual had to be separated over a minimum period of 48 hours. Over the 
course of this study, participants appeared for testing sessions over a period of 2-3 
weeks. Because of this, it is likely female participants were in the middle of the 
menstrual cycle for at least one if not multiple sessions, which may have reduced 
their performance capacity depending on the phase they were in. The physiological 
processes involved in the menstrual cycle would have reduced oxygen carrying 
capacity significantly when compared to male participants.  
Because it is more likely that male physiology was more likely to remain consistent 
over the specified study period in comparison to females, the percentage difference 
in performance caused directly by the menstrual cycle should be factored into the 
equation when looking at performance differences between sexes. To ensure this, 
additional methods of measuring StO2 are needed and values should be collected 
more often to ensure female participants still have the physiological capabilities to 
exercise to the best of their abilities. Future analysis should involve a sex based 
comparison to fully determine if any particular trends or patterns in performance can 
be identified based on sex. 
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CONCLUSION 
In conclusion, this study expands on the research surrounding the use of NZBC on 
endurance performance under simulated altitude. No significant differences in any 
physiological variables (StO2, HR, PO) and psychological variables (RPE) during 
exercise contributed to 10-km TT performance remaining unchanged between 
conditions. This may provide important information to recreational athletes with 
regards to the effectiveness of ergogenic aids prior to and following exercise under 
simulated altitude, the time taken for identifiable effects on performance to be seen 
and the form of supplements that should be taken.  
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5.0 OVERALL SUMMARY & RECOMMENDATIONS 
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5.1 THESIS SUMMARY 
Athletes use ergogenic aids to improve their physiological and psychological 
preparation prior to exercise, increase efficiency during exercise and reduce 
recovery time following exercise [27]. NZBC is an ergogenic aid that has been shown 
to improve endurance performance through anthocyanin induced vasodilation and 
vasorelaxation [76], via the release of NO via phosphorylation of eNOS [71]. The 
primary body of research suggests that intake of NZBC is most effective following 
intake over a period of 7 days at a dose between 300 mg and 600 mg. However the 
optimal dosing strategy of NZBC and subsequent performance has not been defined 
and dosing in studies is determined based on manufacturers guidelines. No data is 
currently available analysing the effects of a single bolus of NZBC on TT cycling 
performance. An important aspect of identifying the true effects of an ergogenic aid 
is to explore effects in exercise disciplines and intake protocols with minimal or no 
previous coverage. These findings can then be used to identify whether the 
magnitude of changes seen post-intake matches those in previous research.  
Therefore the aim of this thesis was to identify the influence and potential 
implications of acute NZBC intake on 10-km TT cycling performance. Physiological 
and psychological parameters measured during exercise including PO, VO2, HR, 
RER and RPE and physiological recovery post exercise via [La] were measured 
based on the methods used from existing human and exercise research. These were 
used to conduct two novel studies analysing the effects of NZBC following intake of 
three different doses as well as performance under simulated altitude in recreational 
athletes. Thus, this thesis expands greatly on the knowledge provided to researchers 
and athletes regarding the implementation of NZBC. 
Section 3 presents a novel study that sought to examine the acute effects of NZBC 
intake on 10-km TT cycling performance and physiological parameters in 
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recreationally active individuals. This study also examined the influence of dose 
modification of NZBC on variables including HR, PO, VO2 and [La] by comparing a 
dose of 300 mg with a dose of 600 mg and a third dose of 900 mg. In study 1, we 
hypothesised that acute intake of NZBC would induce physiological changes, leading 
to enhanced TT cycling performance. Additionally, we stated that a dose-response 
adaption would occur following NZBC intake with the magnitude of these effects 
significantly greater following 900 mg in comparison to 300 and 600 mg NZBC.  
We failed to support that hypothesis but did show a strong trend towards a significant 
improvement in TT performance following 900 mg of NZBC at an overall difference 
of 2.45% faster when compared to 600 mg and 300 mg NZBC. Additionally, Peak 
PO was significantly higher when compared to 600 mg of NZBC and had a strong 
trend towards a significance difference when compared to 300 mg NZBC. Following 
an 8 minute recovery period, no significant difference was found in rate of [La] 
removal following 900 mg of NZBC. There was a significant main effect of NZBC on 
time point following exercise with [La] values lower at 8 min post-exercise compared 
to 2 min post-exercise in all three dose conditions. However this is an indication that 
greater intake of NZBC has no influence on physiological recovery following exercise 
compared with smaller doses.  
Interestingly, no changes in any CV parameters were found between any time point 
at rest and following exercise, suggesting that responses of the CV system to NZBC 
may be time-dependent rather than dose-dependent. In this study, the relationship 
between ingested dose of NZBC and all of the aforementioned parameters was 
curvilinear, with mean values indicating reduced performance following 600 mg 
NZBC. The absence of a plasma anthocyanin check immediately prior to exercise 
accompanied with pre-exercise preparatory stipulations that lacked strong 
conviction, likely contributed to the absence of effects on exercise as a result of 
NZBC intake and resulted in lowered performance as a result.  
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This does not support the findings of studies from Cook et al. [122,128] both of which 
included the same doses of NZBC as used in the present study. However the intake 
protocols differed from the current study with participants taking NZBC over a 7 day 
period in the aforementioned studies while the present research involved a single 
bolus of NZBC, 60 mins prior to exercise. Factors including the activity status of 
participants in the sample, dietary control and supplement use prior to NZBC intake 
and gender might have influenced the results of this study by having a more 
profound effect on performance than the effects seen by NZBC. Between group 
comparisons should be studied in future research to determine where the magnitude 
of these effects is greatest to ensure the ideal intake and experimental protocols can 
be implemented.  
Section 4 presents a follow up novel study that employed the 10-km TT cycling 
protocol, measures of endurance performance and intake of NZBC at a dose of 900 
mg. This study included a bout of exercise under simulated altitude, to determine the 
magnitude of effects seen in conditions eliciting a reduction in FiO2. Exercising under 
NH or HH is commonly used by athletes to induce hormonal changes in the body 
leading to CV and metabolic adaptions that significantly enhance performance at sea 
level. In study 2, we hypothesised that acute intake of NZBC would induce 
physiological changes, leading to enhanced TT cycling performance under NH and 
that the changes would be significantly greater in comparison to a PLA.  
The main finding of this study was that no significant, acute changes were found 
between conditions for TT cycling performance. Difference in values for mean PO 
and RPE during the TT, resting values of SBP, DBP, & HR and post-exercise values 
for [La] were negligible between conditions, matching the findings of Willems et al. 
[154]. A significant main effect was found for [La] values with values significantly 
lower at 10 min post exercise compared to 2.5 min following PLA. This might indicate 
that acute NZBC intake directly prior to exposure of participants to hypoxia provides 
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no impact against post-exercise muscle damage or a buffering of waste products 
under simulated altitude. Therefore we failed to support the research hypothesis for 
this study. However, as intake of 600 mg of NZBC took place over a seven day 
period in Willems et al. [154], it is impossible to determine if the responses seen in 
the current study occurred due to the same underlying physiological mechanisms.  
In similar studies involving a single bolus of BRJ, Macleod et al. [156] found no 
differences in TT cycling performance whereas the difference of 2.2% found by 
Muggeridge et al. [157] matches similar values in studies by Lansley et al. for acute 
BRJ intake [106] and Cook et al. for chronic NZBC intake [118]. Therefore the 
physiological adaptions that occur are likely influenced by the form that BRJ and 
NZBC supplements are taken and the duration of time that they are taken prior to 
performance. Faiss et al. [152] concluded that training status of individuals in a study 
sample is likely going to be a major factor in the physiological responses to 
simulated altitude. Whether NZBC intake amplifies or reduces these adaptions in 
different training population groups is something that requires careful consideration 
in future studies. 
5.2 PRACTICAL APPLICATIONS 
Sport and exercise scientists and nutritionists should look to the following guidelines 
to identify recommendations for athletes preparing for and undertaking short duration 
race-based endurance exercise: 
1. Improvements in TT cycling performance and post-exercise recovery might 
be expected following acute intake of 900 mg NZBC. It is important to note 
that this is based on a sample size of 8 recreationally active individuals and 
changes were not linear depending on dose with a lower magnitude of 
difference seen with 300 mg compared to 600 mg NZBC 
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2. When conducting TT based cycling exercise, a dose-response comparison 
study over both short- and long-term intake protocols will likely be required to 
observe the timeline of physiological events following consumption of NZBC 
3. Acute intake of NZBC appears insufficient for enhancement of TT cycling 
performance and post-exercise physiological recovery under short-term 
exposure to normobaric hypoxia. Recreationally active participants were used 
as the study sample, suggesting there might possibly be a difference 
depending on athletic status.  
4. Acute intake of NZBC has no effects on various CV parameters including HR 
and blood pressure at rest on healthy individuals 
In both studies forming the basis of this thesis, a selection of recreationally active 
individuals were selected to participate, limiting the ability to suggest whether the 
magnitude of the effects of NZBC are different in elite athletes. We were unable to 
meet the required number of participants, thus reducing the ability to determine the 
true effects of NZBC and finding a difference of statistical significance. Prior to 
suggesting concrete guidelines, further research is warranted to conclude the 
presence and magnitude of the effects of NZBC in individuals from all specified 
athletic populations. Studies should include different exercise modalities performed 
for different durations to determine whether physiological adaptions are better suited 
to a particular form of exercise and whether this form of performance improves up to 
a particular time point.   
5.3 RECOMMENDATIONS FOR FUTURE RESEARCH 
The findings presented in this thesis will develop further understanding on the 
influence of NZBC on locomotor-based endurance exercise performance and 
physiological recovery post-exercise. This research puts forward multiple questions 
 126 
that are yet to be answered regarding how NZBC intake can prepare athletes for 
race-based cycling performance. The following areas require further research: 
1. The influence of 900 mg NZBC on medium duration TT cycling performance 
times and post-exercise recovery markers are not truly understood. Linear 
improvements in TT performance and endurance markers between the three 
different dose groups were non-existent with lower performance values 
following 600 mg as opposed to 300 mg. The sample size was also too small 
to indicate whether performance was truly affected by NZBC. Further 
knowledge is required to establish whether these effects are different in a 
study including a chronic, dose-response intake protocol, performance bouts 
> 1 hour in duration and with a sample size matching the calculated power 
requirements of the study.  
2. In physically active individuals, NZBC intake induces cardiometabolic 
changes with the biggest variations seen in resting HR, SBP, DBP, post-
exercise DBP in study 1 and [La] values following exercise in study 2. These 
values were not statistically significant matching the findings of Cook et al. 
[128], Willems et al. [102] and Cook et al [122]. Further research should be 
designed to address whether elite athletes, undertaking chronic endurance 
exercise training, experience the same physiological changes prior to and 
following short-term TT cycling performance. 
3. The underlying physiological adaptions that occur following NZBC intake 
under normal conditions are absent during exercise under simulated altitude 
at moderate hypoxia (FiO2 15%). Therefore more work is needed to 
determine whether this remains the same under severe hypoxia or with a 
chronic, dose-response supplementation prior to the same exercise protocol. 
4. In recreationally active individuals, NZBC appears to have no acute, dose-
response effects on any CV parameters including HR, CO and TPR. Future 
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research with larger study sample sizes and a combination of invasive and 
non-invasive CV measurements will help to determine the magnitude of 
stimulation following NZBC intake at rest and during exercise. A comparison 
between sexes should be measured to determine whether CV adaptions vary 
due to physiological differences between males and females following intake. 
Health status may influence the physiological response to supplements that 
induce changes in CV function. Research should be carried out to address 
whether NZBC intake in individuals with health conditions including 
hypertension or coronary heart disease, has a positive effect on resting CV 
health and whether the magnitude of this interaction occurs in a dose-
response manner. 
LIMITATIONS 
Despite some evidence of physiological recovery following NZBC intake, the 
absence of post-exercise performance measurements in both studies following TT 
cycling performance makes it impossible to truly analyse the effects of NZBC intake 
on the rate of performance recovery. During the TT, readings of CV markers, VO2, 
StO2 and [La] varied heavily between participants, despite equipment calibration. 
The Portapres Model 2 monitoring system has limited data regarding coefficient of 
variation. This study used capsules to provide the supplement and the absence of 
fluid-based NZBC made it impossible to compare how the effects of the ergogenic 
aid might have differed depending on the form that it was taken.  
In both studies, the quantity of NZBC consumed by participants was the only 
indicator of anthocyanin intake in participants. Prior to exercise, no biochemical tests 
were carried out to determine the physiological presence of anthocyanins. Invasive 
measurements such as a blood assay were ideally required to determine whether 
plasma levels of anthocyanin were at a level indicative of changes in CV function. 
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This would also be carried out following exercise to determine if physiological 
recovery markers including [La] were influenced by the amount of NZBC 
anthocyanins remaining in plasma. 
CONCLUSION 
Acute NZBC intake has no statistically significant dose-response effects on medium 
duration TT cycling performance although a strong trend towards significance was 
present following 900 mg of NZBC in comparison to doses of 300 mg and 600 mg. A 
900 mg dose of NZBC had no influence on any physiological variable and pacing 
during a TT cycle under NH, suggesting a reduction in FiO2 presents underlying 
physiological effects not affected by NZBC intake. Despite expanding on the existing 
knowledge regarding intake of NZBC on medium duration TT cycling performance, 
further research is required to determine if these findings would be replicated if a 
chronic, dose-response intake protocol of NZBC is implemented for exercise under 
both normoxic and hypoxic conditions. 
 
 
 
 
 
 
 
 
 
 129 
6.0 REFERENCES 
1. Corbin CB. Concepts in Physical Education, With Laboratories and Experiments. 1981, 
4th ed. W.C. Brown Co. Dubuque Iowa 
 
2.       Joyner MJ & Coyle EF. Endurance Exercise Performance: The Physiology of 
Champions. Journal of Physiology; 2008. 586 (1): 35-44 
 
3.       Foster C, Green MA, Snyder AC & Thompson NN. Physiological Responses During 
Simulated Competition. Medicine and Science in Sport & Exercise; 1993. 25 (7): 877-
882 
 
4.       Stepto NK, Hawley JA, Dennis SC & Hopkins WG. Effects of Different Interval-Training 
Programs on Cycling Time Trial Performance. Medicine and Science in Sport and 
Exercise; 1999. 31 (5): 726-741 
 
5. Giada F, Bertaglia E, De Piccoli B, Franceschi M & Raviele A et al. Cardiovascular 
Adaptions to Training and Detraining in Young and Older Athletes. International 
Journal of Cardiology; 1998. 65 (2): 149-155 
 
6. Mediano FFF, Leifer ES, Cooper LS, Keteyian SJ, Kraus WE & Mentz RJ et al. 
Influence of Baseline Physical Activity Level on Exercise Training Response and 
Clinical Outcomes in Heart Failure: The HF-ACTION Trial. Journal of the American 
College of Cardiology: Heart Failure; 2018. 6 (12): 1011-1019 
 
7. Gabler M, Prieske O, Hortobagyi T & Granacher U. The Effects of Concurrent Strength 
and Endurance Training on Physical Fitness & Athletic Performance in Youth: A 
Systematic Review and Meta-Analysis. Frontiers in Physiology; 2018. 9: 1057-1067 
 
8. Petroczi A, Naughton DP, Pearce G, Bailey R, Bloodworth A & McNamee M. 
Nutritional Supplement Use by Elite Young UK Athletes: Fallacies of Advice Regarding 
Efficacy. Journal of the International Society of Sports Nutrition; 2008. 5: 22-29 
 
9. Fraczek B, Warzecha M, Tyrala F & Pieta A. Prevalence of the Use of Effective 
Ergogenic Aids Among Professional Athletes. Roczniki Panstwowego Zakladu Higieny; 
2016. 67 (3): 271-278 
 
10. Maughan RJ, Burke LM, Dvorak J, Larson-Meyer DE, Peeling P & Phillips SM. IOC 
Consensus Statement: Dietary Supplements and the High-Performance Athlete. British 
Journal of Sports Medicine; 2018. 52 (7): 439-455 
 
 130 
11. Yamamoto J, Harada T, Okada A, Maemura Y, Yamamoto M & Tabira K. Difference in 
Physiological Components of VO2 Max During Incremental and Constant Exercise 
Protocols for the Cardiopulmonary Exercise Test. Journal of Physical Therapy Science; 
2014. 26 (8): 1283-1286 
 
12. Bassett DR & Howley ET. Limiting Factors for Maximal Oxygen Uptake and 
Determinants of Endurance Performance. Medicine and Science in Sport and 
Exercise; 2000. 32 (1): 70-84 
 
13. American College of Sports Medicine. ACSM’s guidelines for exercise testing and 
prescription. 6. Philadelphia, PA: Lippincott Williams & Wilkins; 2000 
 
14. Boutellier U & Spengler CM. VO2max as a Measure of Endurance Performance? 
Schweizerische Zeitschrift fur Sportmedizin und Sporttraumatologie; 1999. 47 (3): 118-
122 
 
15. Tanaka K, Matsuura Y, Kumagai S, Matsuzaka A, Hirakoba K & Asano K. 
Relationships of Anaerobic Threshold and Onset of Blood Lactate Accumulation With 
Endurance Performance. European Journal of Applied Physiology & Occupational 
Physiology; 1983. 52 (1): 51-56 
 
16. Sjodin B & Jacobs I. Onset of Blood Lactate Accumulation and Marathon Running 
Performance. International Journal of Sports Medicine; 1981. 2 (1): 23-26 
 
17. Amann M, Subudhi AW & Foster C. Predictive Validity of Ventilatory and Lactate 
Thresholds for Cycling Time Trial Performance. Scandinavian Journal of Medicine & 
Science in Sports; 2006. 16 (1): 27-34 
 
18. Tanaka H, Monahan KD & Seals DR. Age-Predicted Maximal Heart Rate Revisited. 
Journal of American College of Cardiology; 2001. 37 (1): 153-156 
 
19. Etxegarai U, Insunza A, Larruskain J, Santos-Concejero J, Gil SM & Portillo et al. 
Prediction of Performance by Heart-Rate Derived Parameters in Recreational Runners. 
Journal of Sports Sciences; 2018. 36 (5): 1-9 
 
20. Storen O, Ulevag K, Larsen MH, Stoa EM & Helgerud J. Physiological Determinants of 
the Cycling Time Trial. Journal of Strength and Conditioning Research; 2013. 27 (9): 
2366-2373 
 
 131 
21. Borszcz FK, Tramontin AF, de Souza KM, Carminatti LJ & Costa VP. Physiological 
Correlations with Short, Medium and Long Cycling Performance. Research Quarterly 
for Exercise and Sport; 2018. 89 (1): 120-125 
 
22. Sietsema KE, Cooper DM, Perloff JK, Rosove MH, Child JS & Canobbio MM. 
Dynamics of Oxygen Uptake During Exercise in Adults With Cyanotic Congenital Heart 
Disease. Circulation; 1986. 73 (6): 1137-1144 
 
23. Taylor AT. High-Altitude Illnesses: Physiology, Risk Factors, Prevention, & Treatment. 
Rambam Maimonides Medical Journal; 2011. 2 (1): 22-35 
 
24. Jobson SA, Nevill AM, Palmer GS, Jeukendrup AE, Doherty M & Atkinson G. The 
Ecological Validity of Laboratory Cycling: Does Body Size Explain the Difference 
Between Laboratory- and Field-Based Cycling Performance. Journal of Sport 
Sciences; 2007. 25 (1): 3-9 
 
25. Williams HG. Ergogenic and Ergolytic Substances. Medicine and Science in Sport and 
Exercise; 1992. 24 (9): 344-348 
 
26. Leutholtz B, Kreider R. In: Nutritional Health. Wilson T, Temple N, editor. Totowa, NJ: 
Humana Press; 2001. Exercise and Sport Nutrition; pp. 207–39 
 
27. Kerksick CM, Wilborn CD, Roberts MD, Smith-Ryan A, Kleiner SM & Jager R et al. 
Taylor L. ISSN Exercise & Sport Nutrition Review Update: Research & 
Recommendations. Journal of the International Society of Sport Nutrition; 2018. 15 (1): 
38-95 
 
28. Kay CD. Aspects of Anthocyanin Absorption, Metabolism and Pharmacokinetics in 
Humans. Nutrition Research Reviews; 2006. 19 (1): 137-146 
 
29. Petroczi A & Naughton DP. Supplement Use in Sport: Is There a Potentially 
Dangerous Incongruence Between Rationale and Practise? Journal of Occupational 
Medicine and Toxicology; 2007. 2 (4): 4-17 
 
30. Knapik JJ, Steelman RA, Hoedebecke SS, Austin KG, Farina EK & Lieberman HR. 
Prevelance of Dietary Supplement Use by Athletes: Systematic Review and Meta-
Analysis. Sports Medicine; 2016. 46 (1): 103-123 
 
31. Petroczi A & Naughton DP. The Age-Gender-Status Profile of High Performing 
Athletes in the UK Taking Nutritional Supplements: Lessons for the Future. Journal of 
the International Society of Sports Nutrition; 2008. 5 (2): 1-8 
 132 
 
32. Zdesar Kotnik K, Jurak G, Starc G & Golja P. Faster, Stronger, Healthier: Adolescent-
Stated Reasons for Dietary Supplementation. Journal of Nutrition Education and 
Behaviour; 2017. 49 (10): 817-826 
 
33. Bailey SJ, Fulford J, Vanhatalo A, Winyard PG, Blackwell JR & DiMenna FJ et al. 
Dietary Nitrate Supplementation Enhances Muscle Contractile Efficiency During Knee-
Extensor Exercise in Humans. Journal of Applied Physiology; 2010. 109 (1): 135-148 
 
34. Rawson ES & Persky AM. Mechanisms of Muscular Adaptions to Creatine 
Supplementation. International SportMed Journal; 2007. 8 (2): 43-53 
 
35. Maughan RJ. Contamination of Dietary Supplements and Positive Drug Tests in Sport. 
Journal of Sport Sciences; 2005. 23 (9): 883-889 
 
36.  Tscholl P, Alonso JM, Dolle G, Junge A & Dvorak J. The Use of Drugs and Nutritional 
Supplements in Top Level Track and Field Athletes. American Journal of Sports 
Medicine; 2010. 38 (1): 133-140 
 
37. Hurst P, Kavussanu M, Boardley I & Ring C. Sport Supplement Use Predicts Doping 
Attitudes and Likelihood via Sport Supplement Beliefs. Journal of Sport Sciences; 
2019. : 1-7 
 
38. Zimmerman MB. Vitamin and Mineral Supplementation and Exercise Performance. 
Schweizerische Zeitschrift fur Sportmedizin und Sporttraumatologie; 2003. 51 (1): 53-
57 
 
39. Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R & Collins R et al. 
International Society of Sports Nutrition Position Stand: Safety and Efficacy of Creatine 
Supplementation in Exercise, Sport and Medicine. Journal of the International Society 
of Sports Nutrition; 2017. 14 (1): 1-18 
 
40. Harty PS, Zabriskie HA, Erickson JL, Molling PE, Kerksick CM & Jagim AR. Multi-
Ingredient Pre-Workout Supplements, Safety Implications, and Performance 
Outcomes: A Brief Review. Journal of the International Society of Sports Nutrition; 
2018. 15 (1): 41-68  
 
41. Williams MH. Dietary Supplements and Sports Performance: Introduction and 
Vitamins. International Journal of the International Society of Sports Nutrition; 2004. 1 
(2): 1-6  
 
 133 
42. Halliwell B. How to Characterize a Biological Antioxidant. Free Radical Research 
Communications; 1990. 9 (1): 1-32 
 
43. Naderi A, Rezaei S, Moussa A, Levers K & Earnest CP. Fruit for Sport. Trends in Food 
Science & Technology; 2018. 74: 85-98 
 
44. Manach C, Scalbert A, Morand C et al. Polyphenols: Food Sources and Availability. 
American Journal of Clinical Nutrition; 2004. 79 (5): 727-747 
 
45. Rodriguez-Mateos A, Feliciano RP, Boeres A, Weber T, dos Santos CN & Ventura MR 
et al. Cranberry (Poly)phenol Metabolites Correlate With Improvements in Vascular 
Function: A Double-Blind, Randomised, Controlled, Dose Response, Crossover Study. 
Molecular Nutrition & Food Research; 2006. 60 (10): 2130-2140 
 
46. Marx W, Kelly J, Marshall S, Nakos S, Campbell K & Itsiopoulos C. The Effect of 
Polyphenol-Rich Interventions on Cardiovascular Risk Factors in Haemodialysis: A 
Systematic Review and Meta-Analysis. Nutrients; 2017. 9 (12): 1345 
 
47. Somerville V, Bringans C & Braakhuis A. Polyphenols and Performance: A Systematic 
Review and Meta-Analysis. Sports Medicine; 2017. 47 (8): 1589-1599 
 
48. Venables MC, Hulston CJ, Cox HR & Jeukendrup AE. Green Tea Extract Ingestion, 
Fat Oxidation, and Glucose Tolerance in Healthy Humans. American Journal of Clinical 
Nutrition; 2008. 87 (3): 778-784 
 
49. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM & Lines 
TC. A Critical Review of the Data Related to the Safety of Quercetin and Lack of 
Evidence of in Vivo Toxicity, Including Lack of Genotoxic/Carcinogenic Properties. 
Food and Chemical Toxicology; 2007. 45 (11): 2179-2205 
 
50. Khan F, Ray S, Craigie AM, Kennedy G, Hill A & Barton KL. Lowering of Oxidative 
Stress Improves Endothelial Function in Healthy Subjects with Habitually Low Intake of 
Fruit and Vegetables: A Randomised Controlled Trial of Antioxidant- and Polyphenol-
Rich Blackcurrant Juice. Free Radical Biology and Medicine; 2014. 72: 232-237 
 
51. Bowtell J and Kelly V. Fruit-Derived Polyphenol Supplementation for Athlete Recovery 
and Performance. Sports Medicine; 2019. 49 (1): 3-23 
 
52. Cases J, Romain C, Marin-Pagan C, Chung LH, Rubio-Perez JM & Laurent C et al. 
Supplementation with a Polyphenol-Rich Extract, PerfLoad (R) Improves Physical 
Performance During High-Intensity Exercise. Nutrients; 2017. 9 (4): 421 
 134 
 
53. Decroix L, Tonoli C, Soares DD, Descat A, Drittij-Reijnders MJ & Weseler AR et al. 
Acute Cocoa Flavanols Intake has Minimal Effects on Exercise-Induced Oxidative 
Stress and Nitric Oxide Production in Healthy Cyclists: A randomised Control Trial. 
Journal of the International Society of Sports Nutrition; 2017. 14 (1): 28 
 
54. Cook MD & Willems MET. Dietary Anthocyanins: A Review of the Exercise 
Performance Effects and Related Physiological Responses. International Journal of 
Sports Nutrition & Exercise Metabolism; 2018. 1-27 
 
55. Pandey KB & Rizvi SI. Plant Polyphenols as Dietary Antioxidants in Human Health and 
Disease. Oxidative Medicine and Cellular Longevity; 2009. 2 (5): 270-278 
 
56. Pisoschi AM & Pop A. The Role of Antioxidants in the Chemistry of Oxidative Stress. 
European Journal of Medicinal Chemistry; 2015. 97: 55-74 
 
57. Wallace TC & Giusti MM. Anthocyanins. Advances in Nutrition; 2015. 6 (5): 620-622 
 
58. Kahkonen MP, Heinamaki J, Ollilainen V & Heinonen M. Berry Anthocyanins: Isolation, 
Identification and Antioxidant Activities. Journal of the Science of Food and Agriculture; 
2003. 83 (14): 1403-1411 
 
59. Lyall KA, Hurst SM, Cooney J, Jensen D, Lo K & Hurst RD et al. Short-Term 
Blackcurrant Extract Consumption Modulates Exercise-Induced Oxidative Stress and 
Lipopolysaccharide-Stimulated Inflammatory Responses. American Journal of 
Physiology: Regulatory, Integrative and Comparative Physiology: 2009. 297 (1): 70-81 
 
60. McKenna MJ, Medved I, Goodman CA, Brown MJ, Bjorksten AR & Murphy KT et al. N-
acetylcysteine Attenuates the Decline in Muscle Na+,K+-Pump Activity and Delays 
Fatigue During Prolonged Exercise in Humans. Journal of Physiology; 2006. 576 (1): 
279-288 
 
61. Zhu Y, Ling W, Guo H, Song F, Ye Q & Zou T. Anti-Inflammatory Effect of Purified 
Dietary Anthocyanin in Adults with Hypercholesterolemia: A Randomised Controlled 
Trial. Nutrition, Metabolism and Cardiovascular Diseases; 2013. 23 (9): 843-849 
 
62. Qin Y, Xia M, Ma J, Hao Y, Liu J & Mou H. Anthocyanin Supplementation Improves 
Serum LDL- and HDL- Cholesterol Concentrations Associated With the Inhibition of 
Cholesteryl Ester Transfer Protein in Dyslipidemic Subjects. American Journal of 
Clinical Nutrition; 2009. 90 (3): 485-492 
 
 135 
63. Bowen-Forbes CS, Zhang Y & Nair MG. Anthocyanin Content, Antioxidant, Anti-
Inflammatory and Anticancer Properties of Blackberry and Raspberry Fruits. Journal of 
Food Composition and Analysis; 2010. 23 (6): 554-560  
 
64. Giordano L, Coletta W, Tamburrelli C, D’Imperio M, Crescente M & Silvestri C et al. 
Four-Week Ingestion of Blood Orange Juice Results in Measurable Anthocyanin 
Urinary Levels But Does Not Affect Cellular Markers Related to Cardiovascular Risk: A 
Randomised Cross-over Study in Healthy Volunteers. European Journal of Nutrition; 
2012. 51 (5): 541-548 
 
65. Zamora-Ros R, Knaze V, Lujan-Barroso L, Slimani N, Romieu I & Fedirko V et al. 
Estimated Dietary Intakes of Flavonols, Flavanones & Flavones in the European 
Perspective Investigation into Cancer and Nutrition (EPIC) 24 Hour Dietary Recall 
Cohort. British Journal of Nutrition; 2011. 106 (12): 1915-1925  
 
66. Pojer E, Mattivi F, Johnson D & Stockley CS. The Case for Anthocyanin Consumption 
to Promote Human Health: A Review. Comprehensive Reviews in Food Science and 
Food Safety; 2013. 12 (5): 483-508 
 
67. Bondonno CP, Croft KD, Ward N, Considine MJ & Hodgson JM. Dietary Flavanoids 
and Nitrate: Effects of Nitric Oxide and Vascular Function. Nutrition Reviews; 2015. 73 
(4): 216-235 
 
68. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB & Joyner-Grantham J. 
Vasodilator Factors in the Systemic and Local Adaptions to Pregnancy. Reproductive 
Biology & Endocrinology; 2009. 7: 79-98 
 
69. Rodriguez-Mateos A, Rendeiro C, Bergillos-Meca T, Tabatabaee S, George TW & 
Heiss C et al. Intake and Time Dependence of Blueberry Flavanoid-Induced 
Improvements in Vascular Function: A Randomised, Controlled, Double Blind, 
Crossover Intervention Study With Mechanistic Insights into Biological Activity. 
American Journal of Clinical Nutrition; 2013. 98 (5): 1179-1191 
 
70. Pignatelli P, Lenti L, Sanguigni V, Frati G, Simeoni I & Gazzaniga PP et al. Carnitine 
Inhibits Arachidonic Acid Turnover, Platelet Function, and Oxidative Stress. American 
Journal of Physiology. Heart and Circulatory Physiology; 2003. 284 (1): 41-48 
 
71. Edirisinghe I, Banaszewski K, Cappozzo J, McCarthy D & Burton-Freeman BM. Effect 
of Black Currant Anthocyanins on the Activation of Endothelial Nitric Oxide Synthase 
 136 
(eNOS) in Vitro in Human Endothelial Cells. Journal of Agriculture and Food 
Chemistry; 2011. 59 (16): 8616-8624  
 
72. Cimino F, Speciale A, Anwar S, Canali R, Ricciardi E & Virgili F. Anthocyanins Protect 
Human Endothelial Cells From Mild Hyperoxia Damage Through Modulation of Nrf2 
Pathway. Genes and Nutrition; 2013. 8 (4): 391-399 
 
73. Qiang M. Role of Nrf2 in Oxidative Stress and Toxicity. Annual Review of 
Pharmacology & Toxicology; 2013. 53: 401-426  
 
74. Thomas DD, Liu X, Kantrow SP & Lancaster JR. The Biological Lifetime of Nitric 
Oxide: Implications for the Perivascular Dynamics of NO and O2. Proceedings of the 
National Academy of Sciences of the United States of America; 2001. 98 (1): 355-360 
 
75. Matsumoto H, Takenami E, Iwasaki-Kurashige K, Osada T, Katsumura T & Hamaoka 
T. Effects of Blackcurrant Anthocyanin Intake on Peripheral Muscle Circulation During 
Typing Work in Humans. European Journal of Applied Physiology; 2005. 94 (1): 36-45 
 
76. Ziberna L, Kim JH, Auger C, Passamonti S & Schini-Kerth V. Role of Endothelial Cell 
Membrane Transport in Red Wine Polyphenols-Induced Coronary Vasorelaxation: 
Involvement of Bilitranslocase. Food & Function; 2013. 4 (10): 1452-1456 
 
77. Braakhuis AJ. Effect of Vitamin C Supplements on Physical Performance. Current 
Sport’s Medicine Reports; 2012. 11 (4): 180-184 
 
78. Simon-Schnass I & Pabst H. Influence of Vitamin E on Physical Performance. 
International Journal of Vitamin and Nutrition Research; 1988. 58 (1): 49-54 
 
79. Watson AW, Haskell-Ramsay CF, Kennedy DO, Cooney JM, Trower T & Scheepens 
A. Acute Supplementation with Blackcurrant Extracts Modulates Cognitive Functioning 
and Inhibits Monoamine-Oxidase B in Healthy Young Adults. Journal of Functional 
Foods; 2015. 17: 524-539 
 
80. Gepshtein S, Xiaoyan L, Snider J, Plank M, Lee D & Poizner H. Dopamine Function 
and the Efficiency of Human Movement. Journal of Cognitive Neuroscience; 2014. 26 
(3): 645-657 
 
81. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE & Prior RL. 
Concentrations of Anthocyanins in Common Foods in the United States and Estimation 
of Normal Consumption. Journal of Agriculture and Food Chemistry; 2006. 54 (11): 
4069-4075 
 137 
 
82. Koeppen BH & Herrmann K. Flavonoid Glycosides and Hydroxycinnamic Acid Esters 
of Blackcurrants (Ribes Nigrum). Phenolics of Fruit. Zeitschrift fur Lebensmittel-
Untersuchung und Forschung; 1977. 164 (4): 263-268  
 
83. Kapasakalidis PG, Rastall RA & Gordon MH. Extraction of Polyphenols from 
Processed Black Currant (Ribes Nigrum L.) Residues. Journal of Agriculture and Food 
Chemistry; 2006. 54 (11): 4016-4021 
 
84. Esposito D, Damsud T, Wilson M, Grace MH, Strauch R & Li X et al. Black Currant 
Anthocyanins Attenuate Weight Gain and Improve Glucose Metabolism in Diet-Induced 
Obese Mice with Intact, But Not Disrupted, Gut Microbiome. Journal of Agricultural and 
Food Chemistry; 2015. 63 (27): 6172-6180 
 
85. De Ferrars RM, Czank C, Zhang Q, Botting NP, Kroon PA & Cassidy A et al. The 
Pharmacokinetics of Anthocyanins and Their Metabolites in Humans. British Journal of 
Pharmacology; 2014. 171 (13): 3268-3282 
 
86. Matsumoto H, Inaba H, Kishi M, Tominaga S, Hirayama M & Tsuda T. Orally 
Administered Delphinidin 3-Rutinoside and Cyanidin 3-Rutinoside Are Directly 
Absorbed in Rats and Humans and Appear in the Blood as the Intact Forms. Journal of 
Agriculture and Food Chemistry; 2001. 49 (3): 1546-1551 
 
87. Rothwell JA, Perez-Jimenez J, Neveu V, Medina-Remon A, M’Hiri N & Garcia-Lobato 
P et al. Phenol-Explorer 3.0: A Major Update of the Phenol-Explorer Database to 
Incorporate Data on the Effects of Food Processing on Polyphenol Content. Database 
(Oxford); 2013. 1-8 
 
88. Stull AJ, Cash KC, Johnson WD, Champagne CM & Cefalu WT. Bioactives in 
Blueberries Improve Insulin Sensitivity in Obese, Insulin-Resistant Men and Women. 
Journal of Nutrition; 2010. 140 (10): 1758-1764 
 
89. Wright OR, Netzel GA & Sakzewski AR. A Randomised, Double-Blind, Placebo-
Controlled Trial of the Effect of Dried Purple Carrot on Body Mass, Lipids, Blood 
Pressure, Body Composition, and Inflammatory Markers in Overweight and Obese 
Adults: The QUENCH Trial. Canadian Journal of Physiology and Pharmacology; 2013. 
91 (6): 480-488 
 
90. Tani T, Nishikawa S, Kato M & Tsuda T. Delphinidin 3-Rutinoside-Rich Blackcurrant 
Extract Ameliorates Glucose Tolerance by Increasing the Release of Glucagon-Like 
Peptide-1 Secretion. Food, Science & Nutrition; 2017. 5 (4): 929-933 
 138 
 
91. Xu J-W, Ikeda K & Yamori Y. Upregulation of Endothelial Nitric Oxide Synthase by 
Cyanidin-3-Glucoside, A Typical Anthocyanin Pigment. Hypertension; 2004. 44 (2): 
217-222 
 
92. Wright DC & Swan PD. Optimal Exercise Intensity for Individuals with Impaired 
Glucose Tolerance. Diabetes Spectrum; 2001. 14 (2): 93-97 
 
93. Forstermann U & Munzel T. Endothelial Nitric Oxide Synthase in Vascular Disease: 
From Marvel to Menace. Circulation; 2006. 113 (13): 1708-1714 
 
94. Schrage B, Stevenson D, Wells RW, Lyall K, Holmes S & DaWei D et al. Evaluating 
the Health Benefits of Fruits for Physical Fitness: A Research Platform. Journal of 
Berry Research; 2010. 1 (1): 35-44  
 
95. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE & Prior RL. Lipophilic and 
Hydrophilic Capacities of Common Foods in the United States. Journal of Agriculture 
and Food Chemistry; 2004. 52 (12): 4026-4037 
 
96. Cao G, Alessio HM & Cutlet RG. Oxygen-Radical Absorbance Capacity Assay for 
Antioxidants. Free Radical Biology and Medicine. 1993. 14 (3): 303-311 
 
97. Ikuta K, Mizuta K & Suzutani T. Anti-Influenza Virus Activity of Two Extracts of the 
Blackcurrant (Ribes Nigrum L.) From New Zealand and Poland. Fukushima Journal of 
Medical Science; 2013. 59 (1): 35-38 
 
98. Weidner TG. Literature Review: Upper Respiratory Illness and Sport and Exercise. 
International Journal of Sports Medicine; 1994. 15 (1): 1-9 
 
99. Zheng J, Yang B, Ruusunen V, Laaksonen O, Tahvonen R & Hellsten J et al. 
Composition Differences of Phenolic Compounds Between Black Currant (Ribes 
Nigrum L.) Cultivars and Their Response to Latitude and Weather Conditions. Journal 
of Agricultural and Food Chemistry; 2012. 60 (26): 6581-6593 
 
100. Woznicki TL, Heide OM, Sonsteby A, Wold AB & Remberg SF. Yield and Fruit Quality 
of Black Currant (Ribes Nigrum) are Favoured by Precipitation and Cool Summer 
Conditions. Acta Agriculturae Scandinavica, Section B – Soil & Plant Science. 65 (8): 
702-712 
 
101. Willems MET, Parktin N, Widjaja W & Ajjimaporn A. Effect of New Zealand 
Blackcurrant Extract on Physiological Responses at Rest and During Brisk Walking in 
 139 
Southeast Asian Men: A Randomised, Double-Blind, Placebo-Controlled, Crossover 
Study. Nutrients; 2018. 10 (11): 1732-1742 
 
102. Willems MET, Myers SD, Gault ML & Cook MD. Beneficial Physiological Effects With 
Blackcurrant Intake in Endurance Athletes. International Journal of Sports Nutrition & 
Exercise Metabolism; 2015. 25 (4): 367-374 
 
103. Bonilla Ocampo DA, Paipilla AF, Marin E, Vargas-Molina S, Petro JL & Perez-Idarraga 
A. Dietary Nitrate from Beetroot Juice for Hypertension: A Systematic Review. 
Biomolecules; 2018. 8 (4): 134-146 
104. Jones AM. Dietary Nitrate Supplementation and Exercise Performance. Sports 
Medicine; 2014. 44 (1): 35-45  
105. Kroll JL, Werchan CA, Rosenfield D & Ritz T. Acute Ingestion of Beetroot Juice 
Increases Exhaled Nitric Oxide in Healthy Individuals. PLoS One; 2018. 13 (1): 
e0191030   
 
106. Lansley KE, Winyard PG, Bailey SJ, Vanhatalo A, Wilkerson DP & Blackwell JR et al. 
Acute Dietary Nitrate Supplementation Improves Cycling Time Trial Performance. 
Medicine and Science in Sport and Exercise; 2011, 43 (6): 1125-1131  
 
107. Cermak NM, Gibala MJ & Van Loon LJ. Nitrate Supplementation’s Improvement of 10-
km Time-Trial Performance in Trained Cyclists. International Journal of Sports Nutrition 
and Exercise Metabolism; 2012. 22 (1): 64-71 
 
108. Larsen FJ, Schiffer TA, Borniquel S, Sahlin K, Ekblom B & Lundberg JO et al. Dietary 
Inorganic Nitrate Improves Mitochondrial Efficiency in Humans. Cell Metabolism; 2011. 
13 (2): 149-159 
 
109. Clerc P, Rigoulet M, Leverve X & Fontaine E. Nitric Oxide Increases Oxidative 
Phosphorylation Efficiency. Journal of Bioenergetics and Biomembranes; 2007. 39 (2): 
158-166 
 
110. Wootton-Beard PC, Moran A & Ryan L. Stability of the Total Antioxidant Capacity and 
Total Polyphenol Content of 23 Commercially Available Vegetable Juices Before and 
After In Vitro Digestion Measured by FRAP, DPPH, ABTS and Folin-Ciocalteu 
Methods. Food Research International; 2011. 44 (1): 217-224 
 
 140 
111. Wootton-Beard PC & Ryan L. A Beetroot Juice Shot is a Significant and Convenient 
Source of Bioaccessible Antioxidants. Food Research International; 2011. 3 (4): 329-
334 
 
112. Hopkins WG, Hawley JA & Burke LM. Design and Analysis of Research on Sport 
Performance Enhancement. Medicine and Science in Sport and Exercise; 1999. 31 (3): 
472-485 
 
113. Currell K & Jeukendrup AE. Validity, Reliability and Sensitivity of Sporting 
Performance. Sports Medicine; 2008. 38 (4): 297-316 
 
114. Costa VP, Pertence LC, Paton CD, De Matos DG, Martins JAN & De Lima JRP. 
Physiological Correlations of 10-Km Up-Hill Cycling Performance in Competitive 
Cyclists. Journal of Exercise Physiology Online; 2011. 14 (3): 26-32 
 
115. Willems MET, Myers SD, Blacker SD & Cook MD. CurraNZ Blackcurrant Improves 
Cycling Performance and Recovery in Trained Endurance Athletes. Journal of the 
International Society of Sports Nutrition; 2014. 11 (1): P14 
 
116. Kellmann M, Bertollo M, Bosquet L, Brink M, Coutt AJ & Duffield R et al. Recovery and 
Performance in Sport: Consensus Statement. International Journal of Sports 
Physiology and Performance; 2018. 13 (2): 240-245 
 
117. Thorpe RT, Strudwick AJ, Buchheit M, Atkinson G, Drust B & Gregson W. The 
Influence of Changes in Acute Training Load on Daily Sensitivity of Morning-Measured 
Fatigue Variables in Elite Soccer Players. International Journal of Sports Physiology 
and Performance; 2017. 12 (2): 107-113 
 
118. Cook MD, Myers SD, Blackers SD & Willems MET. New Zealand Blackcurrant Extract 
Improves Cycling Performance and Fat Oxidation in Cyclists. European Journal of 
Applied Physiology; 2015. 115 (11): 2357-2365 
 
119. Strauss JA, Willems MET & Shepherd SO. New Zealand Blackcurrant Extract 
Enhances Fat Oxidation During Prolonged Cycling in Endurance-Trained Females. 
European Journal of Applied Physiology; 2018. 118 (6): 1265-1272 
 
120. Murphy CA, Cook MD & Willems MET. Effect of New Zealand Blackcurrant Extract on 
Repeated Cycling Time Trial Performance. Sports; 5 (2): 25-30 
 
 141 
121. Perkins IC, Vine SA, Blacker SD & Willems MET. New Zealand Blackcurrant Extract 
Improved High-Intensity Intermittent Running. International Journal of Sport Nutrition 
and Exercise Metabolism; 2015. 25 (5): 487-493 
 
122. Cook MD, Myers SD, Gault ML, Edwards VC & Willems MET. Dose Effects of New 
Zealand Blackcurrant on Substrate Oxidation and Physiological Responses During 
Prolonged Cycling. European Journal of Applied Physiology; 2017. 117 (6): 1207-1216 
 
123. Godwin C, Cook MD & Willems MET. Effect of New Zealand Blackcurrant Extract on 
Performance During the Running Based Anaerobic Sprint Test in Trained Youth and 
Recreationally Active Male Football Players. Sports (Basel); 2017. 5 (3): 69 
 
124. Willems MET, Cousins L, Williams D & Blacker SD. Beneficial Effects of New Zealand 
Blackcurrant Extract on Maximal Sprint Speed During the Loughborough Intermittent 
Shuttle Test. Sports; 2016. 4 (3): 42-51 
 
125. Skarpanska-Stejnborn A, Basta P & Pilaczynska-Szczesniak L. The Influence of 
Supplementation with Blackcurrant (Ribes Nigrum) Extract on Selected Prooxidative-
Antioxidative Balance Parameters in Rowers. Studies in Physical Culture and Tourism; 
2006. 13 (2): 51-58 
 
126. Lyall KA, Hurst SM, Cooney J, Jensen D, Lo K & Hurst RD et al. Short-Term 
Blackcurrant Extract Consumption Modulates Exercise-Induced Oxidative Stress and 
Lipopolysaccharide-Stimulated Inflammatory Responses. American Journal of 
Physiology: Regulatory, Integrative and Comparative Physiology: 2009. 297 (1): 70-81 
 
127. Braakhuis AJ, Hopkins WG & Lowe TE. Effects of Dietary Antioxidants on Training and 
Performance in Female Runners. European Journal of Sport Science; 2014. 14 (2): 
160-168 
 
128. Cook MD, Myers SD, Gault ML, Edwards VS & Willems MET. Cardiovascular Function 
During Supine Rest in Endurance-Trained Males with New Zealand Blackcurrant: A 
Dose-Response Study. European Journal of Applied Physiology; 2017. 117 (2): 247-
254 
 
129. Potter JA, Hodgson CI, Broadhurst M, Howell L, Gilbert J & Willems et al. Effects of 
New Zealand Blackcurrant Extract on Sport Climbing Performance. European College 
of Sport Science; 2020. 120 (1): 67-75 
 
 142 
130. Cook MD, Myers SD, Gault ML & Willems MET. Blackcurrant Alters Physiological 
Responses and Femoral Artery Diameter During Sustained Isometric Contraction. 
Nutrients; 2017. 9 (6): 556 
 
131. Hutchison AT, Flieller EB, Dillon KJ & Leverett BD. Black Currant Nectar Reduces 
Muscle Damage and Inflammation Following a Bout of High-Intensity Eccentric 
Contractions. Journal of Nutritional Supplements; 2019. 13 (1): 1-15 
 
132. Hurst SM, Hurst RD, Lyall KA, Roberts JM, Perthaner A & Wells RW et al. 
Consumption of an Anthocyanin Rich Extract Made From New Zealand Blackcurrants 
May Assist Recovery From Oxidative Stress and Maintains Circulating Neutrophil 
Function: A Pilot Study. Frontiers in Nutrition; 2019. 6: 73 
 
133.  Burt DG & Twist C. The Effects of Exercise-Induced Muscle Damage on Cycling Time-
Trial Performance. Journal of Strength and Conditioning Research; 2011. 25 (8): 2185-
2192 
 
134. Samuel J & Franklin C. Hypoxemia and Hypoxia. In: Myers JA, Millikan KW & 
Saclarides TJ (eds.) Common Surgical Procedures. Springer, New York: 2008. P.391-
394 
 
135. Savourey G, Launay JC, Besnard Y, Guinet A & Travers S. Normo- and Hypobaric 
Hypoxia: Are There any Physiological Differences? European Journal of Applied 
Physiology; 2003. 89 (2): 122-126 
 
136. Magalhaes J, Ascensao A, Viscor G, Soares J, Oliveira J & Marques F et al. Oxidative 
Stress in Humans During and After 4 Hours of Hypoxia at a Simulated Altitude of 
5500m. Aviation, Space and Environmental Medicine; 2004. 75 (1): 16-22 
 
137. Pialoux V, Mounier R, Rock E, Mazur A, Schmitt L & Richalet JP et al. Effects of Acute 
Hypoxic Exposure on Prooxidant / Antioxidant Balance in Elite Endurance Athletes. 
International Journal of Sports Medicine; 2009. 30 (2): 87-93 
 
138. Duranteau J, Chandel NS, Kulisz A, Shao Z & Schumacker PT. Intracellular Signalling 
by Reactive Oxygen Species During Hypoxia in Cardiomyocytes. Journal of Biological 
Chemistry; 1998. 273 (19): 11619-11624 
 
139. Mazzeo RS, Child A, Butterfield GE, Mawson JT, Zamudio S & Moore LG. 
Catecholamine Response During 12 Days of High-Altitude Exposure (4,300 m) in 
Women. Journal of Applied Physiology; 1998. 84 (4): 1151-1157 
 
 143 
140. Yuan G, Adhikary G, McCormick AA, Holcroft JJ, Kumar GK & Prabhakar NR. Role of 
Oxidative Stress in Intermittent Hypoxia-Induced Immediate Early Gene Activation in 
Rat PC12 Cells. Journal of Physiology; 2004. 557 (3): 773-783 
 
141. Erecinska M & Silva IA. Tissue Oxygen Tension and Brain Sensitivity to Hypoxia. 
Respiration Physiology; 2001. 128 (3): 263-276 
 
142. Wheaton WW & Chandel NS. Hypoxia. 2. Hypoxia Regulates Cellular Metabolism. 
American Journal of Physiology: Cell Physiology; 2011. 300 (3): 385-393 
 
143. Bickler PE, Feiner JR, Lipnick MS, Batchelder P, MacLeod DB & Severinghaus JW. 
Effects of Acute, Profound Hypoxia on Healthy Humans: Implications for Safety of 
Tests Evaluating Pulse Oximetry or Tissue Oximetry Performance. Anaesthesia and 
Analgesia; 2017. 124 (1): 146-153 
 
144. Cleuziou C, Perrey S, Lecoq AM, Candau R, Courteix D & Obert P. Oxygen Uptake 
Kinetics During Moderate and Heavy Intensity Exercise in Humans: The Influence of 
Hypoxia and Training Status. International Journal of Sports Medicine; 2005. 26 (5): 
356-362 
 
145. Barstow TJ & Mole PA. Linear and Nonlinear Characteristics of Oxygen Uptake 
Kinetics During Heavy Exercise. Journal of Applied Physiology; 1991. 71 (6): 2099-
2106 
 
146. Moller P, Loft S, Lundby C & Vidiendal Olsen N. Acute Hypoxia and Hypoxic Exercise 
Induce DNA Strand Breaks and Oxidative DNA Damage in Humans. FASEB Journal; 
2001. 15 (7): 1181-1186 
 
147. Deb SK, Brown DR, Gough LA, Mclellan CP, Swinton PA & Andy Sparks S et al. 
Quantifying the Effects of Acute Hypoxic Exposure on Exercise Performance and 
Capacity: A Systematic Review and Meta-Regression. European Journal of Sport 
Science; 2018. 18 (2): 243-256 
 
148. Ulrich S, Schneider SR & Block KE. Effects of Hypoxia and Hyperoxia on Exercise 
Performance in Healthy Individuals and in Patients with Pulmonary Hypertension: A 
Systematic Review. Journal of Applied Physiology; 2017. 123 (6): 1657-1670 
 
 144 
149. Coppel J, Hennis P, Gilbert-Kawai E & Grocott MPW. The Physiological Effects of 
Hypobaric Hypoxia versus Normobaric Hypoxia: A Systematic Review of Crossover 
Trials. Extreme Physiology & Medicine; 2015. 4 (2): 1-20  
 
150. Thirlwell C, Schulz L, Dibra HK & Beck S. Suffocating Cancer: Hypoxia-Associated 
Epimutations as Targets for Cancer Therapy. Clinical Epigenetics; 2011. 3 (1): 9 
 
151. Knaupp W, Khilnani S, Sherwood J, Scharf S & Steinberg H. Erythropoietin Response 
to Acute Normobaric Hypoxia in Humans. Journal of Applied Physiology; 1992. 73 (3): 
837-840 
 
152. Faiss R, Von Orelli C, Deriaz O & Millet GP. Responses to Exercise in Normobaric 
Hypoxia: Comparison of Elite and Recreational Mountaineers. International Journal of 
Sports Physiology and Performance; 2014. 9 (6): 978-984 
153. Benoit H, Busso T, Castells J, Geyssant A & Denis C. Decrease in Peak Heart Rate 
With Acute Hypoxia in Relation to Sea Level. European Journal of Applied Physiology; 
2003.  90 (5-6): 514-519 
 
154. Willems MET, Berendsen T, Sahin MA, Myers SD, Blacker SD & Cook MD. Effect of 
New Zealand Blackcurrant Extract on Substrate Oxidation and Cycling Performance in 
Normobaric Hypoxia. Medicine & Science in Sport and Exercise; 2018. 50: 720 
 
155. Teppema LJ & Dahan A. The Ventilatory Response to Hypoxia in Mammals: 
Mechanisms, Measurement and Analysis. Physiological Reviews; 2010. 90 (2): 675-
754 
 
156. Macleod KE, Nugent SF, Barr SI, Koehle MS, Sporer BC & MacInnis MJ. Acute 
Beetroot Juice Supplementation Does Not Improve Cycling Performance in Normoxia 
or Moderate Hypoxia. International Journal of Sport Nutrition & Exercise Metabolism; 
2015. 25 (4): 359-366 
 
157. Muggeridge DJ, Howe CC, Spendiff O, Pedlar C, James PE & Easton C. A Single 
Dose of Beetroot Juice Enhances Cycling Performance in Simulated Altitude. Medicine 
and Science in Sport and Exercise; 46 (1): 143-150 
 
158. Masschelein E, Van Thienen R, Wang X, Van Schepdael A, Thomas M & Hespel P. 
Dietary Nitrate Improves Muscle But Not Cerebral Oxygenation Status During Exercise 
in Hypoxia. Journal of Applied Physiology; 2012. 113 (5): 736-745 
 
 145 
159. Del Coso J, Munoz G & Munoz-Guerra J. Prevalence of Caffeine Use in Elite Athletes 
Following its Removal from the World Anti-Doping Agency List of Banned Substances. 
Applied Physiology, Nutrition & Metabolism; 2011. 36 (4): 555-561 
 
160. Smirmaul B, Moraes A, Angius L, Marcora S, Smirmaul BPC & de Moraes AC et al. 
Effects of Caffeine on Neuromuscular Fatigue and Performance During High-Intensity 
Cycling Exercise in Moderate Hypoxia. European Journal of Applied Physiology; 2017. 
117 (1): 27-38 
 
161. Mariacher C, Gatterer H, Greilberger J, Djukic R, Greilberger M & Philippe M et al. 
Effects of Antioxidant Supplementation on Exercise Performance in Acute Normobaric 
Hypoxia. International Journal of Sports, Nutrition and Exercise Metabolism; 2014. 24 
(2): 227-235 
 
162. Watson AW, Okello EJ, Brooker HJ, Lester S, McDougall GJ & Wesnes KA. The 
Impact of Blackcurrant Juice on Attention, Mood and Brain Wave Spectral Activity in 
Young, Healthy Volunteers. Nutritional NeuroScience; 2019. 22 (8): 596-606 
 
163. Seo Y, Gerhart H, Stavres J, Draper S & Glickman E. Cognitive Function During Post-
Exercise in Normobaric Hypoxia. Medicine and Science in Sport and Exercise; 2016. 
48 (1): 572 
 
164. Kammerer T, Faihs V, Hulde N, Bayer A, Hubner M & Brettner F et al. Changes of 
Hemodynamic and Cerebral Oxygenation After Exercise in Normobaric and Hypobaric 
Hypoxia: Associations with Acute Mountain Sickness. Annals of Occupational and 
Environmental Medicine; 2018. 30: 66 
165. Anwar S, Speciale A, Fratantonio D, Cristani M, Saija A & Virgili F et al. Cyanidin-3-O-
Glucoside Modulates Intracellular Redox Status and Prevents HIF-1 Stabilization in 
Endothelial Cells in vitro Exposed to Chronic Hypoxia. Toxicology Letters; 2014. 226 
(2): 206-213 
 
166. Morales-Alamo D, Guerra B, Santana A, Martin-Rincon M, Gelabert-Rebato M & 
Dorado C et al. Skeletal Muscle Pyruvate Dehydrogenase Phosphorylation and Lactate 
Accumulation During Sprint Exercise in Normoxia and Severe Acute Hypoxia: Effects 
of Antioxidants. Frontiers in Physiology; 2018. 9: 188 
 
167. Jeoung NH. Pyruvate Dehydrogenase Kinases: Therapuetic Targets for Cancer and 
Diabetes. Diabetes and Metabolism Journal; 2015. 39 (3): 188-197 
 
 146 
168. Akram M. Citric Acid Cycle and Role of its Intermediates in Metabolism. Cell 
Biochemistry and Biophysics; 2014. 68 (3): 475-478 
 
169. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE & Prior RL. Lipophilic and 
Hydrophilic Capacities of Common Foods in the United States. Journal of Agriculture 
and Food Chemistry; 2004. 52 (12): 4026-4037 
 
170. Moffett DB, El-Masri HA & Fowler BA. Chapter 6 – General Considerations of Dose-
Effect & Dose-Response Relationships. In: Nordberg GF, Fowler BA, Nordberg M & 
Friberg LT (eds.). Handbook on the Toxicology of Metals.  3rd edition. Massachusetts, 
USA: Elsevier Science;  2007. p.101-115  
 
171. Oja P. Dose Response Between Total Volume of Physical Activity and Health and 
Fitness. Medicine & Science in Sport & Exercise; 2001. 33 (6): S428-453 
 
172. Chang Y-K & Etnier JL. Exploring the Dose-Response Relationship Between 
Resistance Exercise Intensity & Cognitive Function. Journal of Sport & Exercise 
Psychology; 2009. 31: 640-656 
 
173. Lee IM & Skerrett PJ. Physical Activity & All-Cause Mortality: What is the Dose-
Response Relation? Medicine & Science in Sport and Exercise; 2001. 33 (6): S459-
471 
 
174. Butterfield G. Ergogenic Aids: Evaluating Sport Nutrition Products. International 
Journal of Sport Nutrition; 1996. 6 (2): 191-197 
 
175. Grosso G, Micek A, Godos J, Pajak A, Sciacca S & Glavano F et al. Dietary Flavonoid 
and Lignan Intake and Mortality in Prospective Cohort Studies: Systematic Analysis 
and Dose-Response Meta-Analysis. American Journal of Epidemiology; 2017. 185 
(12): 1304-1316 
 
176. Heinrich U, Moore CE, De Spirt S, Tronnier H & Stahl W. Green Tea Polyphenols 
Provide Photoprotection, Increase Microcirculation, and Modulate Skin Properties of 
Women. Journal of Nutrition; 2011. 141 (6): 1202-1208 
 
177. Panickar KS & Anderson RA. Effects of Polyphenols on Oxidative Stress and 
Mitochondrial Dysfunction in Neuronal Death and Brain Edema in Cerebral Ischemia. 
International Journal of Molecular Sciences; 2011. 12 (11): 8181-8207 
 
178. Achten J, Gleeson M & Jeukendrup AE. Determination of the Exercise Intensity That 
Elicits Maximal Fat Oxidation. Medicine & Science in Sport and Exercise; 2002. 34 (1): 
92-97 
 147 
 
179. Watt MJ, Heigenhauser GJF, Dyck DJ & Spiret LL. Intramuscular Triglycerol, Glycogen 
and Acetyl Group Metabolism During 4 H of Moderate Exercise in Man. Journal of 
Physiology; 2002. 541 (3): 969-978 
 
180. Hettinga FJ, De Koning JJ, Broersen FT, Van Geffen P & Foster C. Pacing Strategy 
and Occurrence of Fatigue in 4000-m Cycling Time Trials. Medicine & Science in Sport 
and Exercise; 2006. 38 (8): 1484-1491 
 
 
181. Chuckravanen D & Rajbhandari S. Management of Metabolic Resources for a 20-km 
Cycling Time Trial Using Different Types of Pacing. Journal of Human Sport and 
Exercise; 2015. 10 (1): 95-103  
 
182. Waldron M, Patterson SD & Jeffries O. Inter-Day Reliability of Finapres ® 
Cardiovascular Measurements During Rest and Exercise. Sports Medicine 
International Open; 2017. 2 (1): E9-E15 
 
183. Goodwin ML, Harris JE, Hernandez A & Gladden LB. Blood Lactate Measurements 
and Analysis During Exercise: A Guide for Clinicians. Journal of Diabetes Science and 
Technology; 2007. 1 (4): 558-569 
 
184. Davison RC, Coleman DA, Balmer J, Nunn M, Theakston S & Burrows M et al. 
Assessment of Blood Lactate: Practical Evaluation of the Biosen 5030 Lactate 
Analyser. Medicine & Science in Sport & Exercise; 2000. 32 (1): 243-247 
 
185. Manach C, Williamson G, Morand C, Scalbert A & Remesy C. Bioavailability and 
Bioefficacy of Polyphenols in Humans. I. Review of 97 Bioavailability Studies. 
American Journal of Clinical Nutrition; 2005. 81 (1): 230-242 
 
186. Shapiro SS & Wilk MB. An Analysis of Variance Test for Normality (Complete 
Samples). Biometrika; 1965. 52 (3-4): 591-611 
 
187. Razali NM & Wah YB. Power Comparisons of Shapiro-Wilk, Kolmogorov-Smirnov, 
Lilliefors & Anderson-Darling Tests. Journal of Statistical Modelling and Analytics; 
2011. 2 (1): 21-33 
 
188. Curran-Everett D & Benos DJ. Guidelines for Reporting Statistics in Journals Published 
by the American Physiological Society. Advances in Physiology and Education; 2004. 
28 (3): 85-87 
 
 148 
189. Kurilich AC, Clevidence BA, Britz SJ, Simon PW & Novotny JA. Plasma and Urine 
Responses are Lower for Acylated vs Nonacylated Anthocyanins From Raw and 
Cooked Purple Carrots. Journal of Agricultural and Food Chemistry; 2005. 53 (16): 
6537-6542 
 
190. Remmen JJ, Aengevaeren WR, Verheugt FW, van ver Werf T, Luijten HE & Bos A et 
al. Finapres Arterial Pulse Wave Analysis with Modelflow is not a Reliable Non-
Invasive Method for Assessment of Cardiac Output. Clinical Science; 2002. 103 (2): 
143-149 
 
191. Kamonpatana K, Giusti  MM, Chitchumroonchokchai C, MorenoCruz M, Riedl KM & 
Kumar P et al. Susceptibility of Anthocyanins  to Ex Vivo Degradation in Human Saliva. 
Food Chemistry; 2012. 135 (2): 738-747 
 
192. Conkin J & Wessel JH. Critique of the Equivalent Air Altitude Model. Aviation, Space & 
Environmental Medicine; 2008. 79 (10): 975-982 
 
193. Levine BD & Stray-Gundersen J. “Living High-Training Low: Effects of Moderate 
Altitude Acclimitization With Low-Altitude Training on Performance. Journal of Applied 
Physiology; 83 (1): 102-112  
 
194. Millet GP, Faiss R & Pialoux V. Point: Counterpoint: Hypobaric Hypoxia Induces/Does 
Not Induce Different Responses from Normobaric Hypoxia. Journal of Applied 
Physiology; 2012. 112 (10): 1783-1784 
 
195. Rusko HK, Tikkanen HO & Peltonen JE. Oxygen Manipulation as an Ergogenic Aid. 
Current Sports Medicine Reports; 2003. 2 (4): 233-238 
 
196. Loeppky JA, Roach RC, Maes D, Hinghofer-Szalkay H, Roessler A & Gates L et al. 
Role of Hypobaria in Fluid Balance Response to Hypoxia. High Altitude Medicine & 
Biology; 2005. 6 (1): 60-71 
 
197. Faiss R, Pialoux V, Sartori C, Faes C, Deriaz O, Millet GP. Ventilation, Oxidative 
Stress, and Nitric Oxide in Hypobaric Versus Normobaric Hypoxia. Medicine & Science 
in Sport and Exercise; 2013. 45 (2): 253-260 
 
198. Saito M, Mano T, Iwase S, Koga K, Abe H & Yamazaki Y. Responses in Muscle 
Sympathetic Activity to Acute Hypoxia in Humans. Journal of Applied Physiology; 
1988. 65 (4): 1548-1552 
 
 149 
199. Blitzer ML, Loh E, Roddy MA, Stamler JS & Creager MA. Endothelium-Derived Nitric 
Oxide Regulates Systemic and Pulmonary Vascular Resistance During Acute Hypoxia 
in Humans. Journal of the American College of Cardiology; 1996. 28 (3): 591-596 
 
200. Jennings A, Welsh AA, Fairweather-Tait SJ, Kay C, Minihane AM & Chowienczyk P et 
al. Higher Anthocyanin Intake is Associated with Lower Arterial Stiffness and Central 
Blood Pressure in Women. American Journal of Clinical Nutrition; 2012. 96 (4): 781-
788 
 
201. Hsu AR, Barnholt KE, Grundmann NK, Ln JH, McCallum SW & Friedlander AL. 
Sildenafil Improves Cardiac Output and Exercise Performance During Acute Hypoxia, 
But Not Normoxia. Journal of Applied Physiology; 2006. 100 (6): 2031-2040 
 
202. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K & Archer S. Oral Sildenafil 
is an Effective and Specific Pulmonary Vasodilator  in Patients with Pulmonary Arterial 
Hypertension: Comparison with Inhaled Nitric Oxide. Circuation; 2002. 105 (20): 2398-
2403 
 
203. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H & Weissmann N et 
al. Sildenafil for Treatment of Lung Fibrosis and Pulmonary Hypertension: A 
Randomised Controlled Trial. Lancet; 2002. 360 (9337): 895-900 
 
204. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A & Maripov A et al. 
Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension. Circulation; 2001. 104 
(4): 424-428 
 
205. Subudhi AW, Jacobs KA, Hagobian TA, Fattor JA, Muza SR & Fulco CS et al. 
Changes in Ventilatory Threshold at High Altitude: Effects of Antioxidants. Medicine & 
Science in Sport & Exercise; 2006. 38 (8): 1425-1431 
 
206. Subudhi AW, Jacobs KA, Hagobian TA, Fattor JA, Fulco CS & Muza SR et al. 
Antioxidant Supplementation Does Not Attenuate Oxidative Stress at High Altitude. 
Aviation, Space & Environmental Medicine; 2004. 75 (10): 881-888 
 
207. McGinley C, Shafat A & Donnelly AE. Does Antioxidant Vitamin Supplementation 
Protect Against Muscle Damage? Sports Medicine; 2009. 39 (12): 1011-1032 
 
208. Roach RC, Hackett PH, Oelz O, Bartsch P, Luks AM & MacInnis MJ et al. The 2018 
Lake Louise Acute Mountain Sickness Score. High Altitude Medicine & Biology; 2018. 
19 (1): 4-6 
 
 150 
209. Borg G. The Borg RPE Scale. In: Borg’s Perceived Exertion and Pain Scales. 
Champaign, Illinois, USA; 1998. p.29-39 
 
210. Wilkerson DP, Hayward GM, Bailey SJ, Vanhatalo A, Blackwell JR & Jones AM. 
Influence of Acute Dietary Supplementation on 50 Mile Time Trial Performance. In 
Well-Trained Cyclists. European Journal of Applied Physiology; 2012. 112 (12): 4127-
4134 
 
211. Green DJ, Maiorana A, O’Driscoll G & Taylor R. Effect of Exercise Training on 
Endothelium-Derived Nitric Oxide Function in Humans. Journal of Physiology; 2004. 
561 (1): 1-25 
 
 
 
 
 
 
 
 
 
 
 
